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ABSTRACT 
Biosynthetic studies on the non mevalonatepathway to terpenes 
D.J.Fowler B.Sc. (Hons) Dunelm, GRSC 
Isoprenoids are a class of secondary metabolites that are widely distributed in Nature. 
This thesis describes the synthesis and feeding of isotopically labelled enriched 
substrates to elucidate features of a new mevalonate independent pathway to 
isoprenoids. 
Chapter 2 describes studies with a whole plant system, Mentha citrata, which produces 
the monoterpene linalyl acetate, and a bacterium Escherichia coli which produces 
ubiquinone-8. Feeding experiments with stable isotopically enriched compounds 
demonstrate that the terpene unit of linalyl acetate is biosynthesised via the mevalonate 
independent pathway. Incorporation of deuterium from [6,6-^H2]-glucose, [^ HsJ-alanine 
and ['^ C^H3]-alanine into linalyl acetate show that the conversion to isopentenyl 
pyrophosphate does not proceed via a series of dehydrations. Feeding experiments with 
putative intermediates bearing deuterium into E. coli show that none of the 
intermediates are incorporated. This suggests that E. coli lacks a kinase to activate 
exogenously administered substrates fed as the free alcohols. 
Chapter 3 outlines biosynthesis studies on a meroterpene rosnecatone produced by the 
fungus R. necatrix. Intact incorporation of '^ C from the feeding of [l,2-'"'C2]-acetate 
shows that the terpenoid moiety is produced via the mevalonic acid pathway and the 
non-terpenoid unit is polyketide derived. Incorporation of deuterium from [6,6-^H2]-
glucose fully describes the pentaketide that delivers the non-terpenoid fragment. The 
effect on the metabolite production of changing the growth conditions of R. necatrix is 
investigated. Changing from a static culture to a submerged cultures causes an increased 
rate of growth, an upregulation of the production of cj^ochalasan E and a cessation of 
rosnecatone production. Screening of rosnecatone against two Human cancer cell lines 
shows IC50 values of 4.48|J,M and 5.78|a,M. 
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Chapter 1 
Introduction 
1 Introduction 
Of all the gifts Nature has to offer, none are as varied or colourful as the natural 
products that the hving planet produces. Man has used this diverse array of metabolites 
since the start of recorded history. Records found in Egyptian tombs show the use of 
camphor as a perflmie and the extraction of turpentine by distillation'. Ancient Britons 
used the plant pigment woad as war paint and even the Bible chronicles the use of 
myrrh as a gift to the Infant Christ^ . In recent times natural products have been found to 
be as much a blessing as a curse - whilst bioactive drugs such as clavulanic acid (1) 
have greatly reduced disease and suffering, substances such as cocaine (2) have caused 
as much pain as they were originally prescribed to relieve. 
CO2CH3 
O 
H CO2H 
1.1 Primary and Secondary metabolism 
Primary and secondary metabolism, and hence primary and secondary metaboUtes, are 
often generally described as different classes of natural products. Bu'lock^ describes 
primary metabolites in plants as "substances which could be detected in all plants" 
whereas secondary metabolites are "a variety of substances each of which could be 
obtained fi-om one particular plant species which could be assigned no general 
function". A more recent and complete definition is provided by Mann''; "secondary 
metabolism is metabolism that is not essential for the growth and reproduction of the 
organism" i.e. secondary metabolites have a secondary role in the survival of an 
organism. Secondary metabolites have also been described as species that are produced 
by an organism but have a specific receptor in a different organism. The enzymes 
required for primary metabolism are ubiquitous to ahnost all living organisms whereas 
the machinery for producing secondary metaboHtes (idolites) are often unique to one 
species of a genus. It is difficult to draw a clear distinction between primary and 
2 
secondary metabolites, except in the case of bacterial idolites which are described 
below. Idolites are commonly derived from one of a small number of key intermediates 
as shown in Figure 1-1. 
glucose 
0 
- O H 
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HO-
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Figure 1-1 Diagram showing the biogenesis of common intermediates and their fate 
1.1.1 Bacterial growth and secondary metabolism 
Figure 1-2 below shows the growth profile of a bacterial culture with the cell mass 
plotted against time. 
3^ 
Time 
Figure 1-2 Graph showing cell mass versus time for a bacterial culture 
Initially cell growth is slow and almost linear until such a point as the organism begins 
to rapidly proliferate. This is followed by a period of rapid growth that is described as 
the "log phase" as the cell growth is logarithmic. It is during this time that the organism 
utilises primary metabolic pathways. These deliver metabolites such as DNA/RNA, 
proteins, and lipids - metabolites which are essential to life and are made from the 
exogenous sources such as C O 2 , sugars and amino acids by processes such as glycolysis 
and the tricarboxylic acid cycle (TCA cycle). These primary metabohtes are used to 
manufacture cells and cell machinery. 
As the organism exhausts the supply of nutrients the growth is retarded to such a degree 
that the logarithmic growth rate is halted and replaced by a period where no further 
growth takes place. This is described as the organism entering the "stationary" phase. 
The stationary phase is the time when bacteria change the rate at which metabolic 
pathways are employed by upregulating secondary metabolism at the expense of 
primary metabolism. This is when secondary metabolite production is maximal. These 
secondary metabolites, delivered from pathways such as the mevalonic acid pathway, 
the shikimate pathway and fatty acid biosynthesis, are non-essential to growth as is 
evident from their late production, but are very important to survival. The late onset of 
secondary metabolism is essential as many idolites are fatal to developing cells and thus 
early production would result in severe growth retardation. 
Organisms that grow slower than bacteria have a less clear distinction between primary 
and secondary metabolic production phases. Plants are capable of producing metabolites 
4 
that are non-essential for growth long before growth has finished; an everyday example 
is the smell of garden flowers before they are fully-grown. In systems like these the 
biomechanical machinery of primary and secondary metabolism is inherently linked and 
thus the difference between primary and secondary metabolites is expressed in terms of 
molecular structure rather than biological uses. 
1.2 The function of secondary metabolites 
The role of secondary metabolites in biological systems has been a source of mystery 
and controversy. Although secondary metabolites, in particular plant secondary 
metabolites, have been found to have a variety of functions, the exact reason for their 
biosynthesis is unknown. The vast array of structures, and thus the number of dedicated 
enzymes needed to produce the myriad of compounds, naturally leads one to the 
conclusion that secondary metabolites do perform a valuable function. The precedent 
for the use of idolites such as azadirachtin (12) from the Neme plant and senecionone 
(13) fi-om ragwort {Senecio jacobaea) as antifeedants is well estabhshed deterring 
insects and marrunals respectively. 
COzMe 
O j / O H o. 
HO. ,^  
AcO' 
H MeA 
12 13 
Other idolites are known to possess valuable antibiotic activity and have been used by 
Man. The vast majority of idolites, however, appear to have no obvious purpose or 
reason for production. This has led to the rationalisation of idolite production in terms 
of their evolutionary significance. One hypothesis, proposed by Davies^, is that 
secondary metabolites, particularly antibiotics, were used as part of defence 
mechanisms in an RNA world, p Lactam antibiotics are known to target murein 
peptidoglycan which was present in the first cells, and thus it may appear that the first 
secondary metabolites were responsible for inter-bacterial chemical defence. This 
implies that azadirachtin and senecione are evolutionary supercedants which are more 
sophisticated owing to inter kingdom interaction. Davies' hypothesis has been rejected 
5 
by Cavalier-Smith^ because it fails to account for the initial origin of the required genes 
and because idolites such as the cytochalasins, which affect eukaryotes, appeared before 
the organisms that they adversely affect. Furthermore, as the genes coding for idolite 
production have been conserved over many miUions of years the notion that secondary 
metabolites were used as an evolutionary playground can be dismissed^. Over time 
genes that corresponded to secondary metabolites that give no advantage to the 
organism to the host would be lost with the result that very few secondary metabolites 
would be produced. 
1.3 Secondary metabolites 
1.3.1 Fatty acids andpolyketides 
Fatty acids are a class of compounds that have a common biosynthesis. Owing to their 
lipophilic nature, fatty acids are used by Nature in cell membranes as lipids and are 
employed in energy storage as fats. Both unsaturated and saturated chains are abundant 
in Nature and chain lengths of between eight and twenty carbon atoms are commonly 
encountered. One of the key features of fatty acid biosynthesis is that the chain is built 
up via a series of steps that occur on the surface of the fatty acid synthase that mediates 
chain building. Initially, acetyl-CoA (10) is activated to malonyl-CoA (11) which is 
then transferred onto the surface of an' acyl carrier protein (ACP) as the thioester. 
Subsequent decarboxylative condensation of acetyl-CoA with malonyl-ACP produces a 
P-keto species. Once bound to ACP the chain then proceeds to elongate by 
decarboxylative displacements of thiol ester bound pendant chains that are present on 
the ACP (step i). The P-keto ester is then reduced by enoyl-keto reductase to deliver the 
P-hydroxy acid via NADPH (step ii). The elimination of water by P-hydroxy 
dehydratase delivers the a,P-unsaturated ketone (step iii). The final step of the cycle is 
reduction of the olefmic bond by an enoyl reductase that produces, on the first iteration, 
butyryl-CoA. As the carbon chain is built up from acetate units, only even numbered 
fatty acids are found to occur in Nature. 
SCoA 
10 
SACP 
SCoA 
CoASH 
SACP 
O 
A SCoA 
O O 
HO'''^'^^^SACP 
OH O 
Scheme 1-1 A schematic representation of fatty acid biosynthesis 
After the first cycle, the saturated thioester can then react again with malonyl-CoA to 
repeat the process and increase chain length. 
Unsaturated fatty acids are produced using the same machinery as above. Nearly all 
double bonds produced via fatty acid biosynthesis are cis, which prevents efficient 
packing and affords cell wall rigidity. Fatty acids are also responsible for a high 
proportion of the rare fluorinated natural products, which are most probably derived 
from the use of fluoroacetate (14) as a starter unit^ 
o 
0 Dichapetalum 
O -
toxicarium 
14 15 
Scheme 1-2 Fluoro-oleic acid (15) from fluoroacetate (14) as a starter unit 
Polyketides are a class of secondary metabolites that are also produced via die 
condensation of successive malonyl-ACP units. As studies on the isolation and 
biosynthesis of some polyketide compounds are described later in this thesis, it is 
pertinent to only briefly outline some features of the polyketide pathway. Polyketides 
are formed from the condensation of acetyl-CoA (10) usually with malonyl-ACP (11) 
units in the same iterative manner as fatty acids (Scheme 1-1). The idea that polyketides 
could be built from the successive condensation of acetate units was formulated by 
CoUie^ although the development of the "polyketide hypothesis" was only fully realised 
by Birch"^ some fifty years later. Birch applied the rationale that polyketides were 
derived from the repeated condensation of acetate units to show that the proposed 
structure of eleutherinol (16) was incorrect as it could not be described in terms of head-
to-tail acetate linkages. The revised structure agreed with findings of degradative 
experiments. 
O O 
OH O 
0 0 0 
O OH 
Scheme 1-3 Birch's application of the acetate hypothesis to structure elucidation 
Polyketides are a structurally diverse class of idolites that are abundant in fungi, 
particularly fiingi imperfecti and are also feature heavily in bacterial secondary 
metabolism. The range of structures is increased by the use of units other than acetate. 
17 
Me Me-^,.. 
•"''"^CHO NMe2 
••.o"°^^l OH ^ 
18 
Figure 1-3 Disconnection demonstrating propionate build up of erthromycin A (17) and 
tylosin (18) 
Structures such as the bacterial polyketide erythromycin A (17) are derived uniquely 
from propionate units whereas structures such as the macrocylic component of tylosin 
(18) are formed from acetate, propionate and butyrate units. 
Bioactive polyketides are now known to include antibiotics (e.g. erthromycin A,17), 
carcinogens (aflatoxin B l , 19), nephrotoxins (patulin, 20) and antifungal agents 
(variotin, 21). 
0 OH 
OMe 
19 20 21 
1.3.2 Shikimate derived metabolites 
The shikimic acid pathway delivers aromatic amino acids to both the primary and 
secondary metabolic pathways and is important in higher plants and bacteria. The 
pathway delivers phenylalanine (22) and tyrosine (23), both of which are abundant in 
idolites, and tryptophane (24), which is used predominantly by primary metabolism. 
The pioneering work on the shikimate pathway was performed by Davies, some 70 
years after the first isolation of shikimic acid (8). The pathway is now Well understood 
and features the condensation of erthyrose-4-phosphate (5) with phosphoenol pyruvate 
(4) to produce shikimic acid (8). 
HQ. CO2 HO, CO2 HO, CO2 
^ ^ ^ " ^ ^ (P)6 OH (P)6) OH 
TPN —H (pp OH 
HO, CO2 
Scheme 1-4 Formation of shikimic acid (8) 
Shikimic acid (8) is then converted to chorismic acid (25) by the addition of 
phosphoenol pyruvate (4), which delivers the amino acids phenylalanine (22) and 
tyrosine (23) as shown in Scheme 1-5. 
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Scheme 1-5 Biosynthesis of phenylalanine (22) and tyrosine (23) from chorismic acid 
(25) 
1.3.3 Isoprenoids 
Isoprenoids are a broad class of idolites that include terpenoids, steroids and compounds 
containing prenyl chains such as carotenoids. It has recently been shown" that there are 
two biosynthetic pathways to isoprenoids and the elucidation of the new terpene 
biosynthesis is a major focus of this work. Isoprenoids are more fully described in 
section 1.5 
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1.4 Elucidation of a biosynthetic pathway 
Secondary metabolites are often grouped in terms of their biosynthetic origin. Despite 
the diverse array of secondary metabolites, almost all are derived from one of a small 
number of pathways with structural modifications performed later. Knowledge of a 
biosynthetic pathway can lead to new target compounds for drug discovery as specific 
inhibitors can be designed to knock out key enzymes. In order to understand fially a 
pathway, a number of techniques are available. 
1.4.1 Incorporation of isotopically labelled precursors 
It is often difficult to trace the biosynthesis or cataboHsm of a secondary metabolite. 
However, atoms or bonds can be followed, either by single or multiple labelhng with 
isotopes. Typically the organism is grown in the presence of an appropriately 
isotopically labelled precursor and the resultant metabolite is extracted and analysed by 
NMR or MS techniques. 
1.4.2 Radioisotopes 
The post war production of '''C and as nuclear by-products heralded a new age in 
biosynthetic elucidation by providing ready sources of [1-''*C] and [2-''*C]-acetate. 
Pioneering experiments by Calvin using ' '*C02 with photosynthetic algae showed 
incorporation of '"^ C into the carbonyl carbon of 3-phosphoglycerate (26) demonstrating 
that atmospheric C O 2 is fixed via ribulose-l,5-bisphosphate carboxylase (Scheme 1-6) 
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Scheme 1-6 Incorporation of '"C labelled C O 2 into 3-phosphoglycerate (26) 
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The Table below shows the properties of the most frequently used radioisotopes. 
Radioisotope Emission Half life Specific activity 
(mCi/mA) 
P 12.35 y 2.92 X 10'* 
P 5730 y 62.4 
32p P 87.5 d 1.50 X 10^  
33p 
P 25.5 d 5.32 X 10^ 
P 14.3 d 9.2 X 10^  
Table 1-1 Selected properties of common radioisotopes 12 
Tritium (^H) has been used to trace the biosynthetic course of hydrogen atoms. It has 
magnetic properties that are similar to that of ' H but it is not found in Nature. 
Nucleus Natural abundance /% Spin Relative 
Magnetogyric ratio 
'H 99.976 Vi 1.000 
0 Vi 1.067 
Table 1-2 Comparison of magnetic properties of ' H and 
The disadvantage of as a probe is its relatively high levels of radioactivity. 
Radioisotopes have other associated problems. Being sources of ionising radiation, 
radioisotopes require carefiil monitoring in order to minimise exposure. Furthermore, as 
it is often impossible to discern which of the atoms is bearing the label, each structural 
motif needs to be isolated and analysed separately via degradative techniques. These 
can be technically demanding and time consuming. 
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1.4.3 Stable isotopes 
Stable isotopes are the most widely used chemical technique employed in the 
elucidation of biosynthetic pathways. Many compounds are commercially available 
bearing at least one isotopically enriched atom, typically ^^ C or ^H. Both nuclei are 
magnetically observable. 
Nucleus Spin Natural Abundance/% 
1 0.016 
Vi 1.1 
Table 1-3 Magnefic properties of and '^C 
Deuterium, like tritium, is conventionally used as a probe to trace the fate of hydrogen 
atoms and is amenable to detection using NMR spectroscopy although the sensitivity is 
much lower than for ' H or ^ H . An attractive feature of deuterium labelling is that 
chemical shifts are comparable to proton chemical shifts of the same molecule, which 
alleviates the need for additional resonance assignments. As is a quadrapolar 
nucleus, deuterium signals are much broader than proton or triton resonances. 
Deuterium labelled acetate is commonly used to show that a metabolite is polyketide 
derived. The position of the deuterium label also shows the orientation of the growing 
chain'^ as in the case of altemariol (27). 
O' 
O 
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Scheme 1-7 Incorporation of [2-^H3]-acetate (28) into altemariol (27) 13 
Deuterium incorporation can also be assessed indirectly by '^C-NMR spectroscopy up 
to one carbon away from the site of enrichment. The heavier nucleus induces a subtle 
shift in electron density around the carbon nucleus compared to a C-H bond. This 
causes C-^H carbon resonances to come at higher field than the corresponding C-H 
14 
carbon resonances. This one bond shift is described as an a shift. A two bond p shift of 
0.06 ppm in a '^C-C-^H system is also observable. Similar shifts are found when using 
18 
O, but these are smaller in magnitude. 
Nucleus a-shift per atom /ppm P-shift per atom /ppm 
0.35 0.06 
18Q 0.03 0.001 
Table 1-4 a And p shifts caused by and '^0 
Oxygen-18 has been used to determine the fate of oxygen atoms along the biosynthetic 
pathway and is typically analysed via mass spectroscopy'"*. 
Carbon-13 was first fully realised as a potential tool m biosynthesis by Seto and co-
workers in 1970'^ thirteen years after the first natural abundance '•'C NMR spectrum 
had been obtained'^. '^C Enrichments are typically observed via the increase in peak 
heights in the '^C NMR spectrum. This allows the position of the label to be established 
and, by comparison with other signals in the spectrum, the level of enrichment can be 
calculated. The use of single labelled carbon precursors is generally limited to late 
intermediates on a pathway as early intermediates such as [1-'''C] and [2-'^C]-acetates 
result in low incorporations due to other metabolic processes that occur. The 
correspondingly small increase in '^C-peak height may be below the detectable 
threshold of'^C-NMR. 
The use of double-labelled substrates provides much greater sensitivity and can provide 
additional information. For example, [l,2-'^C2]-acetate is routinely used in "bond 
labelling" whereby the fate of carbon-carbon bonds is followed'^. I f the acetate unit is 
incorporated intact then adjacent '^C nuclei wil l couple to each other, resulting in a 
doublet about the natural abundance '^C peak in the '^C-NMR spectrum. I f the acetate 
unit is catabolised then no doublet will be observed. 
The use of multiply labelled '^C and acetates provides a powerfixl tool for detection 
of the carbon-deuterium bonds'^. A ' ^ C ( ' H } NMR spectrum shows the carbon 
resonance corresponding to '^C-^H as a multiplet whereas a ' ^ C { ' H , ^ H } NMR spectrum 
shows the same resonance as a singlet. Subtracting one spectrum from the other shows 
carbon nuclei with intact C-^H bonds. The a-shift in the ' ^ C { ' H , ^ H } NMR spectrum is 
also additive and hence shows the number of deuterium atoms present 
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1.4.4 Cell free extracts 
Cell free extracts allow the study of biosynthetic reactions by providing the biosynthetic 
machinery in an in vivo setting. Cell free work allows investigation into such features as 
co-factor requirements in enzyme chemistry. It has the advantage over the feeding of 
isotopically enriched compounds that substrates are "turned over" directly by the 
appropriate enzyme rather than requiring activation or metabolic conversion. This has 
proved to be a very usefiil method in the study of the new terpene pathway and is 
discussed later. 
1.4.5 Blocked mutants 
A biosynthetic scheme can be considered in terms of a series of consecutive steps, each 
of which is mediated by a unique enzyme. Disabling one of the enzymes in a mutant 
organism can result in the accumulation of the preceding metabolite such that it can be 
isolated and analysed. 
b c d e f 
A B ^ C D • E F 
b 
A • B 
Figure 1-4 Use of blocked mutants to effect metaboHte isolation 
7.5 Isoprenoids 
The term isoprenoids is used to describe terpenes, terpenoids (oxygen containing 
terpenes), steroids, sterols (steroids containing an alcohol functionahty), and 
carotenoids. The name "terpene" derives from the 14"^  century, and is a debasement of 
the Medieval Latin terbentina, from terebinthus, the free from which oil of turpentine 
was collected. Historically terpenes have fascinated Man and the mapping of their 
biosynthesis and properties reads as a "who's who" of eminent chemists and 
biochemists of the last century. 
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7.5.7 Terpene classification 
Terpenes are described according to the number of contiguous carbon atoms they 
possess. 
Number of carbon atoms Class 
10 monoterpenoids 
15 sesquiterpenoids 
20 diterpenoids 
25 sesterpemoid 
30 triterpenoids 
40 tetrapemoids 
>40 polyterpenoids 
Table 1-5 Classification of terpenoids according to carbon chain length 
Early studies observed that many terpenes known at the time could be described as 
being built up from two molecules of the C 5 isoprene unit. Isoprene (29) was known at 
the time to be a volatile emitted by plants. A retrosynthetic analysis of limonene using a 
Diels-Alder type reaction reveals two molecules of isoprene. Pyrolysis of monoterpenes 
supports this hypothesis yielding two molecules of isoprene (29). 
200°C 
30 29 30 
Scheme 1- 8 Disconnection and pyrolysis of limonene (30) to produce two molecules of 
isoprene (29) 
This approach was successfriUy applied to all terpenes that were known at the time as 
only simple monoterpenes had been isolated and characterised. In 1887, Wallach'^ 
formally proposed the "isoprene rule" which stated that all terpenoids could be 
described in terms of being assembled from a number of isoprene units linked together 
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in a head-to-tail fashion. Terpenoids that meet the isoprene rule are described as regular 
terpenoids. However, with the advent of greater analytical sophistication increasing 
numbers of irregular terpenoids were isolated, such as eremophilone (31)^°, that could 
not be rationahsed by the isoprene rule. 
O 
(31) 
Eremophilone caimot be discormected to give three molecules of isoprene although 
Robinson^° suggested that the structure could be rationalised by the following scheme 
(Scheme 1-9). 
The key step is the formation of a carbocation which promotes a transanuUar methyl 
shift. The resultant carbocation is then neutralised in an elimination reaction. 
(31) 
Scheme 1-9 The coimectivity of eremophilone (31) explained in terms of a 
rearrangment 
Such irregular terpenes led to the formulation of the "biogenic isoprene rule" by 
Ruzicka^'. This states that all terpenes can be described in terms of assembly from 
isoprene with structural modifications provided by simple transformations such as 
proton shifts. The biogenic isoprene rule has proved useful in the classification of 
terpenoids. Thus the irones, a class of C15 terpenoids produced by sword lily rhizomes 
18 
may appear to be sesquiterpenes by virtue of the number of carbons although they are 
22 
actually triterpenoids and are derived from the iridial group . 
O 
32 33 
Scheme 1-10 Conversion of iridial (32) to irone (33) 
The biogenic isoprene rule was correctly inspired and terpenoids are now known to 
derive biosynthetically from the condensation of C5 units. These have been identified as 
isopentenyl pyrophosphate (IPP, 34) and dimethylallyl pyrophosphate (DMAPP, 35) 
which are activated and less volatile forms of isoprene. The condensation of IPP and 
DMAPP is discussed below. 
1.5.2 Formation of terpenes: the interconversion of IPP (34) and DMAPP (35) 
0 (P) P ^ ^ ^0(P)(P 
34 35 
It is well established that DMAPP (35) is formed from IPP (34) by the action of IPP 
isomerase which stereoselectively removes the pro-R. hydrogen" in the isomerisation 
reaction. Concurrent with this is the addition of a proton from the medium to the other 
face of the double bond. As the reaction is stereospecific the methyl groups of DMAPP 
are non-equivalent. The new methyl group has E-geometry. 
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Figure 1-5 Stereochemistry of IPP isomerase^ "^  
Once DMAPP and IPP have been generated, they are then free to combine to form 
longer chain terpenoids. The nature of this condensation has been investigated in 
mammals, although the stereochemical details may differ for IPP and DMAPP 
generated by the new terpene pathway. The latter is described in Section 2.4. 
Comforth^" proposed that the condensation of IPP and DMAPP proceeds in a two step 
manner. The first is the addition of a nucleophilic species, X, across the olefmic bond 
which is followed by the elimination of X and the anti hydrogen atom. The new species, 
famesyl pyrophosphate can be used to deliver monoterpenes, or can react with a further 
molecule of IPP to produce geranyl pyrophosphate (GPP, 36). 
35 34 36 
Scheme 1-11 Proposed formation of GPP (36) from IPP (34) and DMAPP (35) 
The consecutive addition of IPP to GPP can continue indefinitely in an iterative manner 
to deliver the higher terpenoids from famesyl pyrophosphate (FPP, 37), geranylgeranyl 
pyrophosphate (GGPP, 38) and famesylfamesyl pyrophosphate (FFPP, 39). 
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Scheme 1-12 Illustration of how higher terpenes are built up 
Two polymers of the general formula (IPP)n are known - gutta percha (40) and rubber 
(41). The two differ in double bond geometry. Rubber possesses cis linkages and has 
free rotation about the methylene linkage that gives rubber its characteristic flexibility. 
Gutta percha (trans polyisoprene) has less rotation and is correspondingly hard and 
inflexible. It has been known in the West since the nineteenth century and found uses in 
electrical insulation, dentistry^^, and the preparation of the first golf balls. 
H Me 
Me H 
40 
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1.5.3 Monoterpenes 
Monoterpenes are amongst the most widely exploited class of natural products. Owing 
to their relatively low molecular weight, monoterpenes are fragrant and are used 
extensively in perfumes and as flavours in foodstuffs. Menthol (42) has been known for 
over 2000 years and thujone (43) is the hallucinogen found in the drink absynthe. 
Me 
42 43 
Despite their low molecular weight, monoterpenes display a remarkable structural 
diversity, which is accounted for by carbocationic rearrangements. Initially GPP 
isomerases to neryl pyrophosphate (NPP, 44) which can then deliver terpenoids such as 
citral (45) and linalool (46) directly or can eject pyrophosphate to initiate cyclisation via 
the menthane carbocation (47) 
Scheme 1-13 Conversion of GPP (36) to NPP (44), citral (45), linalool (46) and the 
methane carbocation (47) 
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The isomerisation to NPP occurs to bring the cyclising double bond closer to the 
leaving group. The product of the cyclisation, menthane (47), is highly versatile as is 
evident from the bicyclic products that contain between three and six membered rings. 
Monoterpenes such as limonene (30), thujone (43), camphor (48) and carene (49) are 
representative examples. 
30 43 48 49 
Scheme 1-14 Formation of monoterpenes from the menthane carbocation (47) 
1.5.4 Sesquiterpenes 
Sesquiterpenes are assembled by the extension of GPP by IPP (Scheme 1-12) and like 
monoterpenes, they are most abundant in higher plants. By analogy to monoterpene 
biosynthesis, cz5-FPP (37) is isomerised through nerolidyl pyrophosphate (50) to trans-
FPP (51). Both isomers undergo cychsation reactions to deliver a variety of skeletal 
structures. 
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Scheme 1-15 Formation of nerolidyl pyrophosphate (50) and trans FPP (51) from cis 
FPP (37) 
Sequiterpenes exhibit a range of structural diversity to match that of the monoterpenes 
owing to the four double bond centres that can participate in ring formation. 
Scheme 1-16 Formation of first generation sesquiterpene skeletons from FPP 
Sesquiterpenes are essential for the growth and maturation of insects, and plants have 
taken full advantage to construct effective defence mechanisms. The sesquiterpene 
juvabione (52) is a known inhibitor of insect maturity and is produced by the balsam fir 
free, Abies balsamea, in order to prevent insect development. The highly oxygenated 
plant terpenoid artemisinin (53) is a well-known antimalarial drug.^^ 
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1.5.5 Diterpenes 
Diterpenes are derived from the coupling of FPP with IPP to form GGPP (Scheme 1-17) 
and are found in higher plants, fungi, insects and marine organisms. Most are tricyclic 
compounds. 
Scheme 1-17 Formation of diterpene skeletons 
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Diterpenes are important as bioactive agents and three of the most widely studied 
terpenoids are diterpenoids, namely taxol® (54), gibberellic acid (55) and vitamin A 
(56). 
54 56 
Taxol (54) was first isolated from the bark of the Pacific Yew tree (Taxus brevifolia) 
and is highly effective in the treatment of cancer. As removal of the bark causes the tree 
to die, semisynthetic analogues are more viable clinical alternatives. 
GibbereUic acid (55) was the first gibberillin to be isolated and was purified from the 
broth of the fungus Gibberella fujikoroi. G. fujikoroi Is responsible for a disease that 
affects rice in Japan whereby the seedlings grow at a greatly accelerated rate but do not 
mature which renders the crop useless. Other gibberillins have been found in higher 
plants and are now recognised as hormones and growth promoters. Gibberillins share 
the same skeleton and lactone ring as the parent acid with structural variations coming 
from differing positions of hydroxy and double bonds. 
1.5.6 Sesterterpen es 
Very few sesterterpenes are known. Their distribution is the same as for the diterpenes 
and their biosynthesis is analogous with the previous descriptions. 
1.5.7 Triterpenes and steroids -the involvement of squalene 
Triterpenoids form the largest group of terpenoids although their structural diversity is 
relatively small, typically having three or four frised alicyclic rings. They are most 
abundant in higher plants although they are known in animals in small numbers. 
Squalene contributes their skeletons and is formed from the head-head linkage of two 
26 
molecules of FPP^^ Squalene (57) was first isolated from shark hver and has been 
found to be abundant in fiingi, vegetable oils and human earwax. The mechanism of 
squalene synthase proceeds via a carboeationic separated ion pair. Interestingly, the 
reaction proceeds through a cyclopropane intermediate which is formed by removal of 
the pro-S hydrogen from mevalonic acid. This is followed by ring expansion to a 
putative cyclobutane cabocation that is opened by the delivery of hydride from 
NADPH. The ring formation produces the unique head-to-head arrangement of isoprene 
units found in squalene (Scheme 1-18). 
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Scheme 1-18 Formation of squalene (57) 
In 1965 Bloch^^ demonstrated that 2,3-epoxy squalene (58) was the precursor of 
lanosterol (59) in animals and cycloartenol (60) in higher plants. Triterpenes, such as P 
amyrin (61) are also derived from the folding of 2,3-epoxy squalene. 
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Scheme 1-19 Biosynthesis of lanosterol (59), cycloartenol (60) and p-amyrin (61), 
Triterpenoids and steroids have similar applications - both are used in cell membranes 
to control cell rigidity. Cholesterol (62) controls its aligimient in membranes via its 
hydroxy group. The prenyl sidechain is non-polar and allows incorporation into lipid 
bilayers whilst the polar hydroxy head enables it to be incorporated into phospholipid 
layers. Cholesterol is biosynthesised from lanosterol in nineteen steps. The conversion 
may be lengthy, but is vitally important as membranes made from lanosterol are much 
more permeable than the cholesterol containing analogues. 
Scheme 1-20 Conversion of lanosterol (59) to cholesterol (62) 
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1.6 Terpenoid biosynthesis - the mevalonic acid pathway 
1.6.1 Features of the pathway 
Ruzicka's isoprene rule provided a rudimentry understanding of the biosynthesis of 
terpenoids. The first biosynthesis study on terpenoids was performed by Sanderhoff^^ in 
1937 who fed sodium [2-'^ H3]-acetate to yeast. The high level of incorporation of 
deuterium into resultant sterols suggested acetate as a building block. Progress on the 
pathway was slow until the intervention of Comforth, Bloch and Lynden who were later 
awarded the Nobel Prize for chemistry in 1964. Initial feeding experiments^"'^' with 
sodium [l-''*C]-acetate and sodium [2-'''C]-acetate showed the terpenoid skeleton of 
cholesterol was built from alternating acetate-methyl and acetate-carboxylate carbons, 
and that the pendant methyl groups were derived from the methyl groups of acetate. 
Scheme 1-21 Incorporation of [1- C]-acetate (63) labelled into cholesterol (62) 
In 1951 it was shown by Lynen and co-workers''^ that acetate is activated in vivo to its 
thiol ester of coenzyme-A to form acetyl-CoA (10). Subsequently HMG-CoA (64) was 
identified as an intermediate which is formed from the combination of three acetyl-CoA 
units. The first step is a Claisen ester type condensation that is then followed by an aldol 
type condensation. HMG-CoA is an important intermediate as its formation is the rate-
Hmiting step in terpenoid biosynthesis via the M V A pathway. 
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Scheme 1-22 Formation of HMG-CoA (64) from acetyl-CoA (10) 
Conversion of HMG-CoA (64) to IPP requires the loss of one carbon atom. This had 
been noted by Comforth who observed that isotope from [l-'^'CJ-acetate also produced 
'''CO2, suggesting a decarboxylation process. In 1956, workers at Merck, Sharp and 
Dohme found that brewing sediment could replace acetate as the carbon source for a 
mutant sfrain of Lactobacillus acidophilus. Furthermore, when the sediment was fed 
terpenoids were produced at higher levels. Extraction and isolation of the active 
material revealed that the growth enhancing subsfrate was 3,5-dihydroxy-3-methyl 
valeric acid, which is now described as mevalonic acid (MVA, 9). Mevalonic acid was 
firmly established as an intermediate on the pathway when the lactone form of MVA 
(65) was converted by liver extracts into cholesterol. 
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Scheme 1-23 Synthesis and incorporation of [!-"*€] mevalonalactone (65) 
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Work by Arigoni showed that only the 3-i?(-) enantiomer of M V A is produced in vivo^^ 
which was confirmed by feeding experiments with 3-R{-)-MVA and 3-S{+)-MVA in 
which only exogenously administered 3-R{-)-MVA was incorporated. The final steps 
that converts M V A to IPP require the alcohols to become activated to phosphate esters, 
the removal of one carbon atom and the introduction of a terminal double bond. 
Phosphorylation is catalysed by mevalonate kinases that use ATP and Mg "^^  to produce 
the phosphate esters. Subsequent decarboxylation provides IPP as shown in Scheme 1-
24 and EPP is then converted to DMAPP as described in Figure 1-5. This sequence of 
steps, starting from acetate which is processed to HMG-CoA and mevalonic acid to IPP, 
is described as the mevalonic acid pathway. 
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Scheme 1-24 Formation of IPP (34) from HMG-CoA (64) via MVA (9) 
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1.6.2 Other sources of mevalonate 
The scheme outlined above represents the major pathway to MVA, but is not the only 
source of MVA. A minor contribution is from a pathway where leucine (66) is 
converted to HMG-CoA through 3-methylcrotonylcoenzyme A (67). The sequence is 
completed by carboxylation by biotin and finally hydration to produce HMG-CoA (64). 
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Scheme 1-25 Formation of HMG-CoA (64) from leucine (66) 
1.6.3 Unresolved issues on the mevalonate pathway 
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Although the sequence and stereochemistry of the steps on the M V A pathway is well 
known, as early as the 1960's results emerged that appeared to contradict the hypothesis 
that M V A was the universal precursor to isoprenoids. The incorporation of ''*C02 and 
[2-''*C]-MVA into the chloroplasts of seedlings was reported by Trehame and co-
workers in 1966^ *^ who observed that (3 carotene and phytol were labelled by '^C02but 
not [2-''*C]-MVA. For sterols, the reverse was true. The conclusion was drawn that as 
both p carotene and phytol are biosynthesised in the chloroplasts, and sterols are made 
in the cytoplasm, the difference in incorporations was due to the relative permeability of 
the chloroplasts and cytoplasm to M V A and CO2. This agreed with findings'*^ that 
chloroplasts prepared in the laboratory were impermeable to MVA. Similar results were 
observed for the incorporation of ''*C02 and [2-'' 'C]-MVA into monoterpenes and sterols 
produced by Mentha piperita^^. Incorporation of [l-'''C]-acetate into monoterpenes was 
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also observed to be very low (<0.01%) which, it was argued, was due to acetate being 
used for other metabolic pathways. An exhaustive list of incorporations of acetate, 
MVA and CO2 into monoterpenes is provided in an excellent review by Banthorpe"''. In 
experiments where acetate was incorporated into terpenes, significant scrambling of the 
tracer occurred^*. 
Further evidence for the differences between the M V A pathways in the cytoplasm and 
chloroplasts was revealed when [2-"'C]-MVA was fed to Thuja occidentalias . 
Analysis of the thujone that was produced showed incorporation of the '''C label was 
two orders of magnitude higher in the IPP unit than the DMAPP unit. Similar 
asymmetrical labelling was later reported in both enantiomers of camphor'**^  and in the 
sequiterpenes tutin and coriamyrtin'*'. These suggested that two pools of DMAPP 
existed- a pool that was free and sparsely filled and another that was enzyme bound and 
full. Further hypotheses were suggested, such as that high concentrations of 
exogenously administered MVA could inhibit the isomerisation process, resulting in 
low concentrations of DMAPP. 
However, all explanations seemed to overlook that the incorporations were almost 
insignificantly small ( 0.01% ) and prone to error and contamination. The answer to how 
plant monoterpenes are biosynthesised is discussed below. 
1.7 The 1-deoxyxyulose pathway 
1.7.1 Initial studies 
The pioneering work on the early stages of the l-D-deoxyxyulose-5-phosphate (DXP) 
pathway, or mevalonate independent pathway, was performed by Rohmer and co-
workers. The first suggestion that an alternative pathway was operating followed the 
results of feeding experiments with [l- '^C] and [2-'''C]-acetate with the bacterium 
Rhodopseidomonas palustris''^. The aim of the experiment was to determine the origin 
of a non-terpene sidechain in a hopane. Incorporation showed that the sidechain was 
derived from a D-pentose but also revealed incorporation of '^C derived from acetate 
that did not concur with the processing of acetate via mevalonic acid. In addition the 
incorporations were relatively high and showed no evidence of scrambling. The result 
was explained in terms of compartmentation effects, and that the acetate was processed 
to MVA but that two non-equivalent pools of acetate existed. Feeding of [ l - '^C]-
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acetate to E. coli also showed an identical incorporation pattern into the ubiquinone 
sidechain to that found in R. palustris. 
Further experiments"'' in Zymomonas mobilis showed identical results. One of the 
attractive features about using the bacterium Z. mobilis is that many glycolytic enzymes 
are absent and it is capable of growing on a single carbon source. This can lead to 
relatively high levels of incorporation. Isotopically labelled glucoses were fed and the 
incorporation into the isoprenoid fraction of the hopanoids was analysed via '^C NMR. 
It was found that C-3 of IPP was derived from C-2 and C-5 of glucose and C-3 and C-6 
of glucose gave rise to C-5 of IPP. Similar relationships were found between C-1, C-2 
and C-4 of IPP and C-4, C-5 and C-6 of glucose respectively. Feeding experiments with 
Methylobacterium fujiawaense using '•'C enriched glucoses labelled IPP in a similar 
manner to the incorporations in Z. mobilis. Both organisms use the Entner-Doudoroff 
pathway rather than glycolysis for glucose metabolism. In the glycolytic pathway, 
glucose (68) is converted through fructose 1,6 bisphosphate (69) to dihydroxyacetone 
phosphate (70) and D-glyceraldehdye-3-phosphate (GAP, 3). The Entner-Doudoroff 
pathway metabolises glucose to glyceraldehyde-3-phosphate (3) and pyruvate (7). 
Feeding of [ l- '^C] and [6-'^C]-glucose to E. coli and Alicyclobacillus acidoterrestris^^ 
once again showed enrichment of C-1 and C-5 of IPP. 
These results inferred the involvement of pyruvate and a C3 intermediate that would be 
delivered by the Entner-Doudoroff pathway in Z. mobilis and M. fujiawaense and via 
glycolysis in E. coli to provide a branched C5 intermediate. 
H O H 
R O 
O H 
- O H 
- O H 
- O H 
68 
C O © 
Entner-Doudoroff —oH 
H O -
- O H 
- O H 
c o , 0 
glycolysis 
o(p) 
1=0 
H O H 
- O H 
- O H 
Lo(p) 
69 
= 0 
—OH 
- o ® 
p O H 
= 0 70 
Scheme 1-26 Comparison of glycolysis and the Entner-Doudoroff pathway 
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The incorporation of [4,5-'^C2i-glucose into the ubiquinone of M. fujiawaense showed 
labelling of C-2 and C-4 of IPP with satellites corresponding to '^C-'^C coupling. As 
the carbon-carbon bond was incorporated intact, it was judged that the rearrangement to 
the branched skeleton is an intramolecular process. 
[U-'^C]-Glucose fed to Z. mobilis showed '•'C-^^C coupling between C-3 and C-5 in 
addition to ' j '^C-'^C coupling between C-1 and C-2'*^ An enrichment of C-4 was also 
observed. This proved that the C2 unit was derived from pyruvate and explained the 
previously anomalous result of Zhou and White'*'^  who had observed that [methyl-^B.-i\-
lactate was incorporated into the ubiquinone of E. coli. In the context of the mevalonate 
independent pathway, the incorporation represents processing of lactate to pyruvate. 
Furthermore, the previous incorporations of acetate studied by radiolabelling represent 
the processing of acetate to pyruvate via oxaloacetate and incorporation of pyruvate via 
the DXP pathway rather than direct incorporation of acetate via the M V A pathway. 
Investigations into the identity of the C3 unit were conducted using mutants of E. colf^. 
In parallel experiments, cultures were supplemented with [l-'^C]-pyruvate and 
unlabelled glycerol or [l-'^C]-glycerol and unlabelled pyruvate. Pyruvate was 
incorporated into C3 and C5 of IPP irrespective of which enzymes were absent 
demonstrating that two carbons arise from the decarboxylation of pyruvate. The 
experiment also pinpointed GAP as the C3 intermediate. Mutants possessing only the 
enzymes required to convert pyruvate to GAP showed incorporation of '^ C from [1-
'^C]-pyruvate whilst mutants possessing only the enzymes required to convert glycerol 
to GAP showed '^C enrichment from [l-'''C]-glycerol. 
1.7.2 The role of l-D-deoxyxylulose-5-phosphate 
The key intermediate on the mevalonate independent pathway, l-deoxyxylulose-5-
phosphate, was first isolated in 1976 from Streptomyces hydroscopicus'*^. Its 
identification as a precursor to terpenoids was stimulated by an observation by Yokota 
and Sasajima that bacterial and plant cell free preparations were capable of producing 
DXP from GAP and p y r u v a t e ' ' D X P had been shown to be the origin of the C5 units 
in vitamins Bi (71) and (pyridoxone, 72). Initial feeding experiments with E. coli 
inferred the free triol as the intermediate'*^ although more recent studies conducted by 
Laber^ *^  and co-workers have shown that the 5-phosphate ester is the active form in vivo. 
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Scheme 1-27 Incorporation of DXP into vitamins Bi (71) and Be (72) 
DXP was shown to be an intermediate on the mevalonate independent pathway by 
Arigoni^'. Deuterium incorporation from [5,5-^H2]-DX was observed into the 
polyprenyl group of ubiquinone of E. coli. The enzyme that produces DXP from GAP 
and pyruvate, DXP synthase (DXS), was first isolated by Sprenger and co workers^^ 
from E. coli. The enzyme required thiamin as a cofactor which was consistent with an 
acyloin type condensation of pyruvate and GAP. DXS behaves in a transketolase 
manner and has a sequence motif that is recognised to bind the thiamin diphosphate 
cofactor required for pyruvate decarboxylation. When the DXS sequence was compared 
to other known protein sequences significant homology was found between ORF's in 
the plant Arabidopsis thaliana, the cyanobacterium Synechocytis sp. and the Gram 
positive bacterimn Bacillus subtilis. A similar result was also reported by Rohmer^^ 
DXS has now been cloned from B. subtilis^* and was overexpressed from E. coli to 
upregulate ubiquinone and lycopene production. Following this, DXS was cloned from 
peppers^^ and peppermint^^ which showed the synthase gene was 2,172 base pairs long. 
Mechanistically, DXS operates by the thiamin mediated decarboxylative condensation 
of pyruvate and GAP. 
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Scheme 1-28 Formation of DXP (6) from GAP (3) and pyruvate (7) 
1.7.3 2-C-Methylerythritol-4-phosphate 
Clearly DXP must undergo a skeletal rearrangement in order to deliver the branched 
skeleton of IPP. Rohmer and co-workers^'' identified 2-C-methylerythritol-4-phosphate 
(MEP, 73) as the next intermediate on the mevalonate independent pathway. MEP had 
been isolated from various systems as both the 4-phosphate ester and the free tetrol. '^C 
enriched glucose was fed to Corynebacterium ammoniagenes which was known to 
produce MEP when treated with benzylviologen in the stationary phase. MEP and 
menaquinone were isolated and the carbon labelling patterns were compared. An 
identical distribution of '^C labelling was found in both molecules, which suggested a 
role for MEP as an intermediate. 
Synthetic 2-C-methyl-D-erythritol and 2-C-methyl-L-erythritol were fed to E. coli.^^ 
Incorporation of only the D enantiomer was observed. Further studies^^ showed 
incorporation of [2,3,4,5-'^C4]-DX into |3-carotene and ME from Liriodendron tidipa. 
The labelling patterns and levels of incorporation was identical for both molecules. 
'^C-'^C and '^C-'^C coupling constants showed that the C4 backbone of MEP was 
derived from an intramolecular rearrangement of DXP via a pinacol type rearrangement. 
MEP was shown unambiguously to be the first dedicated intermediate on the pathway 
when DXP was converted into p carotene via MEP by cell free extracts of Capiscum 
annum 60 
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MEP is the product of the enzyme, deoxyxylulose reductoisomerase, which initiates 
rearrangement and employs NADPH to afford aldehydic reduction. 
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Scheme 1-29 Formation of MEP (73) from DXP (6) 
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Identical transpositions are known in the biosynthesis of branched amino acids such as 
L-vaHne. In both reactions the hydride is delivered from the oppposite face to the 
migrating group 61 
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Scheme 1-30 Stereochemistry of reductoisomerases in MEP (top) and valine 
biosynthesis (bottom) ^ ' 
DXP reductoisomerase has been cloned and expressed from A. thaliana^^, Mentha x 
piperita'^ and has been isolated from E. coli^. DXP reductoisomerase isolated from E. 
coli uses exclusively the pro-{S) hydride of NADPH which identifies DXP 
reductoisomerase as a class B dehydrogenase. 
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1.7.4 Post MEP intermediates 
One of the key features of the mevalonate independent pathway is both DX and ME, fed 
as the free alcohols, are incorporated at very low levels (-0.3%) into whole cells. 
Consequently, cell free work has been employed to elucidate details of the pathway 
after MEP. 
When E. coli exfracts were incubated with [2-''*C] MEP and ATP a radiolabelled 
product was formed^^. Isolation of the radiolabelled product showed MEP had been 
converted to 4-phosphocytidyl-2-C-methylerythritol (CDP-ME, 74). The enzyme 
responsible for the conversion was purified and the incubation with [2-'''C] MEP was 
repeated with different co-factors. CTP was found to act more efficiently as a substrate 
than ATP and that [a-^^P] CTP delivered •'^ P into the product. [2-^''C] CDP-ME was 
incorporated into P carotene when incubated with chloroplasts of Capsicum annum 
which showed it to be an intermediate on the pathway. Identical results were reported 
shortly afterwards by Seto and co-workers^^. During these investigations, a previously 
unannotated gene, ychb, was found very close on the genome of E. coli to ygbp, the 
gene responsible for CDP-ME synthesis. Ychb was overexpressed in a homologous 
host^ ^ and the recombinant protein was purified. When CDP-ME was incubated in the 
presence of ATP and the protein, 4-phosphocytidyl-2-C-methylerythritol-2-phosphate 
(CDP-MEPP, 75) was formed. [2-'''C]-CDP-MEPP was demonstrated to be an 
intermediate when it was efficiently incorporated into carotenoids produced by C. 
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annum chromoplasts. Again, the same result was reported shortly afterwards by Seto . 
The latest intermediate that has been reported was found using identical methodology to 
that above^ .^ YgbP, the gene responsible for CDP-ME synthesis, was found to be fused 
to another gene, ygbB which expressed a protein, YgbB that converted CDP-MEPP, in 
the presence of Mn "^^  and Mg^" ,^ to 2-C-methylerythritol-2,4-cyclodiphosphate (ME-2,4-
CDP, 76) and CMP. YgbB was also found to convert MEP-CDP to 2-C-methylerythritol 
3,4-cyclomonophosphate (ME-3,4-CMP, 77 ). Incubation of [2-''*C]-ME-2,4-CDP with 
C. annum chromoplasts revealed incorporation into carotenoids whereas [2-^'*C]-ME-
3,4-CMP did not. 
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Scheme 1-31 Formation of post MEP intermediates 
This results suggests that while ME-2,4-CDP (76) is an intermediate on the pathway, 
ME-3,4-CMP (77 ) is not and may simply be a shunt metabolite. ME-2,4-CDP had been 
previously isolated from benzylviologen treated Desulfovibrio desulfuricans^° although 
no connection to the mevalonate independent pathway had been established at that time. 
1.7,5 Distribution of the mevalonate independent pathway 
In the light of recent feeding experiments it is now known that higher plants and certain 
Gram negative bacteria, notably Pimelobacteria (cyanobacteria and proteobacteria) use 
the mevalonate independent pathway. Green algae^' are also known to use the new 
pathway. By contrast, animals are known to use the M V A pathway; searches for DXP 
reductisomerase in mammalian gene sequences have proved fruitless. Furthermore, 
mevalonin, a known inhibitor of the M V A pathway, has been clinically proven to 
reduce levels of patients' cholesterol which can only be explained in terms of the MVA 
pathway. 
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The pattern that '^C from [2-'^C]-acetate was incorporated into sesquiterpenes produced 
by the liverwort Heteroscyphus planus initially suggested a mevalonate origin of the 
terpene although the level of incorporation was low (0.3% atom)''^ and prone to 
significant error. Later studies with DX showed operation of the mevalonate 
independent pathway^'' although a minor contribution from the mevalonate pathway was 
observed. Similar simultaneous labelhng patterns have been found to be common in 
higher plants. Investigations with plant cultures revealed that the site of terpene 
manufacture determines the route of biosynthesis. When cultures of higher plants 
{Hordeum vulgare, Lemna gibba and Daucus carotta) were fed with [l-'''C]-glucose 
two clearly distinct incorporation patterns were revealed^''. Sterols were produced via 
the MVA pathway and carotenoids were synthesised via the mevalonate independent 
pathway. Identical results emerged from studies whereby sterols and carotenoids were 
produced by different pathways. These results can be rationalised in terms of the site of 
terpene biosynthesis. It is well established that sterols are produced from GGPP in the 
cell cytoplasm that clearly operates via the mevalonate pathway whereas carotenoids 
and monoterpenes are produced in plant chloroplasts that use the mevalonate 
independent pathway. However, there appears to be "cross talk" between the two pools 
and that IPP, FPP and prenyl pyrophosphates can be transported between the cytoplasm 
and chloroplasts. Striking evidence for this was reported by the group of Arigoni^^. 
When gingko embryos were incubated with [l-'^C]-glucose, 98% of GGPP was 
produced by the mevalonate independent pathway. The remaining 2% was of mixed 
origin; 20% was derived from IPP from M V A and FPP from the mevalonate 
independent pathway; the rest was composed of FPP produced from MVA and one unit 
of IPP synthesised via the mevalonate independent pathway. Similarly, lima beans 
showed incorporation of [l-'''C]-glucose that were consistent with monoterpenes 
derived from the mevalonate independent pathway, sesquiterpenes from an equal 
contribution from both pathways and diterpenes predominantly from the new pathway^^. 
In Gram Positive bacteria (those that are non photosynthetic and lack an outer 
membrane) both pathways have been shown to operate. Indeed, in Streptromyces 
aeriouver both pathways operate simultaneously^^. During the exponential growth phase 
the mevalonate independent pathway is used to deliver the prenyl chain of a 
menaquinone. When monoterpenes are produced in the stationary phase the mevalonic 
acid pathway is employed. Other Gram Positive bacteria such as Mycobacteria use only 
the mevalonic acid pathway^^. 
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In evolutionary terms the distribution of the mevalonate independent pathway correlates 
with current thinking about how organisms evolved. Gram Negative bacteria are 
thought to have been assimilated into cells that would later evolve to become plant cells. 
The Gram Negative bacteria, and all their biosynthetic pathways, then constitute the 
chloroplasts of Dictyozoa. The evolution of fiingi and animals, and plants and algae, 
represent a divergence in the pathways to terpene biosynthesis. The chloroplasts of 
Dictyozoa were retained in plants and algae, and hence the mevalonate independent 
pathway is found in these organisms. This contrasts with fimgal and animal cells which 
lost their chloroplasts and hence the ability to manafacture terpenes by the mevalonate 
independent pathway. 
1.7.6 Post ME-2,4-CDP intermediates and IPP formation 
As yet, no other features of the mevalonate independent pathway are known. 
Hypotheses relating to putative intermediates and issues regarding the interconversion 
of IPP and DMAPP are discussed in Chapter 2. 
1.8 Precis 
This thesis is divided into four main chapters. Chapter 2 relates to studies on the 
mevalonate independent pathway that operates in the plant Mentha citrata and the 
bacterium Escherichia coli. Feeding studies and synthesis of labelled intermediates are 
discussed. Chapter 3 concerns the growth and isolation of a meroterpene from the 
fungus R. necatrix. Structure analysis and biosynthetic studies are also described. 
Isolation and structure elucidation of a metabolite from Xylaria grammicin completes 
the chapter. Chapter 4 is the experimental section. 
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Chapter 2 
The biosynthesis of linalyl 
acetate by M . citrata and 
ubiquinone-8 by E . coli 
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2 The biosynthesis of metabolites by the mevalonate independent 
pathway 
This chapter describes studies that have been performed on the mevalonate independent 
pathway using whole plant cultures of Mentha citrata and cultures of the bacterium 
Escherichia coli. Initially the chapter describes the isolation and purification of linalyl 
acetate and the assignment of proton and carbon NMR resonances. The chapter then 
reports the results of feeding experiments using '^C and labelled compounds to M. 
citrata and E. coli and information about the extent that the mevalonate independent 
pathway operates in the context of compartmentalisation. The synthesis and feeding of 
stable isotope labelled compounds concludes the chapter. 
2.1 Introduction to M. citrata 
For this study of the mevalonate independent pathway, plant tissue cultures of M. 
citrata and whole cell cultures of E. coli were used. It is pertinent to briefly describe 
each system in turn. 
Plant tissue cultures have many advantages over whole plant cultures in biosynthetic 
studies as outlined below. 
Plant tissue cultures Whole plant culture 
Maturity in ~30 days 
Can be grown easily in simple medium 
Easy introduction of labelled precursors 
Low maintenance 
Maturation in 1 -4 months 
Typically require soil 
Complex transport mechanism via roots 
Require regular tending 
Table 2-1 Comparison between plant tissue and whole plant cultures 
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2.1.1 The production of linalyl acetate by M. citrata 
The cultures of M. citrata were a gift from Dr Richard Robins (CNRS, Nantes) and 
were initially generated by Hamill and co-workers^^. In order to enhance terpenoid 
production, shooty M. citrata cultures were transformed with a variety of strains of 
Agrobacterium tumefaciens. The use of Agrobacterium to effect secondary metabolite 
production is well described*'^  although the mechanism is not well understood. 
Transformation involves infecting the plant with Agrobacterium which transfers T-
DNA which, in turn, decreases the auxin/cytokynin ratio in the transformed plant. This 
results in the retardation in growth of stem tissue with a concordant increase in leaf 
growth. Previous studies with M. citrata cultures had shown that linalyl acetate (78) 
production is localised in terpenoid producing glands that are situated on the underside 
of the leaf and thus enhanced leaf growth leads to increased terpenoid production. 
The work had also investigated the effect of external physical conditions on the rate of 
growth and terpenoid production^'. Linalyl acetate production was found to be maximal 
when the transformed cultures were grown in 3% sucrose and Murashige and Skoog 
medium. Under these conditions, it was reported that after 41 days growth up to 800jug 
of linalyl acetate per flask was produced. Linalool 46, the parent alcohol of linalyl 
acetate, was also produced, but at much lower level (21/ig/flask). 
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2.7.2 Extraction of linalyl acetate from M. citrata 
One of the primary objectives in this programme was to isolate and fully characterise 
linalyl acetate. Intially the method of Hamill^' was used in which the plant tissue was 
collected and dried between filter papers and air dried for one hour. The tissue was then 
homogenised three times in a Waring blender with HPLC grade heptane at 4°C and the 
heptane decanted into a centrifiige tube. Following centrifrigafion at 4°C, the 
supernatant liquid was decanted and the solvent removed under reduced pressure. The 
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last traces of heptane were removed under high vacuum for one minute. This method 
proved to be very successfiil as it repeatably delivered lOmg of Hnalyl acetate per flask 
and was quick and effective. This method (Procedure 1) was employed for all of the 
initial experiments but was stopped when it was the result of a fire when the blender 
cracked. 
Other extraction procedures were explored to modify the procedure. The method found 
to be the best replacement was the soxhlet extraction of plant tissue with heptane. 
However, the amount of linalyl acetate that was extracted was found to be 
approximately half that when using the Waring blender (5mg/flask). The soxhlet 
method is herein-described as procedure 2. Both procedures gave samples of linalyl 
acetate that were identical to commercial linalyl acetate (GC-MS, NMR). 
2.1.3 Analysis of linalyl acetate 
It was important to have fully assigned ' H and '^C NMR spectra of linalyl acetate. 
A DEPT experiment allowed assignment of the resonance at 83 ppm to C-3 and the 
olefmic signal at 113ppm to C-1 . The carbon signal at 132 ppm did not appear in the 
DEPT spectrum and could thus be assigned to C-7. 
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Figure 2-1 DEPT of linalyl acetate showing the degrees of protonation of each carbon 
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Figure 2-3 HETCOR Of linalyl acetate 
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COSY and HETCOR analysis in tandem enabled differentiation of the olefinic protons 
of C-2 and C-6. As the carbon resonance of C-1 had been assigned to the signal at 
113ppm, it was obvious from analysis of the HETCOR spectrum to assign the signals 
at 5.0 ppm to C-1. The COSY spectrum showed clear coupling to proton resonances at 
4.9 ppm which were shown in the HETCOR spectrum to correlate to the resonance at 
142 ppm. Thus the 142ppm resonance was assigned to C-2. Examination of the 
resonance at 124 ppm showed that it was attached to protons at 4.9 ppm which gave off 
diagonal coupHng to resonances in the COSY spectrum to signals at 2.0 ppm. Hence, 
the signals at 124 and 2.0 ppm represent the carbon and proton resonances respectively 
of C-6. Assignment of the aliphatic protons at C-4 and C-5 was made easier by the fact 
that the proton at C-6 couples to the diastereomeric protons at C-5. Analysis of the 
COSY spectrum showed coupling of C-6 to the cenfre of a pair of muliplets at l.Sppm , 
both of which correlate to the resonance at 22.5 ppm in the HETCOR. This is entirely 
consistent with those resonances being derived from C-5. Hence the remaining 
methylene resonances at 40.0 and 1.9 ppm are from C-4. This is further demonstrated 
by the proton muftiplicity (a doublet of doublets corresponding to coupling to the two 
non equivalent protons of C-5). Difficuhies were encountered when assigning the 
methyl resonances however. A literature search for similar structural motifs as those 
found in linalyl acetate revealed an assignment to chinesin I (79), a plant 
phloroglucinol*^. Chinesin possesses a pendant terpenoid derived unit that is identical to 
that in linalyl acetate. 
17.9 ppm 25.8 ppm 
Figure 2-4 Terpenoid motif in chinesin (79). '^C-NMR shifts of the terpene unit are 
shown 
The carbon NMR of chinesin showed that the cis and trans methyl groups gave signals 
at 17.9 and 25.8 ppm respectively. These corresponded almost exactly to two methyl 
resonances at 17.8 and 25.9 ppm in the spectrum of linalyl acetate, which tentatively 
suggested that the signals were due to C-8 and C-9 respectively. This was confirmed by 
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nOe analysis which showed that irridiation of the C-6 proton gave enhancement of the 
protons corresponding to the carbon at 25.9 ppm. 
:}.c 1 -J I . a 
Figure 2-5 N O E S Y of hnalyl acetate 
Carbon number 5c/ppm 5H/ppm 
1 113.3 5.25 
2 124.0 5.89 
3 83.1 -
4 39.9 1.75 
5 22.5 1.85 
6 142.0 5.10 
7 132.0 -
8 17.8 1.58 
9 25.9 1.69 
10 23.9 1.55 
11 170.1 -
12 22.4 2.01 
Table 2-2 ' H and ' ^ C - N M R resonances of linalyl acetate 
N M R is very useful as an analysis technique for biosynthetic studies, but is only 
moderately sensitive. In order to assess low levels of incorporation, a G C - M S protocol 
50 
was developed and samples of linalyl acetate were analysed by Dr Jack Hamilton 
(Queen's University, Belfast). GC-EIMS of Hnalyl acetate proved to be unfruitful as 
neither the molecular ion nor any useful daughter fragments were observed. However, 
when GC-CIMS was performed with methane as the carrier gas, an ion corresponding to 
the loss of acetic acid was detected. This pseudo molecular ion was used throughout the 
course of the experiments to determine levels of incorporation. In order to produce 
accurate results, GC-CIMS was recorded 10 times and the values were averaged to give 
levels of incorporation when corrected for natural abundance. 
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Figure 2-6 Illustration of the formation of the pseudo molecular ion of linalyl acetate 
(78) 
2.2 Biosynthesis of ubiquinone in E . coli 
In addition to whole plant cultures of M. citrata, E. coli was selected to investigate the 
mevalonate independent pathway as it was being used concurrently by other research 
groups. E. coli has many features that make it attractive for use in biosynthetic 
investigations such as the rate of cell growth (2-3d), the ease of maintenance and its 
ready availability. Of the broad spectrum of idolites that are produced by E. coli, 
ubiquinone (80) and menaquinone (81) are probably the most important in terms of 
biological activity and they have been used as tools for determining features of the 
mevalonate independent pathway in bacteria. 
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Arguments have been put forward that categorise the quinones as primary, rather than 
secondary metabohtes. This reasoning, however, does not consider that ubiquinones are 
dehvered by secondary metabohc pathways such as the shikimate, mevalonate and 
mevalonate independent pathways. Both of the quinones are used to mediate respiratory 
electron transfers owing to the redox abiUty of the quinone nucleus. 
Scheme-2-1 Reduction of the quinone nucleus 
Ubiquinones are described by the number of IPP derived building blocks that form the 
prenyl chain. Ubiquinone-8, for example, has eight repeat units in the prenyl unit 
resulting in a C40 sidechain. Prenyl chain lengths between ten and fifty carbon atoms 
have been reported. 
Ubiquinone-10 was the first ubiquinone to be isolated, and was extracted from bovine 
heart by Morton and coworkers*^ in 1958. The name ubiquinone was coined by Morton 
owing to its universal distribution. Indeed, the only organisms in which ubiquinones 
have not been detected are blue green algae and Gram-positive bacteria, 
hi bacteria, ubiquinones are biosynthesised fi^om chorisimic acid, with extensive 
flinctionalistion afforded by molecular oxygen and SAM. 
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Scheme 2-2 Biosynthesis of ubiquinone from chromismate (25) in bacteria 
2.2.1 Growth ofE. coli 
Cultures of E. coli DH5a were obtained from Dr Tony Fawcett (Biological Sciences, 
Durham) and were grown in standard LB medium. In accordance with standard practice, 
starter cultures (35ml) were seeded and grown for three days. Starter cultures were 
initially inoculated from an agar plate, and subsequently from cultures stored in 
glycerol solution (10%) at -20°C. Production cultures (500ml) were inoculated from 
starter cultures (5ml) and grown for three days. At the outset a time course study of cell 
density was undertaken. The most straightforward method to record cell density is via 
absorbance at 600nm and a maximal absorbance of 1.96 A was found after 26 hours, 
which corresponds to the beginning of the stationary phase. 
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2.2.2 Extraction of ubiquinone 
The extraction and purification of ubiquinone is well documented although most 
literature methods describe its extraction from mammalian hearts. In this programme the 
procedure described by Rohmer '^' from E. coli was followed. Cells were collected by 
centrifugation which were then freeze-dried overnight to afford 1 g/1 of cells. The cells 
were then extracted three times into chloroform/methanol by heating under reflux. 
Removal of the solvent yielded a brown oil which, after extraction with heptane and 
column chromatography, gave ubiquinone-8. Initially, purification was performed using 
preparative TLC, but this was found to be unsuitable owing to poor chromatographic 
resolution and the need to run multiple plates i f large amounts (200mg) of crude extract 
were obtained. This procedure allowed the isolation of relatively pure ubiquinone-8 
(NMR). 
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Figure 2-7 ' H N M R spectrum of ubiquinone-8 isolated from E. coli 
Ubiquinone-8 was routinely isolated at a level of ~800^g/l, which required that 4 litres 
of broth were innoculated in order to obtain sufficient ubiquinone for N M R analysis. 
54 
2.3 Preliminary feeding experiments 
The first objective of the program was to determine whether hnalyl acetate was 
biosynthesised using the mevalonate independent pathway or MVA pathway by M. 
citrata. The feeding of sodium [l,2-'''C]-acetate and [l-'''C]-glucose were identified as 
key experiments to estabhsh which pathway produced the terpene fragment of hnalyl 
acetate. It is was known that ubiquinone-8 from E. coli is produced via the mevalonate 
independent pathway, and consequently only [6,6-^H2]-glucose and [^Hs-methyl]-
methionine were fed in order to establish whether the cultures were behaving in a 
similar manner to those in the reported literature. 
2.3.1 Feeding of sodium [l,2-^C]-acetate (S2) to M. citrata 
Sodium [l,2-'^C2]-acetate was fed to two cultures of M. citrata to a final concentration 
of lOmM. The cultures were grown under standard conditions with fructose as the sugar 
source. At the end of the incubation, linalyl acetate was extracted using procedure 1. 
The resultant '^C-NMR spectrum (Figure 2-8) showed that all of the intact acetate was 
located in C-11 and C-12 as evident from the Ji3c-i3ccoupling of 58.9 Hz between C-11 
and C-12. No incorporation into the terpene moiety was evident from this experiment. 
M. citrata 
Scheme 2-3 Incorporation of [l,2-'^C2]-acetate into linalyl acetate 
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Figure 2-8 '^C-NMR of linalyl acetate after feeding [l,2-"C2]-acetate. ' V " c 
Coupling corresponding to the intact incorporation of an acetate unit are 
shown in the inset plots. 
13, 
2.3.2 Feeding of fl-'^CJ glucose (S3) to M. citrata - operation of the mevalonate 
independent pathway 
The feeding of [l-'^C]-glucose emerged as a key experiment to delineate which 
pathway produced the terpene fragment of linalyl acetate. Almost all organisms are 
capable of using glucose as a carbon source, which makes it ideal for biosynthetic 
investigations. [l-'''C]-Glucose is processed via glycolysis through known 
intermediates, as described in chapter one, which means that the biosynthetic route of 
the label can be elucidated from the incorporation pattern. 
[l-'^C]-Glucose labels IPP differently depending on which pathway is involved as 
shown below in Scheme 2-4. Thus, [l-'^C]-glucose is a powerful tool for determining 
which is the dominant pathway for terpene biosynthesis. 
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Scheme 2-4 Processing of [l- '^C] glucose (83) to IPP (34) via the mevalonate 
independent pathway and the MVA pathway 
[l-'^C]-Glucose was administered to two flasks of M citrata to a final concentration of 
8.4 mM and the cultures were harvested after 25 days. Linalyl acetate was extracted 
using procedure 1 and analysed by '^C NMR spectroscopy. 
In order to estimate the level of isotopic enrichment it was necessary to normalise the 
peak heights of the resultant spectrum relative to the natural abundance spectrum. C-3 
of linalyl acetate was selected a reference peak as it is labelled by neither pathway. 
Accordingly, each peak height in the spectrum that was obtained after feeding [l-'^'C]-
glucose was divided by the height of C-3. Finally, each peak height was corrected for 
natural abundance '"'C by dividing each peak height of the labelled linalyl acetate by the 
peak height of the same signal in the '^C-NMR of an unlabelled sample of linalyl 
acetate. This analysis provided the enrichments as shown in Table 2-3. 
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Carbon no Z,^ ve/ of enrichment 
1 2.50 
2 1.60 
3 1.10 
4 1.40 
5 2.29 
6 1.31 
7 1.58 
8 2.44 
9 1.66 
10 2.31 
11 1.13 
12 3.90 
Table 2-3 Enrichment of carbon signals after feeding with [l-'^C]-glucose relative to 
C-3. Values in bold type indicate significantly enriched '^C signals 
There is a clear enrichment of carbon atoms 1, 5, 8,10 and 12 and a small enhancement 
of carbons 2, 7 and 9. The labelling pattern is consistent with [l-'^C]-glucose being 
processed via the mevalonate independent pathway as outlined in Scheme 2-4. The 
enrichments into C-2 and C-4, which are not a result of incorporation via the 
mevalonate independent pathway, are due to incorporation of C-1 of glucose through 
mechanisms other than those shown in Scheme 2-4. 
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2.3.3 Feeding of sodium [2,2,3,3-^H4]-succinate to M. citrata and E . coli 
Sodium succinate (84) was fed to M. citrata owing to its availability as a pyruvate 
surrogate. Succinate (84) is processed to pyruvate (7) via the TCA cycle. 
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Sclieme 2-5 Processing of sodium [2,2,3,3-^H4]-succinate (84) to pyruvate (7) 
It was anticipated that the feeding of succinate would result in deuterium incorporation 
into linalyl acetate and provide information about the concentrations of precursors that 
were required for successful enrichments. 
Accordingly, sodium [2,2,3,3-'^H4]-succinate was pulse fed to two cultures of M. citrata 
on days 7, 14, and 19 and the plant tissue was extracted using procedure 1. GC-MS 
analysis was performed ten times and the results were averaged to ensure that 
enhancements were statistically significant. Analysis of the linalyl acetate after feeding 
sodium [2,2,3,3-^H4]-succinate showed an enhancement of the M+1 ion (0.14%). The 
data is shown in Figure 2-9. 
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Figure 2-9 GC-MS Determined incorporation vs molecular weight after feeding 
[2,2,3,3-^H4]-succinate (84) to M. citrata 
The level of incorporation is low but significant and represents the incorporation of one 
deuterium atom into linalyl acetate. This is consistent with the processing of succinate 
via the TCA cycle and incorporation into linalyl acetate from [3-^H]-pyruvate as shown 
in Scheme 2-5. The result was very encouraging as it demonstrated that the GC-CIMS 
protocol was capable of detecting very low levels of enrichment and that whole cell 
plant tissue cultures of M citrata were capable of using exogenously administered 
substrates. Furthermore, the incorporation showed that the pyruvate end of DXP was 
amenable to investigation by the use of surrogate substrates. This prompted an 
investigation using a number of potential precursors that would allow the origin of the 
methyl hydrogen atoms of DXP to be traced. 
In the analogous experiment in bacteria, sodium [2,2,3,3-^H4]-succinate (84) was fed to 
eight production cultures (500ml) of E. coli to a concentration of l . l m M . Ubiquinone-8 
was extracted according to standard procedures and was analysed via ^H-NMR. 
However, no enrichment of deuterium was observed. This is possibly due to the low 
concentration at which sodium [2,2,3,3-^H4]-succinate was fed to E. coli 
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2.3.4 Feeding of alanine 
Previous work in Durham*'* had demonstrated the use of alanine as an excellent 
pyruvate surrogate in fimgus. Alanine is processed in vivo to pyruvate by 
transamination. 
O 
©NH3 O 
85 7 
Scheme 2-6 Formation of pyruvate (7) from alanine (85) 
One of the attractive features about the use of labelled alanine was that both [3-'^C] and 
[3-^H3]-alanine were commercially available and the preparation of enatiopure 
[3-'^C^H3]-alanine was reported in the literature. It was anticipated that alanine would 
provide a method of determining whether the methyl protons of MEP were abstracted 
during the conversion of MEP to EPP. 
2.3.5 Synthesis ofD-P-^C^HsJ-alanine (S6) 
The synthesis of D-[3-'^C^H3]-alanine (86) was followed using Seebach's oxazolidinone 
methodology*^ as modified by Chesters and O'Hagan*'*. Treatment of benzoyl-2-(;-
butyl)-3-methylimidazolidin-4-one (87) with LDA at -78°C yields the anion which can 
then be reacted with a suitable electrophile. In the case of methyl iodide, the 
methylation proceeds with stereochemical control owing to the steric bulk of the tert-
butyl group that hinders attack from one face to give benzoyl-2-(/-butyl)-3,5-
dimethylimidazolidin-4-one (88). Acid hydrolysis at elevated temperature and pressure 
yields alanine (85). 
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Sclieme 2-7 Synthesis of alanine (85) from benzoyl-2-(/-butyl)-3-methyhmidazolidin-4-
one(87) 
Treatment of benzoyl-2-(f-butyl)-3-methylimidazolidin-4-one (87) with methyl iodide 
gave benzoyl-2-(/-butyl)-3,5-dimethylimidazolidin-4-one (88) in a moderate yield 
(65%). Unreacted starting material was recovered by column chromatography. 
Hydrolysis in a sealed tube with 6M HCI at 180°C yielded a black powder, which after 
purification over Dowex, gave alanine as a white crystalline solid. 
The synthesis was repeated using ['''C^HaJ-methyl iodide with a similar yield for the 
first step to give benzoyl-2-(f-butyl)-3-methyl-5-['^C^H3]-imidazolidin-4-one (89). 
ydrolysis with 6M at 180°C and purificafion by Dowex yielded [3-'^C^H3]-alanine (86) 
as a white crystalline solid. 
2.3.6 Feeding of [3-^C]-alanine (9Qi) to M. citrata 
The feeding of [3-'^C]-alanine (90) was a key experiment as it was essential to 
determine the regiochemistry of the incorporation of alanine into linalyl acetate. 
Processing of alanine to acetate and incorporation via the M V A pathway would result in 
the retention of all three acetate methyl protons and hence an isolated M+3 
incorporafion from [3-^H]-alanine could not be conclusively interpreted as the retention 
of all three protons of pyruvate via the mevalonate independent pathway. 
Alanine was found to be acutely toxic to M. citrata and chronically toxic to cultures of 
E. coli. When cultures of M. citrata were supplemented with alanine at 5mM, the shoots 
blackened and died within 3 days. Feeding alanine above 5mM caused death within 24 
hours. Ultimately, labelled substrates were fed at 3mM to cultures of M. citrata, which 
caused significant growth retardation and a much lower yield of linalyl acetate 
(3mg/flask compared to a typical lOmg/flask). This is partly due to the onset of necrosis 
which required that the cultures were harvested on day 17 rather than day 23. A similar 
sensitivity to nitrogen was observed by Hamill^* who observed that the use of a medium 
with a high nitrogen content diminished the yield of linalyl acetate. Incubation oiE. coli 
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with unlabelled alanine at 2mM resulted in the cessation of ubiquinone production and a 
concomitant decrease in dry cell mass (250mg/l rather than lg/1). Consequently, 
experiments with labelled alanine and E. coli were not pursued. 
Accordingly, [3-^^C]-alanine was fed to two cultures of M. citrata that were harvested 
using procedure 1 and analysed via '^C-NMR. In order to assess incorporation, the peak 
heights were measured and normalised by dividing each individual peak height by the 
height of the C-3 peak. Each peak height was corrected for natural abundance '^C by 
dividing each peak height of the labelled linalyl acetate by the peak height of the same 
signal in the '^C-NMR of an unlabelled sample of linalyl acetate. This gives 
incorporations that are reported in Table 2-4. The peaks corresponding to C-7 and C-11 
were not observed in the '^C-NMR owing to the small amount of linalyl acetate that was 
isolated (3mg/flask). 
Carbon no Level of incorporation 
1 1.10 
2 1.25 
3 1.54 
4 1.22 
5 1.50 
6 1.28 
7 n.d. 
8 2.00 
9 1.22 
10 1.90 
11 n.d. 
12 2.33 
Table 2-4 Incorporation of [3-'^C]-alanine (90) into linalyl acetate. Bold figures 
indicate significant incorporation 
Enrichment was observed into C-8, C-10 and C-12. This corresponds to processing of 
[3-'^C]-alanine (90) to pyrvuate (7) and incorporation via the mevalonate independent 
pathway as shown in Scheme 2-8. 
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Scheme 2-8 Incorporation of [3-'^C]-alanine (90) into linalyl acetate (78) 
In separate experiments, [S-^H?] and [3-'^C^H3]-alamne were fed to two cultures of M 
citrata. Both experiments showed identical growth retardation and yielded similarly low 
levels of linalyl acetate (3mg/flask). GC-MS Analysis of linalyl acetate isolated after 
feeding [3-^H3]-alanine showed enhanced M-t-1 and M+3 ions. The feeding of [3-
'^C^H3]-alanine gave enhanced M-t-2 and M+A ions. Each sample was examined ten 
times and the mean incorporations are shown in Figure 2-10. 
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Figure 2-10 GC-MS Incorporation of [3-^H3] ( • ) and [3-'^C^H3]-alamne ( • ) into 
linalyl acetate 
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The enrichment in the M+3 ion after feeding [S-'^ HaJ-alanine and incorporation into the 
M+4 ion after feeding [S-'^ C^HsJ-alanine correspond to the incorporation of ^Ha and 
'•^ C^Hs respectively. This shows that all three deuterium atoms were retained during the 
conversion of DXP to IPP by the mevalonate independent pathway. Furthermore, there 
is a significant M+1 enrichment after feeding [S-^HsJ-alanine and a corresponding M+2 
enrichment after feeding [3-'^C^H3]-alanine. In both cases, this corresponds to 
incorporation of one deuterium, which is due to the processing of [3-'^H3]-pyruvate (91) 
via the TCA cycle to succinate and incorporation of [3-^H]-pyruvate (92) as described 
in Scheme 2-9. 
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Scheme 2-9 Loss of two deuterium atoms from pyruvate after processing via the TCA 
cycle 
As all three deuterium atoms are retained and thus the mevalonate independent pathway 
does not remove the methyl protons of MEP during linalyl acetate biosynthesis. This 
limits the processes by which MEP is converted to EPP by precluding a dehydration 
involving any of the methyl protons. 
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Scheme 2-10 Incorporation of deuterium into linalyl acetate (78) from [3- HsJ-alanine 
(93) which precludes the dehydration shown 
2.3.7 Feeding of [6,6-H2]-glucose to M. citrata 
Although the terminal protons of DXP had been shown to be retained during bacterial 
terpene biosynthesis by Rohmer analogous studies in plants had not been performed. 
Thus the origin of the C-5 protons of DXP in plants were unknown and this was 
approached by feeding [6,6- H2]-glucose (94). As already demonstrated with [1 - C]-
glucose, [6,6-^H2]-glucose will be processed via glycolysis to dihydroxyacetone 
phosphate (70) and GAP (3), which are interconverted by triose phosphate isomerase. 
Accordingly, [6,6-^H2]-glucose was administered to two cultures of M. citrata to a final 
concentration of 8.4mM. Linalyl acetate was extracted using procedure 1 and analysed 
via GC-CIMS. The sample was run ten times and the mean values are shown in Figure 
2-11. 
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Figure 2-11 GC-MS Incorporation of deuterium from [6,6- H2]-glucose into linalyl 
acetate 
There is an enrichment of M+1 and M+2 ions and a small but significant incorporation 
into the M+4 ion. Significantly, the M+2 ion shows the highest level of incorporation 
(5.97%) representing retention of both deuterium atoms. Accordingly it can be deduced 
that both C-5 protons of DXP (6) are retained during plant terpene biosynthesis. 
The high level of enrichment of the M+2 ion also gave rise to a statistically significant 
enhancement of the M+4 ion. This arises from a small population of linalyl acetate 
molecules which are derived from the statistical combination of two C5 units both of 
which are labelled with two deuterium atoms (5.97% x 5.97%= 0.36%). 
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Scheme 2-11 Incorporation of deuterium from [6,6-^H2]-glucose (95) into linalyl 
acetate (78) by M. citrata 
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The retention o f both deuterium atoms shows that the conversion o f MEP to IPP via the 
mevalonate independent pathway does not proceed via dehydration involving the C-4 
protons o f MEP. 
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Figure 2-12 Disallowed transformation 
These findings were consistent wi th those reported in bacteria and Irom the feeding of 
[6,6-'^H2]-glucose to cyanobacteria^^. 
The level o f incorporation in this experiment was significantly higher than that observed 
after feeding [l-^^C]-glucose. This is presumably due to the competing operation o f the 
oxidative pentose phosphate pathway that significantly metabolises C-1 o f glucose. 
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Scheme 2-12 Loss o f C-1 o f glucose by the pentose phosphate pathway 
The oxidative pentose phosphate pathway uses glucose to generate N A D P H and ribose-
5-phosphate for nucleic acid biosynthesis and can be upregulated to supply N A D P H 
when required. Following oxidation to 6-phosphonogluconolactone (96) and 6-
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phosphonogluconate (97) the carbon derived from C-1 o f glucose is lost as CO2 and 
would account for ^^ C loss from [l-' ' 'C]-glucose. 
2.3.8 Feeding of [6,6-^HJ-glucose to E. coli 
Although the mevalonate independent pathway has recently been shown to operate in E. 
coli, it appeared appropriate to conduct an initial feeding experiment wi th a substrate for 
which the results were already known. Accordingly [6,6-^H2]-glucos© was fed to E. coli. 
to a final concentration o f 1.4 m M to E. coli and the cultures were grown under standard 
conditions for 3 days. Ubiquinone was isolated and purified according to the standard 
method. N M R Analysis o f the sample revealed incorporation o f deuterium, which 
was evident from the peaks at 1.6 and 2.0 ppm. 
Figure 2-13 H N M R Showing incorporafion o f deuterium from [6,6- H2]-glucose into 
ubiquinone-8 by E. coli 
These peaks represent incorporation o f deuterium into the methyl and methylene 
protons o f the prenyl chain after processing o f glucose to [3,3-'^H2]-GAP (98) and [3,3-
H2]-pyruvate (99) via the mevalonate independent pathway. 
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Scheme 2-13 Incorporation o f [6,6-^H2]-glucose (94) into ubiquinone (80) by E. coli 
2.3.9 Incorporation of /methyl-^HjJ-methionine into ubiquinone by E . coli 
^-Adenosyl methionine (SAM) is the source o f the methoxy methyl groups o f the 
quinone nucleus in ubiquinone. The feeding o f methionine was a valid experiment as it 
was anticipated that it would provide a another sample o f ubiquinone for ^H-NMR 
analysis. Accordingly, [we^Z-^HBl-methionine was fed to eight cultures (500ml) o f E. 
coli and the ubiquinone extracted according to the standard procedure. ^H-NMR showed 
two peaks in an approximate ratio o f 2 : 1 (Figure 2 - 1 4 ) . This represents incorporation 
into the methoxy groups and quinone methyl groups. Although the two methoxy groups 
are resolvable by ' H N M R , quadrapolar line broadening causes coalescence into a broad 
peak at 3.97 ppm. No incorporation o f deuterium into the prenyl chain was observed. 
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Figure 2-14 N M R o f ubiquinone after feeding o f [we^/ij/Z-^Hs]-methionine to coli 
This confirmed that the methoxy methyl groups are derived from methionine and, in 
turn from SAM. The experiment was encouraging as it reaffirmed that deuterium 
incorporation into ubiquinone could be readily observed by ^H-NMR. 
2.3.10 The fate ofH-3 ofDXP -feeding of labelled glycerols 
<>• 
Glycerol (100) has long been established as good surrogate for GAP (3). The conversion 
of glycerol (100) to GAP (3) via dihydroxyacetone phosphate (70) is mediated by triose 
phosphate isomerase. 
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Scheme 2-14 Conversion o f glycerol (100) to GAP (3) 
As the conversion proceeds through oxidation o f C-2, the deuterium atom at C-2 is lost 
which Umits the use o f [^H5]-glycerol as a probe to explore the fate o f the C-4 hydrogen 
o f DXP. As glycerol is prochiral, substitution o f a proton by a deuterium at C-1 or C-3 
renders the molecule chiral. This allows either the C-1 or C-3 protons to be mapped in 
2 87 
pairs, in the case o f chiral glycerols, or simultaneously, in the case o f [ HsJ-glycerol . 
2.3.10.1 Feeding of glycerol to M . citrata 
A n initial experiment was performed to test the toxicity o f glycerol to cultures o f M. 
citrata. Pulse feeding on days 4,11 and 21 to a final concentration o f 5mM was found to 
encourage growth with a concomitant 50% increase in the wet tissue mass. 
A repeat experiment was performed using [^HgJ-glycerol (101) (Sigma Aldrich 
chemicals, U K ) which was fed as described above. The cultures were grown under 
standard conditions and harvested using procedure 2. GC-CIMS Analysis o f the 
resulting linalyl acetate was performed ten times and the mean enrichment values are 
shown in Figure 2-15. 
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Figure 2-15 Incorporation o f deuterium from [^Hs]-glycerol 
Both the M + 1 and M+2 ions show significant enrichment and correspond to 
incorporation o f one and two deuterium atoms respectively. The M+2 ion shows 
mcorporation o f only two deuterium atoms into linalyl acetate and, in the absence of an 
M+3 enrichment, revealed that only two deuterium atoms from [^HsJ-glycerol (101) 
were incorporated into linalyl acetate. 
When [^HgJ-glycerol was fed at 3mM, the level o f incorporation was much lower but 
mirrored the 5 m M incorporations. The presence o f an M + 2 ion (0.45 ± 0.07%) was 
accompanied by a small M + 1 (0.15 ± 0.11%) with no observable M+3 ion (0.04 ± 
0.02%)). This confirmed that two deuterium atoms were carried through from [^Us]-
glycerol. 
2.3.10.2 Feeding of (2R)-[l,l-H2]-glycerol (Idl) and (2S)-[l,l-^H2]-glycerol to 
M . citrata 
There are two possible isotopomers o f GAP that would lead to incorporation o f two 
deuterium atoms into linalyl acetate. The incorporation o f two deuterium atoms could 
be the result o f glycerol delivering either [1,3-^H2]-GAP (104) or [3,3-^H2]-GAP (98) 
which could then be incorporated into linalyl acetate via the mevalonate independent 
pathway. 
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Scheme 2-15 Possible explanations for incorporation o f two deuterium atoms 
The difference in the two proposed isotopomers shown in Scheme 2-15 is the position 
o f the deuterium atoms. Isotopomer 104 has one deuterium derived f rom the each o f the 
pro-S and pro-R arms whereas 98 has both deuterium atoms from the pro-R arm of 
glycerol. Chiral glycerols bearing deuterium provide a convenient method of 
independently labelling each arm of glycerol and hence were identified as suitable 
substrates to determine which o f the deuterium atoms had become incorporated. 
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Scheme 2-16 The fate o f the pro R and pro S protons o f glycerol 
Accordingly, both (2R)-[l,l-^H2]-glycerol (102) and (2S)-[l,l-^H2]-glycerol (103) 
(prepared by Dr Jens Nieschalk in Durham) were fed to cultures o f M. citrata. (2R)-
[l,l-'^H2]-Glycerol (102) was fed to two cultures o f M citrata to a final concentration of 
5 m M and the linalyl acetate was extracted using procedure 2 and analysed via GC-
CIMS. The sample was analysed ten times and the mean values are shown in Figure 2-
16. 
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Figure 2-16 Incorporation o f deuterium from (2i?)-[l,l-^H2]-glycerol (102) into linalyl 
acetate 
Both M+1 and M+2 ions showed enrichment, which corresponds to the incorporation o f 
one and two deuterium atoms respectively. Significantly, the M+2 ion shows that both 
deuterium atoms were incorporated from the pro-R arm o f glycerol. 
In the complimentary experiment, (2S)-[l,l-^H2]-glycerol (103) to a final concentration 
of 5mM. The linalyl acetate was extracted by procedure 2 and was analysed via GC-
CIMS. The mean values after ten runs showed that was no observable enrichment o f 
either the M + 1 or M + 2 ion. This corresponds to the loss o f both deuterium atoms from 
the pro-S arm of glycerol. 
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Scheme 2-17 Incorporation o f deuterium from [^Hsj-glycerol (101) into linalyl acetate 
(78) by M. citrata 
This supported the result after feeding [6,6-^H2]-glucose (94) which had shown that 
both o f the protons o f C-3 o f GAP are retained during the biosynthesis o f linalyl acetate. 
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2.3.10.3 Feeding offHgJ-glycerol (101) to E . coli 
k i the same experiment in bacteria, cultures o f E. coli were supplemented with [^Hg]-
glycerol ( Ig ) and the ubiquinone was harvested according to the standard procedure. 
N M R Analysis showed peaks at 1.59 and 2.04 ppm, which corresponded to 
incorporation o f deuterium into the prenyl methyl and methylene groups as shown in 
Figure 2-17. 
ftilH X.I Omxrr^ 
Figure 2-17 N M R O f ubiquinone after feeding [^HgJ-glycerol (101) to E. coli 
Two isotopomers o f ubiquinone can reasonably be formed after feeding [^HgJ-glycerol 
(101). These correspond to the loss or retention o f the aldehydic deuterium of the 
subsequently formed GAP. Loss o f the aldehydic hydrogen o f GAP introduces 
deuterium into the methyl and terminal methylene groups o f the prenyl chain (105) 
whereas retention of the aldehydic proton introduces an additional deuterium atom 
(106) into the prenyl chain as shown in Scheme 2-18. 
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Scheme 2-18 Possible incorporation o f deuterium from [ HgJ-glycerol (101) showing 
the isotopomers o f ubiquinone resulting from either loss or retention o f 
the aldehydic hydrogen o f GAP 
The abundant isotopomer can be estimated by the integral ratios o f the methylene 
protons to the methyl protons. The relative ratios o f the methylene and methyl peak 
areas after feeding [6,6-^H2]-glucose was 2.25:1. The deviation f rom 2:1 represents 
higher incorporation from GAP than pyruvate. 
Retention o f the aldehydic proton would cause incorporation into the methylene groups 
and increase the ratio to approximately 3:1. However, loss o f the aldehydic deuterium 
would cause labelling that is identical to that observed for [6,6-^H2]-glucose (2.25:1). 
fritegration o f the peaks o f ubiquinone after feeding [^HgJ-glycerol (101) showed that 
the ratio o f methylene to methyl peak areas after feeding [^HgJ-glycerol (101) was 
1.62:1. As the ratio is significantly lower than 3:1, the incorporation suggests loss o f the 
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aldehydic proton o f GAP, just as was observed in M . citrata. The discrepancy between 
the expected ratio (2.25:1) and that which was observed (1.65:1) is perhaps due to a 
poor signal to noise ratio. 
2.3.10.4 Discussion of feeding labelled glycerol to M . citrata and E . coli 
It was anticipated that two deuterium atoms would be lost from glycerol when it was 
metabolised to GAP (3). The deuterium at C-2 is removed upon oxidation o f glycerol 
(100) to DHAP (70), and one o f the C-1 protons is removed by the acfion o f triose 
phosphate isomerase. Incorporation o f the two deuterium atoms into linalyl acetate (78) 
by M. citrata f rom (2i?)-[l,l-^H2]-glycerol (102) and the corresponding absence of 
deuterium enrichment after feeding (25)-[l,l-^H2]-glycerol (103) indicated that the 
aldehydic proton o f GAP was lost. The incorporation o f deuterium into the ubiquinone 
of coli suggested an identical enrichment corresponding to the loss o f the aldehydic 
proton o f [1,3,3-^H3]-GAP (109) 
One o f the more obvious mechanisms where the deuterium atom could be lost is 
through a reversible oxidation. GAP Is known to be converted to 1,3-
biphosphoglycerate (BPG, 110) by the acfion o f glyceraldehyde-3-phosphate 
dehydrogenase in the presence of NAD*. BPG Is biologically important as it is used in 
the manufacture o f ATP. 
OH OH 
109 111 
Scheme 2-19 Conversion o f [1,3,3-^H3]-GAP (109) to [3,3-^H2]-BPG (112) wi th loss o f 
the aldehydic deuterium atom of GAP 
NAD^ INADP^H 
9 Q, D 
As GAP and BPG are in rapid equilibrium the action o f gIyceraldehyde-3-phosphate 
dehydrogenase would resuU in the complete loss o f deuterium from C - L 
Deuterium could also be removed by DXP synthase. DXP synthase catalyses the 
formafion o f DXP from GAP (3) and pyruvate (7) and utihses TPP (113) as a co-factor. 
The mechanism o f TPP mediated aldol type condensations is well established and the 
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formation o f DXP (6) is shown in Scheme 2-20. Initially the thiazoline ring reacts with 
an electrophile to a form a Schi f f s base. In the case o f DXP synthase, the electrophile is 
pyruvate. The complex then undergoes decarboxylation to generate an "activated 
aldehyde" species. This negative charge is readily localised into the aromatic ring which 
confers stability on the acyl anion equivalent. Nucleophilic attack o f GAP produces TPP 
bound DXP (114) and classically the reaction would be expected to proceed via the 
route marked A . Removal o f a hydroxy proton by a base produces DXP and releases 
TPP. 
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Scheme 2-20 Proposed mechanism of TPP mediated synthesis o f DXP (6) 
However, once the final Sch i f f s base complex has been formed, there is another site in 
addition to the hydroxy proton that can be attacked by the base. Rather than absfracting 
the hydroxy proton, the base could remove the deuterium atom at C-3 to generate a ene-
diol (115) which could collapse to dehver DXP (6). This differs from the classical 
mechanism in that the proton (in this case a deuterium) that is removed is not the most 
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acidic proton. Given that this is a deviation from the classical mechanism, i t seems more 
plausible that the deuterium is removed by reversible oxidation to DBG. 
2.4 Tracing the fate ofH-4 of DXP 
The final proton that was amenable to biosynthetic investigation was H-4 o f DXP which 
is derived from H-2 o f GAP. Before describing experiments that were performed, it is 
pertinent to describe how the fate of H-4 differs in plants and bacteria. H-4 is implicated 
in the isomerisation and prenyl transferase reactions. Studies on the isomerase and 
prenyl transferase for mevalonate independent pathway are ongoing. 
One o f the first studies on the fate o f H-4 o f D X was performed using [4-^H]-l-D-
deoxyxylulose (116)^1 When E. coli was fed labelled [4-^H]-DX, deuterium 
incorporation into ubiquinone (80) was observed only into the terminal olefinic bond 
that corresponds to the DMAPP unit. No incorporation into the IPP derived chain was 
found by either MS or ^H NMR. 
O HO D 
/^k^^X^OH E.coli 
OH 
go 
Scheme 2-21 Ijicorporation o f deuterium into the DMAPP unit o f ubiquinone (80) 
The authors argued that this demonstrated that i f both a prenyl transferase and EPP 
isomerase operated on IPP derived f rom the mevalonate independent pathway in 
bacteria, then their relative stereochemistries must be opposite. This contrasts with the 
M V A pathway the same proton {pro-K) is abstracted by both the isomerase and prenyl 
fransferase. 
Poulter and co-workers^^ demonsfrated that the interconversion o f IPP (34) and DMAPP 
(35) results in the loss o f the pro-R proton from C-2 o f IPP (34), which is derived from 
H-4 o f DXP. Whether the proton was retained during the course o f the biosynthesis 
from DXP was not investigated as the work focused on the incubation of IPP with EPP 
isomerase from E. coli. Poulter argued that these experiments show that the E. coli 
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isomerase removes the pro-R proton and the E. coli prenyl transferase abstracts the pro-
S proton. 
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Sclieme 2- 22 Incorporation o f one deuterium (Hs) from [4-^H]-DX (116) as a result of 
a prenyl transferase and isomerase which abstract different protons o f 
IPP {E. coli) 
Analogous studies have been performed in plant systems. The work o f Arigoni^*' 
demonstrated that the relative stereochemistries o f the prenyl transferase and isomerase 
of Catharanthus roseus are the same, just as in the M V A pathway. When [2-'^C,4-^H]-
deoxyxylulose (117) was fed to Catharanthus roseus, incorporation o f '^C but not 
was observed. This inferred that either the deuterium atom was lost as a result o f 
unknown steps on the mevalonate independent pathway or was removed by both the 
prenyl transferase and the isomerase (Scheme 2-23). 
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Scheme 2-23 Absence o f deuterium incorporation (Hs) from [4 -^H] -DX (116) as a 
result o f a prenyl transferase and isomerase which absfract the same 
protons o f EPP (34) in Catharanthus roseus 
Clearly, this contrasts with the case o f incorporation of deuterium from [4-'^H] 
deoxyxylulose into E. coli. This could be rationalised by one o f two hypotheses. The E. 
coli prenyl fransferase and isomerase could stereoselectively absfract different protons 
of C-2 o f IPP whereas in Catharanthus roseus the same proton is removed by both the 
prenyl transferase and isomerase. Alternatively, the incorporations could also be 
interpreted as being the result o f a difference in the mevalonate independent pathways 
in bacteria and plants which have prenyl fransferases and isomerases with identical 
stereochemistry. More work needs to be performed before a fuller understanding is 
gained. 
2.4.1 The role of IPP isomerase in the mevalonate independent pathway 
There is a growing opinion that the results o f incorporation into E. coli represent the 
divergence o f the mevalonate independent pathway into routes that deliver IPP and 
DMAPP separately. 
Poulter and co-workers have identified the prenyl fransferase o f E. coli as having the 
same relative stereochemistry as the isomerase''. This is incompatible wi th the 
interconversion o f IPP (34) and DMAPP (35) to infroduce deuterium from [4 -^H]-DX 
(116) into the DMAPP derived chain o f ubiquinone (80) and is represented in Scheme 
2 - 2 4 . 
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Scheme 2-24 Illusfration that IPP isomerase is not significant in the mevalonate 
independent pathway in E. coli. Hs (deuterium) is found to be 
incorporated but would be removed in the isomerisation reaction 
This is a clear demonstration that DMAPP (35) is not formed as the result o f EPP 
isomerase in E. coli. Furthermore, studies by Rohmer^^ have indicated that only one IPP 
isomerase is present in E. coli and that no other enzyme caters for the interconversion o f 
IPP (34) and DMAPP (35). This eliminates the possibility that numerous isomerases 
exist wi th alternative stereochemistry which would allow the incorporation o f deuterium 
from [4-^H]-DX (116) by Scheme 2-24. Conclusive proof that IPP isomerase is not 
essential for terpenoid formation in E. coli was provided when the ipi gene encoding for 
IPP isomerase was deleted^^. Growth o f the organism demonstrated that terpene 
production was occurring, as terpenoids such as ubiquinone are essential for growth. 
Furthermore, species such as Synechocytis sp., a cyanobacterium which produces 
terpenes via the mevalonate independent pathway, are known to be deficient in IPP 
isomerase^'* and genome analysis shows no homologue for the enzyme. When an ipi 
gene from yeast was inserted into Synechocytis sp. carotenoid producfion was not found 
to be enhanced which suggests that Synechocytis has developed a method to produce 
terpenoids via the mevalonate independent pathway without the use o f EPP isomerase. 
This contrasts wi th the pathway in plants and the bacterium Zymomonas mobilis^^ in 
which it has been demonstrated that IPP isomerase is essential to terpenoid formation. 
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2.4.2 Synthesis ofDX 
In order to investigate the fate of H-4 of DXP in M. citrata, a synthetic sample of [4-
^H]-DX was prepared.. 
Enzymatic methods had been used in the Hterature to prepare samples of DXP. The 
isolation of DXP synthase allowed preparation of samples of DXP carrying '^C or ''*C 
from the appropriately labelled pyruvate or GAP. The methodogy has been used to 
prepare samples of [l- '^C] & [2,3,4,4-^^C4]^^ [1,2-'^C2] & [2,3-^^C2f and [2,4-'^C2]-
98 2 
DXP . This method is unsuitable for the preparation of [4- H]-DX as it would require 
[1-^H]-GAP which is not commercially available. Furthermore, the product of the 
reaction, DXP, is not a suitable substrate for whole cell systems as cell walls are 
impermeable to phosphate esters. 
Spenser and co-workers^^ prepared [2,3-'^C2]-DX for use in studies on the biosynthesis 
of vitamins Bi (71) and Be (72). The synthesis was completed in twelve steps with a net 
yield of 16%. The C-5 framework was built using a HWE coupling using O-
benzylacetaldehyde (118) and triethyl-[l,2-'^C2]-phosphonacetate (119). The 
stereogenic centres were established by the use of a Sharpless epoxidation which was 
followed by a Payne rearrangement. Functional group interconversions produced the 
acetonide protected tetrose (120) which was converted to a pentose by a Grignard 
reaction. Deprotection yielded [2,3-'^C2]-DX (121). Whilst the stereochemical 
configuration of C-4 remained unchanged, C-3 was originally set up as an centre. 
Hydrolysis of the gew-acetoxy sulphide results in inversion of configuration of C-3 
which then retains its stereochemical integrity through the remaining steps (Scheme 2-
25). 
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Scheme 2-25 Synthesis of [2,3-'^C2]-DX 121' 
Reagents and conditions; i) (EtO)2PO'^CH2'^C02C2H5, ii) LiAlH4, DCM iii) Sharpless 
oxidation iv) NaOH then PhSH v) (CH3)2C(OCH3)2, POCI3 vi) MCPBA vii) NaOAc, 
AC2O viii) K2CO3 ix) MeMgBr x) Swem oxidation xi) 2M HCl, MeCN xii) H2, Pd/C 
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However, this route was unsuitable for the synthesis of [4- H]-DX (116) as the label 
would need to be introduced from the first step. 
A different approach was taken by Poulter and Blagg'°° to produce both DX (122) and 
DXP (6). Rather than using synthetic protocols to build in the required stereochemistry, 
a chiral starting material was used. Using (-)-2,3-0-isopropyhdene-D-threitol (123), DX 
(122) and DXP (6) were synthesised in five and eight steps respectively in overall yields 
of 69% and 58%..The synthesis initially employed protection of the primary alcohol as 
TIPS followed by oxidation and Grignard addition to yield the C-5 alcohol. Oxidation 
by TPAP and subsequent deprotections gave DX. DXP was produced using a similar 
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strategy except that the aldehyde was masked as a 1,2 dioxolane to enable phosphate 
ester formation with trimethyl phosphite (Scheme 2-26). 
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Scheme 2-26 Synthesis of DX (122) and DXP (6 ) (Poulter and Blagg) 
Reagents; i) NaH, TIPS-Cl, 96% ii) Swem oxidation iii) MeMgBr, 88% iv) TPAP, 
NMO, 97% v) AcOH, THF, H2O, 84% vi) HO(CH2)20H, TsOH, 88% vii) TBAF, THF, 
99% viii) P(0Me)3, TeCU ix) TMSBr, H2O, HCl, 90% 
Again, this method did not allow for a facile introduction of deuterium into C-4 
although it did provide an efficient route to [1-^H3]-DX and DXP. 
A similar methodolgy was employed by Boland and Piel"" whereby the stereochemistry 
was set from the outset using diastereomerically pure 2,3-0-isopropyhdene-D-tartrate 
(124). 
In order to differentiate between the two ester groups whilst maintaining stereochemical 
integrity, the dimethyl ester of 2,3-0-isopropyhdene-D-tartrate (124) was treated with 
pig liver esterase (PLE). Reduction of the remaining ester group using "superhydride" 
allowed facile introduction of deuterium and left the acid functionality unchanged. After 
treatment with methyl lithium to afford the methyl ketone the isopropylidene group was 
hydrolysed under standard conditions. 
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Scheme 2-27 Synthesis of [5,5-^H2]-DX 125 (Boland) 
Reagents i) PLE, 25°C ii) LiBEtjD/THF, Ih iii) MeLi iv) 2M HCI/H2O/CH3CN 
Later work'*'^ revised the procedure to combine the reduction and alkylation into a one 
pot procedure which reduced the number of equivalents of methyl lithium that were 
required. Again, the introduction of deuterium onto the C-4 position by this route was 
impractical, 
The most versatile syntheses of DX were outlined by Giner^°'^ who described three 
routes to DX bearing deuterium and '^C in a variety of positions. These syntheses differ 
from the syntheses using tartrate as in the preparations described by Giner, the 
stereochemistry is built in using a diastereoselective reaction and an achiral substrate. 
The syntheses use (E)-5-benzyloxy-3-pentanone (126) as an intermediate that can be 
converted to DX (122) in two steps. Stereoselective formation of 5-benzyl-l-deoxy-D-
xylulose (127) is achieved by the use of an asymmetric Sharpless dihydroxylation. 
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Scheme 2-28 Synthesis of DX (122) from (E)-5-benzyloxy-3-pentanone (126) 
Reagents i) AD-Mix p ii) H2, Pd/C 
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Three different routes to (E)-5-benzyloxy-3-pentanone (126) have been described which 
allow great synthetic flexibility. By the first route, the C-5 skeleton was built by the 
addition of methylmagnesium bromide with (E)-4-benzyloxy-2-butenal (130). 
Subsequent oxidation of the resulting primary alcohol (131) gave the required 
pentanone. 
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Scheme 2-29 Synthesis of (E)-5-benzyloxy-2-pentanone (126) from (E)-4-benzyloxy-2-
butenal (130) 
Reagents i) MeMgBr ii) Swem oxidation 
This route enabled labelling of C-1 with either '^C, or a combination of '^C and i f 
a labelled Grignard reagent was used. 
The routes that were most convenient were the use of a Wittig coupling or 
functionalisation of 0-benzylacetylene (132) to produce (E)-5-benzyloxy-2-pentanone 
(126). The latter route enabled introduction of deuterium at either the 3 or 4 position by 
the use of either LiAlH4 or D2O. Reduction of propagyl alcohol (133) with LiAl^H4 
infroduces deuterium into the 3 position whilst the 4 position is deuterated upon the use 
of LiAlH4 and quenching the reaction with D2O. 
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Scheme 2-30 Synthesis of (E)-5-benzyloxy-2-pentanone (126) from benzylacetylene 
(133) 
Reagents i) Acetaldehyde ii) LiAlH4 i i i) Swem oxidation 
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The third route started with benzyloxyacetaldehyde (118) and delivered (E)-5-
benzyloxy-2-pentanone in one step (126). 
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103 Scheme 2-31 Synthesis of DX (122) from benzyloxyacetaldehyde (118) 
Reagents i) Ph3P=CHCOCH3 ii) Ad-Mix p iii) H2, Pd/C 
This latter route appeared the most amenable to the introduction of deuterium at C-4 as 
the use of [l-^H]-0-benzylacetaldehyde (134) would enable straightforward access to 
[4-^H]-(E)-5-benzyIoxy-2-pentanone (135) and thus [4-^H]-DX (116). 
Benzyloxyacetaldehyde (118) is unstable to decomposition and thus must be prepared 
as required. There are several reports that describe the preparation of 
benzyloxyacetaldehyde (118) of which the most attractive appeared the deprotection of 
benzyloxyacetaldehyde diethyl acetal (136)'°'' (Scheme 2-32) 
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Scheme 2-32 Synthesis of benzyloxyacetaldehyde (118) from benzyloxyacetaldehyde 
diethyl acetal (136) 
Reagents i) TFA, H2O, CHCI3 
Accordingly, benzyloxyacetaldehyde diethyl acetal (136) was treated with TFA, water 
and chloroform for 90 minutes. Work-up of the reaction after this time gave a 48% yield 
of benzyloxyacetaldehyde (118), which was purified by column chromotography. 
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Longer reaction times resulted in a lower yield corresponding to the formation of by-
products due to decomposition. 
The aldehyde was then promptly reacted with l-triphenylphosporanylidene-2-
propanone ui THF to yield (E)-5-benzyloxy-2-pentanone (126) as outlined in Scheme 2-
3l"^^. None of the (Z) isomer was observed by ' H - N M R analysis, 
hicubation of the olefin with AD-Mix p overnight at 0°C cleanly produced a product 
with a lower Rf than that of (E)-5-benzyloxy-2-pentanone (126) which, after workup, 
gave 5-benzyl-l-deoxy-D-xylulose (127) as a white semisolid'''^. In order to establish 
the stereochemical purity of 127 a chiral shift reagent was employed. Titration of the 
diol against Eu(hfc)3 showed increased line broadening and shifting of the methyl 
resonance as the concentration of Eu(hfc)3 increased. However, even at a concentration 
of 20mg ml"' of Eu(hfc)3 only one methyl resonance was observed which suggested that 
the product was enantiomerically piire. This was supported by optical rotation 
measurements. The optical rotation ( [a ]D^53 .4 , c 0.1, CDCI3) o f the (E)-5-
benzyloxy-2-pentanone (126) was found to be almost identical to the material reported 
by Giner'"^ ([a]D=52.9, c 0.1, CHCI3) which was in turn identical to the optical 
rotation from the same material derived from D-tartaric acid^^. 
Removal of the benzyl protecting group via hydrogenolysis in the presence of catalytic 
Pd/C afforded DX (122) as a colourless oil'°^. In spite of a seemingly clean reaction for 
the AD-mix reaction it was essential to purify the diol via column chromatography as a 
constituent of the crude diol mixture prevented benzyl removal. 
DX (122) was found to decompose on standing to a complex mixture of products. DX 
(122) Is known to readily cyclise to give [3-1-deoxy-D-xylulofliranose (137) which can 
then eject a hydroxyl group and dimerise to from di-p-l-deoxy-D-xylulofuranose-
2,3':3,2'-dianhydride (138 f \ 
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99 Scheme 2-33 Cyclisation of DX 
Free DX was not amenable to GC-MS analysis and in order to obtain a suitable mass 
spectrum, DX was per-acetylated. Treatment of DX with a 1:1 mix of acetic 
anhydride and pyridine produced the per-acetylated sugar with a corresponding 
molecular ion at 278. The reaction was halted by the removal of pyridine under high 
vacuum and the crude mixture was analysed by GC-MS. A GC-MS protocol was an 
essential prerequisite for this study it allowed which calculation of the level of 
deuterium enrichment for the labelled product. 
One of the easiest methods to introduce deuterium is via reduction of a carbonyl 
group with a deuterated reducing reagent. Accordingly benzyloxyacetaldehyde (118) 
was reduced with LiAl^H4 to generate [l,l-^H2]-benzyloxyethanol (139). This enabled 
deuterium to be effectively incorporated into the alcohol terminus. 
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Scheme 2-1 Synthesis of [1,1-'^H2]- benzyloxyethanol (139) 
Reagents i) TFA, H.O, CHCI3 ii) KMn04 ii i)LiAlH4 
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Treatment of [l,l-'^H2]-benzyloxyethanol (139) under Swem conditions'*'^ produced [1-
^H]-benzyloxyacetaldehyde (134) in moderate yield (64%) and with complete retention 
of deuterium (GC-MS, '^C-NMR) 
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Scheme 2-35 Swem oxidation of [1,1- H2]-benzyloxyethanol (139) 
Wittig coupling with l-triphenylphosporanylidene-2-propanone produced [4-^H]-(E)-5-
benzyloxy-2-pentanone (135) in good yield. Successfril dihydroxylation with AD-mix p 
gave [4-^H]-5-benzyl-DX (140) which had an identical optical rotation to the unlabelled 
product. Removal of the benzyl protecting group via hydrogenolysis gave [4- H]-DX 
(116). As [4-^H]-DX (116) was pulse fed over the course of the growth period, fresh [4-
^H]-DX (116) had to be prepared on the day of feeding. 
0 
OBn 
134 
BnO 
D O 
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HQ D O 
HO 
OH 
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Scheme 2-36 Summary of the synthesis of [4-^H]-DX (116) 
Reagents i) Ph3P=CHCOCH3 ii) Ad-Mix P iii) H2, Pd/C 
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2.4.3 Feeding off4-^HJ-DX (116) to M.citriit!i 
[4-^H]-DX (116) Was fed to two cultures of M. citrata at a final concentration of 7mM 
on days 4, 11 and 18, and the crude extract was collected by procedure 2. Analysis of 
the resulting linalyl acetate by NMR showed a region of intensity at 5.1 ppm. 
Figure 2-18 ^H-NMR Of linalyl acetate (78) after feeding [4-^H]-DX (116) 
The weak signal intensity at 5.1 ppm suggested incorporation into the protons at 5.14 
ppm of linalyl acetate, corresponding to incorporation into the DMAPP derived unit. No 
incorporation into H-2 at 5.88 ppm was observed. However, this enrichment could also 
be due to deuterium incorporation into another metabolite in the product mixture. 
Confirmation of incorporation of deuterium into linalyl acetate (78) was pursued by 
GC-MS analysis. The analysis was performed ten times and mean values are presented 
in Figure 2-19. 
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Figure 2-19 hicorporation of [4-^H]-DX (116) into hnalyl acetate (78) 
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GC-MS analysis suggested enrichment of the M+1 ion although the level of 
incorporation was complicated by a large standard error that accompanied the data. 
Similarly, there is a large margin of error associated with the M+2 ion. The standard 
error of the M+1 ion is caused by two of the ten runs that have relatively high M+ ions. 
This data is presented in Table 2-5. 
Run no. M M+1 M+2 
1 99.66 0.52 -0.18 
2 100.31 -0.21 -0.09 
3 99.72 0.50 -0.22 
4 100.24 -0.35 0.11 
5 99.78 0.23 0.00 
6 99.79 0.35 -0.14 
7 99.32 0.44 0.24 
8 99.65 0.19 0.17 
9 99.41 0.38 0.22 
10 99.57 0.23 0.20 
Table 2-5 Data for each individual GC-MS analysis of Hnalyl acetate (78) after feeding 
[4-^H]-DX (116). High M+ ions are shown in bold 
Although the enrichment of the M+1 ion suggests the retention of one deuterium atom, 
due to the standard deviation the retention of neither or both deuterium atoms cannot be 
dismissed on the basis of GC-MS analysis. 
2.5 Synthesis of [4,5,5,-^H3J-DX(141) 
One of the problems when assessing incorporation into the M+1 ion is to determine a 
statistical significance above natural abundance. The problem is less significant for 
M+2 and M+3 as their natural abundance values are much lower. Accordingly, more 
accurate incorporations can often be obtained from double or triple labelled precursors. 
Feeding [6,6-^H2]-glucose (94) to M. citrata had already shown that the C-5 protons of 
DXP were retained during the biosynthesis of linalyl acetate and accordingly [4,5,5-
^H3]-DX (141) became a synthetic target, ft was expedient to synthesise [4,5,5-'^H3]-DX 
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using the same strategy that was used to make [4-^H]-DX (116). Retrosynthetic analysis 
of [4,5,5-^H3]-(E)-5-benzyloxy-3-pentanone (142j offered a synthesis from commercial 
[-Hfil-ethylene glycol (143) 
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Scheme 2-37 Retrosynthesis of [4,5,5-^H3]-(E)-5-benzyloxy-3-pentanone (142) 
A survey of the literature revealed that the monobenzyl protection of ethylene glycol 
(144) had been performed previously with benzyl bromide (145) and sodium hydride'°^. 
However, when ethylene glycol was treated with one equivalent of NaH and one 
equivalent of benzyl bromide only the diprotected product (146) was isolated (Scheme 
2-38). When the reaction was monitored via TLC it was clear that the di ether was 
formed preferentially to the monoether (147). Attempts to introduce kinetic control by 
performing the reaction at 0°C and -78°C resulted in identical product profile but at a 
slower rate. 
HO. 
^OH BnO. OBn 
144 146 
Scheme 2-38 Formation of 1,2-0-dibenzyl ethylene glycol (146) 
Reagents i) NaH, BnBr 
In the event it was found that treatment of ethylene glycol with half an equivalent of 
potassium hydroxide and one equivalent of benzyl bromide (145) generated the mono 
ether (147). This was adapted from a procedure which used equivalent ratios to prepare 
3-(3-phenylprop-2-enyloxy)propanol (148) from cinnamyl bromide (149) and 1,3-
propandiol (150)"°. 
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Scheme 2-39 Use of cinnamyl bromide (149) to prepare 3-(3-phenylprop-2-
enyloxy)propanol (148, Kizil"°) 
When ethylene glycol (144) and benzyl bromide (145) were substituted in the reaction 
in a 1:1 ratio in THF, none of the benzyl ether was formed. However, when DMSO was 
used as the reaction solvent a product was formed by TLC that possessed a lower Rf 
than the dibenzyl ether (146). After 30 minutes the reaction worked up. NMR Analysis 
showed that the new spot corresponded to the mono benzyl ether (147). When the 
reaction time was increased, formation of the dibenzyl ether (146) was observed until it 
was the only product. Attempts to enforce kinetic control by cooling the reaction and 
increasing the reaction time caused the products to be formed at a reduced rate, but in 
the same ratio as for the reaction under ambient conditions. In spite of a low yield (40% 
based on the amount of benzyl bromide), these conditions were used to prepare [1,1,2,2-
^H4]-benzyloxyethanol (151) from [l,l,2,2-^H4]-ethylene glycol (143). 
R D . D D 
" ° X ^ O H ^ " ° ^ 0 B „ 
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143 151 
Scheme 2-40 Synthesis of [l,l,2,2-^H4]-benzyloxyethanol (151) from [1,1,2,2-^H4]-
ethylene glycol (143) 
Reagents i) BnBr (leq), KOH (0.5 eq), DMSO 
Treatment of [l,l,2,2-^H4]-benzyloxyethanol (151) with Swem conditions gave [1,2,2-
^H3]- benzylacetaldehyde (152). However, it was necessary to perform the oxidation 
using deuterium labelled reactants as triethylamine was found to abstract the acidic a-
protons. When the reaction was quenched by the addition of H2O, subsequent 
tauteromerisation gave rise to a distribution of [1,2-'^ H2] (153) and [1-^H2]-
benzylacetaldehyde (134) in the ratio of 1:3 ('^C-NMR). 
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Scheme 2-41 Loss of deuterium during the Swem oxidation of by the action of residual 
triethylamine 
Standard Witfig coupling yielded [4,5,5-'^H3]-(E)-5-benzyloxy-2-pentanone (142) and 
successful dihydroxylation dehvered [4,5,5-^H3]-5-benzyl-DX (154). 
Hydrogenolysis of [4,5,5-^H3]-5-benzyl-DX (154) in EtOH with Pd/C gave rise to 
significant loss (-60%, NMR) of deuterium from C-5. This was possibly due to radical 
abstraction of deuterium and quenching by nascent hydrogen or transfer of the hydroxyl 
proton from ethanol. 
O HO D O HOD 
O HOD O HO D 
OBn 
OH D OH H D 
EtOH EtO« 
Scheme 2-42 Suggested loss of deuterium by radical abstraction in Vd/C/Hz reaction 
When hydrogenolysis was performed using EtOD, formation of DX was accompanied 
with a greater retention of deuterium. GC-MS analysis of the triacetate derivative 
showed that the major isotopomer was [4,5,5-^H3]-DX (141, 67%). Lower populations 
of [4,5-^H2]-DX (155, 31%) and [4-^H]-DX (116, 2%) were also present. 
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The mixture was fed to two sets of M citrata cultures and each was worked up 
separately via procedure 2. Each sample was then analysed ten times via GC-MS and 
the mean incorporation values are shown in Figure 2-20, 
C 0.4 
5 0.2 
c-0.2 
Figure 2-20 Incorporation of deuterium into linalyl acetate after feeding [4,4,5-^H2]-DX 
(141). Separate experiments are shown by adjacent bars 
On both sets of M+1 data, the standard error is large, and thus no conclusion can be 
drawn about whether a single deuterium atom was incorporated. Similarly, the M+3 
enhancements, which would correspond to retention of all three deuterium atoms, have 
small mean values and have large associated errors. Analysis of the M+2 ions does 
however suggest incorporation of two deuterium atoms, although in both cases the 
potential enrichment is subject to a wide margin of error. From these results, no definite 
conclusion can be draw; although the M+2 ion appears to indicate incorporation of two 
deuterium atoms the standard deviation is too large to have confidence that the 
enrichment represents a bona fide incorporation into linalyl acetate. 
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2.6 Working hypothesis for the conversion ofMEP to IPP 
A revised working hypothesis was subsequently developed based on the discovery that 
the mevalonate independent pathway proceeds via the cyclo-diphosphate (76, Figure 2-
43). Removal of the tertiary hydroxyl group yields a carbocation (156) that can be 
stabilised by the formation of an epoxide (157,158) from either of the two hydroxyl 
groups. Attack by NADPH (159) yields a source of hydride that can be used to effect 
dehydrations - in this scheme, the same hydrogen is added and removed and the 
hydrogen atoms that originate from MEP are left intact. Mapping of the protons of DXP 
and MEP showed that all the protons that were present in DXP and MEP were retained 
in the final isoprenoid, but did not shed light on any processes that would introduce and 
remove the same proton. Dehydration can proceed via the hydroxyl at either C-2 or C-4 
to produce a vinylic alcohol (160, 161). Attack of hydride, which may be preceded by 
activation of the alcohol to a good leaving group, yields IPP (34) or DMAPP (35). 
This would offer a rational account for the formation of the pyrophosphate group and 
mechanisms by which IPP and DMAPP are formed independendy. Four of the putative 
intermediates were identified as synthetic targets for feeding experiments, in addition to 
ME, isopentenyl alcohol and dimethylallyl alcohol and are shown in Figure 2-6. 
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Scheme 2-43 A working hypothesis for the formation of IPP and DMAPP via the 
mevalonate independent pathway in bacteria 
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Figure 2-6 Synthetic targets 
ME (166) was chosen as a target as it is the last known intermediate that is incorporated 
on the mevalonate independent pathway and would test whether incorporation into 
linalyl acetate could be detected. 
A potentially limiting feature of this strategy was whether free alcohols can be activated 
to the phosphate level for inclusion in the biosynthesis. To determine i f a kinase was 
present that could activate the alcohols to the required phosphate level, the parent 
alcohols of IPP and DMAPP were chosen as substrates. It was anticipated that these 
would be a gauge of which substrates could be expected to be incorporated when fed as 
alcohols. 
2.6.1 Synthesis of putative intermediates 
2.6.1.1 [Ul-^HJ-DMAA (167) 
3-Methyl-but-2-ene-l-ol (dimethyl allyl alcohol, DMAA), was synthesised in a one step 
reduction from the ethyl ester of 3-methyl-but-2-ene-l-oic acid (168) using Hthium 
aluminium hydride'''. 
OEt . ^Y^>^OH 
O 
(168 165 
Scheme 2-44 i) LiAlH4, ether 
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The reaction proceeded in good yield and prompted synthesis using LiAl^H4 which 
dehvered 2g of [1,1-^H2]-DMAA (167)"l 
2.6.1.2 Synthesis of[l, 1,2-H3]-1,2 dihydroxy 4-methyl but-3-ene (\ 60) 
A synthetic scheme for the synthesis of 1,2 dihydroxy-4-methyl-but-3-ene (160) was 
devised, starting from D-mannitol (169). It was anticipated that either '^C or could be 
incorporated into the olefmic methylene group during the Wittig coupling reaction. 
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Scheme 2-45 i) Zn,acetone,3h ii) NaI04, DCM, Ih iii) MeMgBr, ether 
iv) PDC, 3A Molecular sieves, acetic acid, DCM, 12h v) Ph3P=CH2, 
THF 
Protection of D-mannitol ((169) to form the acetonide (170 ) was achieved using zinc 
and acetone"^ and was oxidised to D-glyceraldehyde acetonide (171) by sodium 
metaperiodate"". Grignard addition gave the alcohol (172) in moderate yield (58%) as a 
mix of diastereomers (3:1)"^. 
Oxidation of the secondary alcohol proved to be difficuh. A variety of oxidising 
conditions were tested (MnOz , pyridinium chlorochromate and Swem conditions) but 
these did not afford oxidation to the ketone and only gave recovery of the starting 
material. The method that was found to work most efficiently used pyridinium 
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dichromate (PDC) with catalytic acetic acid and dry molecular sieves"^. Under these 
conditions, ketone 174 was produced cleanly. 
The Wittig olefination proved unsatisfactory and gave low yields (10-15%) of 174. This 
contrasts with literature reports which describes a 30% isolated yield, albeit on an 11 
gram scale^ .^ The low yield is undoubtedly due to the product being held in the 
triphenyl phosphine oxide solid which is a byproduct of the reaction. Furthermore, the 
crude product readily decomposes on silica, and made isolation and purification very 
difficult. In light of this, an alternative strategy for 160 was employed. 
The synthesis of 160 was achieved by Dr Andy Humphrey (Durham). The carbon 
skeleton was built fi-om the Grignard addition of isopropenyl magnesium bromide to 
diethyl oxalate (175). The crude product was treated with LiAl^ILt to afford 176 
bearing three deuterium atoms. 
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Scheme 2-46 i) MeC(CH2)MgBr ii) L I A R H 4 
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2.6.1.3 Synthesis of 177 
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Scheme 2-47 i) NaB^H4 i i ) THP, H"" iii) LiAl^H4 iv) MeOH, 
Compound 177 was synthesised by Dr Andy Humphrey with five deuterium atoms 
starting fi-om diethyl 3-oxoglutarate as outlined in Scheme 2-47. 
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2.6.1.4 Synthesis of \%2 
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Scheme 2-48 i) C H C I 2 , A; ii) THP, H "^; iii) LiAl^H4; iv)H^, MeOH 
Compound 182 was synthesised by Dr Andy Humphrey in four steps from acetol. The 
carbon skeleton was built from a Wittig coupling which was protected by THP. 
Reduction by LiAl^H4 followed by deprotection gave 182. 
2.6.1.5 Synthesis of ISl 
O 
187 
Scheme 2- 49 i) LiAl^H4 
Compound 187 was prepared by Dr Andy Humphrey in a one step reduction of 3-
methyl-2(5 H)-furanone with lithium aluminium deuteride. 
2.6.1.6 Synthesis of [l,l-^H2]-isopentenyl alcohol (\88) 
[l,l-^H2]-Isopentenyl alcohol (188) was synthesised by Dr Andy Humphrey in two 
steps from allyl bromide 189. Conversion of allyl bromide to the Grignard (190) by 
refluxing with magnesium was followed by reaction with solid C O 2 . A standard 
LiAl^H4 reaction gave (188) in 45% yield. 
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2.6.2 Feeding of putative intermediates to E. coli 
The intermediates were fed at the concentrations outlined below and worked up 
following the standard protocol. 
Substrate Structure Cone 
176 
D OH 
1.3mM 
177 
OH OH 
l . l m M 
182 1.2mM 
187 D ^ y ^ ^ ^ OH 
OH 
1.4mM 
Table 2-6 Table showing the concentration of putative intermediates fed to E. coli 
In each experiment, ubiquinone was collected according to the standard procedure and 
analysed via ^H-NMR. The ^H-NMR spectrum of ubiquinone after feeding 176 , 182 
and 187 are shown in Figure 2-7. 
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Figure 2-7 NMR of ubiquinone after feeding 177,182 and 187 to E. coli 
None of the three spectra show significant signals that could be due to incorporation of 
deuterium into ubiquinone. However, NMR of the ubiquinone after feeding 176 to 
E. coli showed a sharp peak at 4.0ppm and regions of intensity at 3.7 and 1.7 ppm 
(Figure 2-8). The peak at 3.7 ppm is due to deuterium from residual ethanol used in the 
extraction process. 
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Figure 2-8 H NMR Spectrum of ubiquinone after feeding 176 to E. coli 
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Incorporation into the methoxy groups is evident from the signal at 4.1 ppm. As the 
methyl groups are derived from SAM, the incorporation of deuterium corresponds to 
labelling of SAM and hence methionine. A possible method by which deuterium could 
be incorporated into methionine is after oxidation of 177 to yield [1,1-^H2]-
formaldehyde (191). Loading of methionine (192) and incorporation into the methoxy 
groups would account for the observed peak. 
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Scheme 2-51 Suggested labelling of methionine from 177 
© NH3 
192 
The peak at 1.7 ppm could represent incorporation into the prenyl chain but also could 
be due to incorporation of deuterium into lipids that contaminated the sample. From 
these results, no conclusion about whether 177 is an intermediate can be drawn. 
2.6.3 Feeding of [4,4-^H2]-ME (\ 62) to E. coli 
[ 4 , 4 - ' H 2 ] - M E was fed to E. coli in order to determine whether the cultures developed in 
Durham could incorporate M E in a similar maimer to as those described in the 
literature. Accordingly, [4 ,4-^H2]-ME (162) was fed to E. coli to a fmal concenfration of 
1.4mM and the resultant ubiquinone was analysed via N M R . The spectrum is shown 
in Figure 2-9. 
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Figure 2-9 ^H NMR of ubiquinone (80) after incubating of [4,4-^H2]-ME (162) with E. 
coli 
A region of intensity between 1.8-2.3 ppm suggests labelling of the prenyl chain. The 
signal could correspond to deuterium being carried through and incorporated into the 
prenyl chain as shown in Scheme 2-52. 
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Scheme 2-52 Possible mode of incorporation of [4,4- H2]-ME (162) into ubiquinone 
(80) 
However, the weakness of the experiment is the low level of incorporation. The peak 
could be accounted for by contamination from small amounts (50 i^g) of highly labelled 
(40%) metabolites. Literature reports^^ describe incorporation of deuterium from 
deuterium labelled ME and show that E. coli is capable of accepting free ME as an 
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exogenously administered substrate. In these reports, significant signals in the ^H-NMR 
are reported. However, this may have been a consequence of the larger amounts of 
ubiquinone that were isolated in the literature examples (6-8mg) compared to 3mg from 
this study. 
2.6.4 Feeding of [1,1-^H2]-DMAA (167) and [1,1-H2]- isopentenyl alcohol to 
E. coli and M . citrata 
In order to establish whether latter intermediates on the pathway could be incorporated, 
[1,1-^H2]-DMAA (167; and [l,l-^H2]-isopentenyl alcohol (188) were fed to E. coli and 
M. citrata. Accordingly, [1,1-^H2]-DMAA (167) was pulse fed separately to two sets of 
M citrata cultures to final concentrations of 3mM and 5mM and the cultures were 
harvested via procedure 2 on day 17. Each sample was analysed ten times and the mean 
incorporations are shown in Figure 2-21. 
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Figure 2-21 Incorporation of [1,1-'^H2]-DMAA (167) into linalyl acetate by M citrata 
Feeding of [1,1-^H2]-DMAA (167) at 3mM showed enrichments of the M+1, M+2 and 
M+3 ions which suggested incorporation of one, two and three deuterium atoms 
respectively. This contrasts vAxh the incorporation into linalyl acetate after feeding 
DMAA at 5mM, which showed incorporation into the M+2, M+3 and M+4 ions. The 
relatively large standard errors and differences in the incorporations between each 
experiment do not provide any confidence that DMAA had been incorporated into 
linalyl acetate. Hence, the enrichments do not represent the straightforward 
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incorporation of deuterium into linalyl acetate by a prenyl fransferase/isomerase 
mechanism. The incorporations could be due to metabolism and re-introduction of 
deuterium. 
In the same experiment in bacteria, [1,1-^H2]-DMAA (167) was fed to eight cultures of 
E. coli to a fmal concenfration of l . l m M . The resultant ubiquinone was harvested 
according to the standard procedure and analysed via ^H-NMR. No signals or areas of 
intensity were observed, indicating no significant incorporation of DMAA (167) into 
ubiquinone by E. coli. 
In a parallel experiment, [l,l-^H2]-isopentenyl alcohol (188) was fed to two cultures of 
M citrata to a final concentration of 1.8 mM, and the resulting linalyl acetate analused 
by GC-MS. No enhancement of the M+1 or M+2 ions was observed. 
Likewise, cultures of E. Coli were supplemented with [l,l-'^H2]-isopentenyl alcohol 
(188). Analysis of the resultant ubiquinone by ^H-NMR did not show any signals. 
2.6.5 Analysis of results after feeding putative intermediates 
There is no evidence that the mevalonate independent pathway does not deliver IPP and 
DMAPP. Hence the lack of incorporation of [l,l-^H2]-isopentenyl alcohol (188) and 
[1,1-^H2]-DMAA (167) indicates that there is no kinase to activate exogenously 
administered alcohols to the required phosphate level. In the Ught of this, alcohols 176 , 
177, 182, 187, would not be incorporated as they lack the phosphate or pyrophosphate 
motif 
These results also suggest that E. coli is capable of activating ME to MEP in vivo. In the 
case of ME, only monophosphorylation is required to produce the relevant intermediate, 
whereas post MEP intermediates require the introduction of at least a pyrophosphate 
group. Furthermore, i f the pyrophosphate is delivered intramolecularly as depicted in 
the working hypothesis, all post MEP intermediates would be present in vivo as the 
pyrophosphate and hence the organism is less likely to recognise intermediates fed as 
the free alcohol. Although feeding of intermediates as their pyrophosphate esters seems 
like a feasible method of study, cell walls are impenetrable to phosphate and 
pyrophosphate esters. 
These findings are summarised in Figure 2-21. Dashed lines indicate that substrates fed 
as free alcohols are transported into the cell, converted to the phosphate and used. The 
bold lines indicate that all intermediates on the pathway are present as pyrophosphates. 
n o 
Hence, although intermediates may be transported into the cell, they are not recognised 
or activated as pyrophosphates. Pyrophosphates are not transported into the cell. 
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Figure 2-21 Working hypothesis of the mevalonate independent pathway and the 
activation to the pyrophosphate level 
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2.7 Conclusions 
The feeding of [l,2-'''C2]-acetate and [l-'^C]-glucose to M. citrata reveal that linalyl 
acetate is biosynthesised exclusively via the mevalonate independent pathway. The 
results of feeding [3-'^C]-alanine to M. citrata show that alanine is processed via the 
mevalonate independent pathway and the incorporation of [3-^Ha]-alanine and [3-
•^'C^HaJ-alanine show retention of all three methyl protons during the biosynthesis of 
linalyl acetate. Similarly, [6,6-'^H2]-glucose and [^HgJ-glycerol show retention of the C-5 
protons of DX. These results place limitations on the processes by which MEP can be 
converted to IPP in plants. 
The incorporation of deuterium into ubiquinone after feeding [6,6-^H2]-glucose to E. 
coli verify that ubiquinone is biosynthesised via the mevalonate independent pathway. 
Synthesis and feeding of [4-^H]-DX to M citrata suggests partial retention of deuterium 
although the level of incorporation is low and has a large variance. 
Feeding of synthetically prepared DMAA and isopentenyl alcohol bearing deuterium 
did not give any incorporation into linalyl acetate or ubiquinone. Likewise, putative 
intermediates bearing deuterium were fed to E. coli and showed no incorporation of 
deuterium into the terpenoid unit of ubiquinone. Perhaps these intermediates could not 
be activated to their pyrophosphate esters. 
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3 Studies on fungal metabolites 
This chapter describes the isolation and characterisation of a meroterpene, rosnecatone, 
from Rosellinia necatrix and studies on metabolite production as a function of growth 
conditions. The feeding of stable isotope labelled compounds and their incorporation is 
also discussed. 
The identification of a metabolite, epoxydon, from Xylaria grammicin is described and 
studies on metabolite production in X. grammicin conclude the chapter. Results of 
screening rosnecatone and epoxydon against Human cancer cell lines are described. 
3.1 Fungal metabolites 
Fungi produce a vast array of unique secondary metabolites, the distribution of which is 
very different to that in plants and bacteria. The majority of polyketides isolated have 
been obtained from fungal sources, particularly fiangi imperfecta Most ftangal 
polyketides are aromatic and are derived from one of three aromatic sources; 
acetylphloroglucinol (193), orsellinic acid (194) and 6-methylsalicylic acid (195)."^ 
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Scheme 3-1 Biosynthesis of acetylphloroglucinol (193), orsellinic acid (194) and 6-
methylsalicyhc acid (195) 
Fungal aromatics are largely polyketide rather than shikimate in origin, and hence the 
shikimate pathway is much less widely used in fimgi than in bacteria and plants. 
Nevertheless, the pathway is still used to deliver aromatic amino acids such as L-
phenylalanine (22) and L-tyrosine (23), as described in chapter 1. 
Far fewer fungal terpenes than fiingal polyketides are known and although fungal 
terpenes have a limited distribution, fimgi often represent a unique source of the few 
terpenes they produce. Monoterpenes and sesquiterpenes are rare, and collectively 
number less than forty. Those that are known demonsfrate a variety of hi and tri cyclic 
structures, which are similar to sesquiterpenes observed in plants. Likewise, diterpenes 
and sesterterpenes have similarly limited distributions, of which the gibberillins are the 
most important examples. Steroids and triterpenoids account for the majority of the 
fungal terpenoids. A l l fungal sterols possess the standard tetracyclic skeleton and are 
often found in bacteria. 
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3.2 Mixed metabolites 
In the context of this project, two of the most important classes of metaboHtes that are 
derived from more than one biosynthetic pathway are the meroterpenoids and the 
cytochalasins. 
3.2.1 Meroterpenes 
Meroterpenoids are a diverse class of secondary metabolites that exhibit a wide range of 
structures and biological activity. Over 700 such compounds have been reported"^, 
some of which demonstrate antifungal and larvicidal activities'^^, whilst others are 
inhibitors of mammalian acetylcholinesterase and protein famesyltransferase'^°. 
Originally the name "meroterpene" was coined by Comforth'^' to describe all mixed 
metabolites containing a terpene fragment. More recently Simpson's definition, that 
meroterpenes are mixed metabolites containing terpenoid and polyketide fragments'^^ 
has been gaining acceptance. 
Surprisingly few biosynthetic studies have been performed on meroterpenes. The most 
thorough study was performed by Staunton on metabolites produced by Aspergillis 
variecolor, Aspergillis ustus and Aspergillis terreus. Isotopic labelling studies showed 
that the Aspergillis meroterpenes 196 and 197 were produced by the condensation of 
orsellinic acid (194) with FPP (37). Most significantly though, incorporation of [1,2-
'^C2]-acetate (63) into the terpenoid derived imits showed that the terpene moiety was 
delivered by the M V A pathway 123,124 
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Scheme 3-2 Incorporation of [l,2-'^C2]-acetate (63) into meroterpenes produced hy A. 
utus 
More recently, incorporation of [l-^^C]-glucose showed diat the prenyl chain in 
boviquinone (198), a metabolite of Chrogomphus rutilus, was produced by the MVA 
pathway'^^. Meroterpenoid quinones fulf i l the same role as ubiquinones in bacteria and 
animals and appear to be membrane associated electron transfer agents. 
Surprisingly little is known about the extent to which the mevalonate independent 
pathway operates in fungi. Previous work'^^ in fungi feeding labelled glucose and 
acetate revealed exclusive operation of the mevalonic acid pathway in a study on 
hopanoid (199) biosynthesis. 
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Scheme 3-3 Feeding of [l-'^C]-glucose (68) to A. aleyrodis shows incorporation into 
the hopanoid (199) via the MVA pathway 
I f the hypothesis that the mevalonate independent pathway is largely localised in 
chloroplasts is correct, then as fUngi do not have chloroplasts, all fungal terpenes would 
be expected to be biosynthesised via the M V A pathway. 
3.2.2 Cytochalasins 
Cytochalasins are a class of compounds that are derived from acetate and L-
phenylalanine. They possess fused tricyclic structures comprising a fused pyrrole-
cyclohexane ring substituted with a macrocylic ring. The first cytochalasins A (200) 
and B (201) were isolated in 1966 by Tamm and Rothweiler'^^ and were shown to have 
the structures below. 
»0H / \ / .O 
200 201 
Nearly thirty cytochalasins have been isolated and characterised and have attracted 
attention because of their biological properties. The name cytochalasin is derived from 
the Greek K.VX.OC^, meaning cell, and xakacxC,, meaning relaxation and refers to the 
action of cytochalasins on mammalian cells. A l l cytochalasins inhibit cell division in 
vivo and, at high concentrations, cause ejection of the cell nucleus. In particular. 
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cytochalasin B inhibits cell movement by altering cells' shapes to that of a thin disc and 
cytochalasin E causes cells to develop bearing a "thick scalloped margin" 
By virtue of their nitrogen atom, cytochalasins are formally alkaloids, but it is most 
helpful to consider their biosynthesis in terms of a phenylalanine/polyketide pathway. 
Work by Tamm, Vederas and coworkers showed that cytochalasin B is built from 
acetate'^ ^ and p h e n y l a l a n i n e T w o pendant methyl groups are derived from 
methionine and the lactone oxygen is derived from a Bayer-Villiger oxidation . 
»0H 
J O 
0 
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Figure 3-1 The origin of cytochalasin B (201) from acetate, methionine and 
phenylalanine. 
3.3 Fungal growth techniques 
There are two techniques that are commonly employed for growing fungi in the 
laboratory. The first is to grow the mycelium on the surface of the static medium where 
the mycelium grows to cover the surface of the liquid. This method is widely employed, 
as it is straightforward and is very efficient in terms of space utihsation. However, it 
does suffer from a number of disadvantages, of which the most significant is 
inhomogeneous growth. As the mycelium spreads across the surface by sporulation, the 
mycelium mat contains patches of mature and immature mycelia. This can be used to 
advantage to ensure that the feeding of a substrate is concomitant with the appropriate 
period of growth. In a static culture, there is a significant nutrient gradient within the 
mycelium as the areas on the surface of the mat rely on nutrients being transported 
through the fungus. This results in static cultures growing much slower than submerged 
cultures. 
Submerged cultures represent an alternative method. In a submerged culture, the broth 
is inoculated with mycelium and shaken rapidly so that growth occurs within the 
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medium. As there is no nutrient gradient and there is increased aeration and greater 
dispersion of spores, submerged cultures grow at a much faster rate than static cultures. 
Subsequently, accelerated growth results in growth homogeneity. However, the 
production profile of submerged cultures may be radically different firom the same strain 
incubated as a static culture. 
3.4 Rosnecatone 
Rosnecatone was first isolated by Edwards'^' in 1997 fi-om Rosellinia necatrix The 
strain had been collected fi-om Portugal and represents one of over one hundred 
Rosellinia species that have been described to date'^ ^. The structure of rosnecatone was 
determined by X-ray crystallography and notably possesses a hemiterpene moiety 
substituted with a hydroxyl group. The central nucleus displays extensive 
fLinctionahstion and oxygenation. 
OH O 
The primary basis for selecting rosnecatone as a candidate for biosynthetic study was 
the presence of the terpene derived moiety in this metabolite. The primary aim of the 
programme was to investigate the origin of the hemiterpenoid moiety from either the 
MVA or mevalonate independent pathway. In addition, the presence of a polyketide or 
shikimate derived nucleus afforded an additional detail of biosynthetic enquiry. 
Edwards had also found that in mature cultures o^ R. necatrix, rosnecatone production 
was accompanied by the producfion of cytochalasin E (203) 
203 
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Cytochalasin E is structurally different from other cytochalasins in that it possess a 
carbamate residue. It had also been isolated previously from R. necatrix'^'' and 
Aspergillis clavatus'^^ and possesses antibiotic and cytotoxic properties that are typical 
of the other cytochalasins. Although there is no formal report on the biosynthesis of 
cytochalasin E (203), it is almost certainly related to cytochalasin B (201) in that it is 
formed from phenylalanine, methionine and a polyketide chain. In the case of 
cytochalasin E (203), the polyketide derived chain is one acetate unit smaller than 
cytochalasin B (201). The presence of two oxygen atoms in the macrocycle suggests the 
intervention of a further Bayer- Villiger oxidation during the biosynthesis. 
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Scheme 3-4 Bayer-Villiger formation of the carbamate residue of cytochalasin E (203) 
3.4.1 Growth ofR. necatrix 
Rosellinia are slow growing fungi and require six to eight weeks to achieve cell 
maturity. One of the first objectives of the project was to determine the maximal growth 
conditions for rosnecatone production as a static culture. Using malt broth supplemented 
with 6% glucose, mycelial growth ceased after six weeks. This was evident by the 
formation of dark areas on the mycelium mat. 
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Figure 3-2 Six-week-old culture of R. necatrix showing the upper side mycelial mat and 
spores 
Extraction of the broth with ethyl acetate yielded a tacky brown oil that gave 
rosnecatone as a white crystalline solid after column chromatography. During initial 
investigations, rosnecatone production ceased after one generation with a concomitant 
decrease in the mycelial mat thickness. Repeated attempts to elicit rosnecatone 
production failed as subsequent generations did not grow. Fresh cultures were grown 
from a slant that had been used previously to seed the producing cultures. Rosnecatone 
production was restored, but at very low levels (3-5mg per 300ml flask) which 
decreased vanishingly in subsequent generations. 
A new sample of R. necatrix was obtained from Edwards (Bradford) and was initially 
found to yield rosnecatone in batches of 250mg from each flask (300ml). However, 
upon repeated subculturing from flask to flask, the amount of rosnecatone dramatically 
decreased with each subculturing, in spite of apparently healthy growth. 
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Figure 3-3 Rosnecatone production (mg/flask) as a function of the number of times 
subcultured (generation) 
When the cultures were inoculated from a new slide containing R. necatrix spores, 
rosnecatone production was resumed but at much lower levels, typically no more than 
20mg of pure rosnecatone per flask (300ml). Thus, it appeared that rosnecatone 
production decreases as a function of time. 
Edwards also found that rosnecatone production was maximal at 23°C but halted at 
27°C'" . Although this is difficult to rationalise it does support experimental findings as 
cultures of R. necatrix that were grown below 27°C produced rosnecatone more 
consistently than cultures grown at 31°C. Other external factors also caused variations 
in rosnecatone production. For example, light had a significant effect, as cultures grown 
in darkness were slow to reach maturity (typically 12 weeks), had correspondingly thin 
mycelium beds and did not produce rosnecatone. 
The propensity of fungi to alter their production profile is well known. Localised 
mutations can occur in a mycelium, which although may cause no apparent physical 
differences, can cause biochemical variations. These variations can manifest themselves 
as the cessation of secondary metabolite production. Subculturing from such a mutated 
mycelium area causes subsequent generations to lack the capacity for secondary 
metabolite production. Such mutations could account for the decreasing yields of 
rosnecatone although it was beyond the scope of this project to investigate this. 
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3.4.2 Extraction and purification of rosnecatone 
Following the procedure described by Edwards, the broth of a mature culture of R. 
necatrix was extracted several times with ethyl acetate. Removal of the solvent 
generated a dark brown oil which, after purification by preparative TLC, gave 
rosnecatone as a white crystalline solid. This initial method was of limited use as prep. 
TLC is only appropriate for small amounts of material. Furthermore, it was often 
difficult to perform EtOAc extractions due to the formation of emulsions caused by 
small mycelium fragments. This problem was overcome by saturating the broth with 
sodium chloride prior to extraction. I f a large amount of debris was present then a 
filtration under gravity was performed. Column chromatography of the crude extract 
gave rosnecatone that was of higher purity ( ' H , '^C N M R ) than that obtained by prep. 
TLC and afforded separation when large amounts of crude extract were delivered. The 
recovery of rosnecatone from the cells was insignificant. 
3.4.3 Spectral assignment of rosnecatone 
The structure of rosnecatone is secure from an X-ray crystal structure solved in 
Bradford. However, the '•'C and ' H N M R spectra had not been assigned unambigously. 
In order to conduct a biosynthetic study, a secure assigrmient of the ' H and ^^ C N M R 
spectra was required. 
Figure 3-4 ' H - N M R of rosnecatone ( 202) 
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Figure 3-5 ' ^ C - N M R spectrum of rosnecatone ( 202) 
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Assignment of the proton methyl resonances was trivial as the ' H N M R shows two 
singlets and one doublet in the high field region. Integration showed that each peak 
corresponds to three protons. The doublet is derived from C-9 and revealed coupling to 
the olefinic proton of C-8. A ' H - ' H C O S Y spectrum of rosnecatone showed the proton 
resonance at C-9 gave an off diagonal peak at 19.2 ppm whilst the two singlets 
correlated with carbon resonances at 25.9 and 18.7 ppm. These were in good agreement 
with the assignment of the terminal methyl groups in linalyl acetate. 
Once C-9 and H-9 had been assigned, it was relafively straightforward to assign the 
peaks for C-7 and C-8. Off diagonal coupling between the protons of C-9 and the 
multiplet at 5.92 ppm demonstrated that the C-8 proton came at 5.92 ppm. As expected, 
H-8 gave a further off diagonal resonance that corresponded to coupling to H-7. On this 
basis, H-7 was assigned as the resonance at 6.00 ppm. ' ^ C - ' H H E T C O R Analysis 
confirmed that C-7 and C-8 resonances were those at 121.6 and 135.0 ppm respectively. 
Further examination of the H E T C O R spectrum revealed that the carbon peak at 
62.0ppm gave rise to a correlation that was directly between the two proton resonances 
at 4.40 and 4.58 ppm. This could only arise from a diastereotopic methylene group 
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i.e. C-10. This left only two pairs of peaks that were left unassigned in the proton 
spectrum; a pair of doublets at 3.79 and 4.87 ppm and another pair downfield at 5.08 
and 5.10 ppm. The major difference between the signals was that although both H-3 and 
H-4 protons that were bonded to a tertiary alcohol, H-12 was olefinic. This was apparent 
in the HETCOR spectrum whereby the proton resonance at 5.10 ppm correlated with an 
olefinic signal at 120.2 ppm. From this the H-12 resonance was assigned to 5.10 ppm 
and the H-11 resonance to 5.08 ppm. Using the HETCOR spectrum, C-11 was found 
contribute the signal at 65.4 ppm. 
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Figure 3-6 HETCOR of rosnecatone ( 202) 
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Figure 3-7 COSY of rosnecatone ( 202) 
By deduction, the remaining proton resonances were due to H-3 and H-4, which gave 
correlations in the HETCOR spectrum at 57.7 and 64.1 ppm respectively. Of the non-
protonated carbons, the carbonyl peak at 195.5 could be assigned in a straightforward 
manner to C-1. The remaining centres, C-5, C-6 and C-13, could however, not be 
assigned unambiguously without recourse to an HMQC experiment. 
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Figure 3-8 HMQC of rosnecatone ( 202) 
HMQC Analysis revealed the enhancements as shown below by correlation peaks. 
Proton number Enhanced signal 
12, 14, 15 139.3 
4,10a, 10b 147.7 
7 131.0 
Table 3-1 Results from HMQC of rosnecatone ( 202) 
r 'i" OH o / - N 
Figure 3-9 Selected HMQC coupUngs 
This data revealed that C-5 is assigned to 147.7, C-6 as 131.0 and C - 1 3 as 139.3. 
The complete assignment of rosnecatone is described below. 
Atom 5c 5H 
1 195.5 -
2 60.5 -
3 57.7 3.79 
4 64.1 4.87 
5 147.7 -
6 131.0 -
7 121.6 6.00 
8 135.0 5.92 
9 19.2 1.83 
1 0 62.1 4.40, 4 .58 
1 1 65.4 5.08 
12 120.2 5 . 1 0 
13 139.3 -
1 4 25.9 1.74 
15 18.7 1.70 
Table 3-2 ' H and '"'C resonances of rosnecatone 202) 
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5.5 Biosynthetic studies on rosnecatone (202) 
The biosynthetic origin of rosnecatone is not clear. The pendant C-5 unit is clearly of 
terpenoid origin whilst the remaining structure could be delivered from either the 
shikimate or polyketide pathways. 
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Scheme 3-5 Three putative biosynthetic origins for rosnecatone ( 202) 
Furthermore, there are two possible ways in which a polyketide skeleton could arise. 
The hydroxymethyl carbon, C-10, could derive from either a carboxylate carbon or a 
acetate methyl carbon depending on which way the polyketide chain is assembled. 
Clearly there are two pathways by which the terpenoid moiety could be generated either 
via the MVA pathway or the mevalonate independent pathway. 
The most straightforward way to determine the origin of the non terpenoid moiety was 
to feed isotopically labelled acetate to the fungus and assess the labelling pattern in 
rosnecatone. 
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3.5.1 Feeding of sodium [l,2-'^C2]-acetate 
The feeding of sodium [ 1,2-'^C2]-acetate emerged as a key experiment to delineate the 
pathway by which the terpene fragment was biosynthesised. As described in chapter 2, 
the MVA pathway delivers two intact acetate units into IPP whereas the mevalonate 
independent pathway delivers only one intact unit. Furthermore, the level of 
incorporation of acetate by the mevalonate independent pathway is usually very low as 
a consequence of processing via the TCA cycle, and hence the incorporation is often not 
observed. 
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Figure 3-10 Incorporation of [l,2-'^C2]-acetate (63) into EPP (34) via the MVA or 
mevalonate independent pathway 
The feeding of sodium [l,2-'^C2]-acetate was also anticipated to delineate a shikimate 
or polyketide origin for the remainder of the molecule. The difference between the 
shikimate and polyketide pathways is the connectivities that each would employ to 
deliver the core of rosnecatone. Polyketide assembly from acetate units will maintain 
the integrity of the all carbon-carbon bonds of the non terpene unit whereas a shikimate 
origin would result in intact incorporation into only two bonds. 
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Scheme 3-6 Predicted incorporation patterns from sodium [l,2-^^C2]-acetate (63) into 
rosnecatone ( 202) by polyketide and shikimate assembly 
Sodium [l,2-'^C2]-acetate was pulse fed in three doses to cultures of R. necatrix to a 
final concentration of 4mM, and the rosnecatone was extracted after 36 days following 
the standard protocol. '^C NMR Analysis of the resultant rosnecatone showed 
incorporation of intact carbon-carbon bonds consistent with a polyketide assembly. 
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Figure 3-11 '^C NMR resonances of the terpene unit of rosnecatone showing 'Juc-uc 
couphng. The peaks correspond to the bonds shown in bold on the 
structures 
132 
Carbon atom 4 //'/"w ^J("C-'^C)/Hz 
1 195.5 42.1 
2 60.5 42.4 
3 57.7 56.9 
4 64.1 56.9 
5 147.7 55.0 
6 131.0 54.6 
7 121.6 49.7 
8 135.0 48.6 
9 19.2 49.9 
10 62.1 49.5 
11 65.4 50.1 
12 120.2 50.1 
13 139.3 41.3 
14 25.9 41.3 
15 18.7 -
Table 3-3 'Ji3c-i3c Coupling constants from rosnecatone after '^ C data (125.7 MHz) for 
rosnecatone showing [ 1,2-'^ C2]-acetate incorporation. 
'•'C-'^C Couplings between C-11 and C-12 and between C-13 and C-14 was evident 
from the '^C NMR spectrum and indicated intact incorporation into four carbons of the 
terpenoid moiety. No coupling was observed to C-15. These enrichments are consistent 
with the incorporation of acetate into the terpene unit via MVA (9) and the MVA 
pathway. Furthermore, the 'Jl3c-I3c coupling constants of the non-terpenoid derived 
enrichments revealed contiguous incorporation of acetate as each carbon was coupled to 
one of its neighbouring carbon atoms. This pattern is consistent with a polylcetide 
origin of the non terpenoid moiety of rosnecatone. 
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Scheme 3-7 Incorporation of '•'C from [ 1,2-'^ Ca]-acetate (63) into rosnecatone ( 202) 
This biosynthetic outcome adds further support to the hypothesis that the mevalonate 
independent pathway is localised in chloroplasts as fungi do not possess chloroplasts. 
3.5.2 Determining the orientation of the acetate assembly in the polyketide chain 
The feeding of sodium [ 1,2-'^ Ca]-acetate (63) to a culture of R. necatrix indicated that 
the non-terpenoid derived nucleus of rosnecatone was polyketide derived, but the result 
does not delineate which carbon atoms were derived from C-1 and C-2 of acetate. As 
described in Scheme 3-7, there are two general ways by which a putative pentaketide 
can fold to form rosnecatone. Each carbon atom can be derived from either a methyl 
group or a carboxylate carbon depending on the orientation of the polyketide assembly. 
The classical method of determining which carbon atoms are derived from the methyl 
group of acetate is to feed acetate bearing an isotopic label at either C-1 or C-2. For this 
investigation, single label '^C was unsuitable as the levels of incorporation were very 
low. An enrichment of similar magnitude (0.3-0.4%) to that observed after feeding [1,2-
'•'Ca]-acetate would result in an undetectable increase in '^C-NMR peak height. In an 
alternative approach, sodium [2-^H3]-acetate (28) was chosen as a potential probe as 
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deuterium has a low natural abundance (0.016%) and deuterium incorporations can be 
measured by NMR. 
In the event, sodium [2-^H3]-acetate (28) was added to a culture of R. necatrix to a final 
concentration of 4mM. After 36 days the flask was worked up and the resultant 
crystaUine rosnecatone was analysed via deuterium NMR. The spectrum is shown in 
Figure 3-12. 
Figure 3-12 NMR Of rosnecatone after feeding sodium [^H3]-acetate (28) 
There is a region of intensity in the methyl group region between 1.7-1.9 ppm. The peak 
at 1.7 ppm is accompanied by a peak at l.Sppm which is approximately half the 
intensity indicating possible incorporation of deuterium into the three methyl groups at 
C-9, C-14 and C-15. The isolation of a crystalline sample of rosnecatone gave us 
confidence that the enrichment was due to deuterium that was incorporated into 
rosnecatone rather than deuterium incorporation into a contaminating metabolite, such 
as a lipid. 
Most significant is the apparent deuterium incorporation into C-9. If this is the case then 
the incorporation of acetate from a putative pentaketide can be summarised as shown in 
Scheme 3-8. 
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Scheme 3-8 Conversion of acetate (28) to rosnecatone ( 202) 
The incorporadon of deuterium from [^ HaJ-acetate into C-14 and C-15 of the terpenoid 
group is again consistent with processing of acetate via the MVA pathway. 
In view of the low incorporation of deuterium from sodium [^HaJ-acetate, another 
experiment was undertaken to reinforce this result. [6,6-^H2]-Glucose (94) is 
metabolised to acetate and delivers deuterium into the C-2 of acetate in vivo. 
Accordingly, [6,6-^H2]-glucose was pulse fed to cultures of R. necatrix to a final 
concentration of 7mM. The sample of rosnecatone that was isolated after feeding [6,6-
^H2]-glucose was crystalline, which again gave confidence that signals in the NMR 
spectrum were due to incorporation into rosnecatone. Analysis by NMR revealed a 
similar spectrum to that recorded after feeding [^HaJ-acetate. The NMR is shown in 
Figure 3-13 
5 » T F n-H5» 
Figure 3-13 NMR of rosnecatone ( 202) after feeding [6,6-^H2]-glucose (94) 
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The H NMR spectrum of the resulting rosnecatone showed signals at 1.7 and 1.8 ppm 
which again indicated incorporation of deuterium into the three methyl groups C-9, C-
14 and C-I5. No other deuterium signals were apparent. 
Clearly, the signals in the NMR after feeding [6,6-^H2]-glucose are more intense 
than those in the NMR after feeding sodium [^H3]-acetate. This is a direct 
consequence of isolating more rosnecatone (43mg) from the flask supplemented with 
[6,6-^H2]-glucose than the flask fed with [^HsJ-acetate (23mg) which gives an increased 
signal to noise ratio and provides a more accurate and reliable indication of deuterium 
incorporation. It may also represent a higher level of incorporation, however a 
quantitative assessment of this was not carried out. The incorporations after feeding 
[6,6-^H2]-glucose into the terpenoid derived unit are again consistent with the 
processing of acetate via the MVA pathway. 
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Scheme 3-9 Incorporation of deuterium from [6,6-^H2]-glucose (94) into rosnecatone 
202) 
3.5.5 Analysis of deuterium incorporation into rosnecatone 
The polyketide origin of rosnecatone has some similarity to the biosynthesis of mellein 
(204). Mellein (204) was shown to originate from acetate by Simpson and Holker'"'^ and 
it bears a structural similarity to rosnecatone. Conomon structural features are the C3 and 
Ci groups that correspond to C-7 to C-10 of rosnecatone and a central six membered 
ring. 
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The incorporation of acetate into mellein suggests that it is delivered from a putative 
pentaketide (205) which then undergoes modifications to mellein (204). 
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Scheme 3-10 Outline of the biosynthesis of mellein (204) 
Investigations with [2-^H3]-acetate revealed that a substantial loss of deuterium 
occurred. The methylene site marked * of 206 lost almost all the deuterium from 
acetate, presumably due to enolisation during the biosynthesis. This would correspond 
to the loss of deuterium from C-3 of rosnecatone, and indeed no deuterium was retained 
at that site in the experiment. Enolisation would also explain the loss of deuterium from 
C-7 in rosnecatone. The similarity between mellein and rosnecatone both in structure 
and biosynthesis allows a hypothesis to be developed in which mellein is a biosynthetic 
precursor to rosnecatone (Figure 3-11). 
An elimination of water establishes the pendant chains that form C-7 to C-10 of 
rosnecatone. Reduction of the carboxylic acid (207) followed by hydroxylation and 
oxidation would yield the polyketide nucleus (208). Epoxydation, electrophilic 
substitution of DMAPP and hydroxylation complete the transformation. 
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Scheme 3-11 Proposed biosynthesis of rosnecatone from mellein (204) 
3.6 The effect of changing from a static culture of R. necatrix to a submerged 
culture 
Static cultures of R. necatrix required six weeks to reach the stage at which they could 
be harvested for metabolite isolation. It would have been advantageous i f this time 
period could have been reduced and accordingly a method was sought which would 
facilitate faster growth. As described in section 3.3, shaken cultures generally grow 
much faster than static cultures due to improved aeration, spore dispersal and nutrient 
supply, and thus an experiment was undertaken to establish a submerged culture of R. 
necatrix. 
Both spores and mycelium were used as inoculate Erlenmeyer flasks containing either 
standard culture medium or defined medium. The defined medium contained 2% 
glucose and a trace mineral solution which had previously been developed for use with 
another submerged fungus, Beavaria bassiana, which was used in Durham'''^. No 
growth was observed for any conditions in which the defined medium was used. 
Initially the cultures grown in the standard medium were very slow to grow. After ten 
days a thin mycelium formed on the surface of the broth which, after extraction, gave 
the same metabolite profile as a stafic culture. 
However, when a sample of innoculum from this culture was used to seed flasks 
containing standard medium, growth of the submerged culture proceeded very rapidly. 
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Within three days a thick suspension of white mycehum had formed with a significant 
decolourisation of the broth. After five days the broth was highly viscous and no further 
decolourisation or growth was observed. 
Figure 3-14 Five day old submerged culture of K necatrix 
One of the key objectives was determine i f submerged cultures of R necatrix produced 
rosnecatone. The easiest way to compare the metabolite production profile was via 
TLC. Using EtOAc as the eluent and anisaldehyde stain, rosnecatone appears as a deep 
red spot with an Rf value of 0.66 and cytochalasin E (203) produces a blue spot with an 
Rf value of 0.73. 
Accordingly, samples of crude extracts of a six and twelve week old static cultures of R. 
necatrix were compared by TLC to a crude extract of a five day old submerged culture 
of R. necatrix. The crude extract of the submerged culture was prepared by extraction 
of the broth and mycelium with EtOAc to give a brown oil. TLC Showed that 
rosnecatone was not produced in the submerged culture of R. necatrix and that 
metabolite production had been channelled entirely towards cytochalasin E. which was 
confirmed by visualisation of the plate under UV prior to staining with anisaldehyde. 
Colimin chromatography of the crude extract of the subemerged cutlure gave 
cytochalasan E as a colourless oil which gave ^^ C and ' H - N M R spectra which were 
identical to those rejwrted in the literature'^^. 
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Figure 3-15 TLC of broth extracts showing cytochalasin E production from a 
submerged culture of R. necatrix (lane 2). 
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Figure 3-16 ' H N M R spectrum 
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of cytochalasin E (203) isolated from a submerged 
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Figure 3-17 " C NMR spectrum of eytoehalasin E (203) isolated from a submerged 
culture of/?. necatrix 
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Cytochalasin E generally emerges only after six week in a static culture. The production 
of cytochalasin E within five days under submerged culture conditions, suggests that the 
rapid growth rate of the submerged culture caused production of the late onset 
metabolites rather than rosnecatone, which is observed during the course of growth. 
Alternatively, the production of cytochalasin E within five days by a submerged culture 
can also be rationalised in terms of a response to the conditions and represent the 
formation of a stress metabolite. I f this is the case, then the production of cytochalasin E 
in week six from a static culture represents a sudden stress to the organism. Such a 
stress could be caused i f all the nutrients in the medium became exhausted. 
3.7 Biological testing of fungal metabolites 
One of the significant features of natural products is their biological toxicity. In view of 
the low molecular weight and high level of functionality found in rosnecatone it 
appeared appropriate to screen rosnecatone for potentially useful activity 
In collaboration with workers at the Patterson Institute for Cancer Research, 
Manchester, rosnecatone was tested against two cancer cell lines. The National Cancer 
Institute protocol was followed whereby a fixed number of cells is plated in a 96 well 
plate with a dtrafion of the compound under invesdgation. These were incubated for 5 
days and the IC50 (the concentration of compound with inhibits 50% of cell growth) was 
measured. 
In experiments with two cell lines, rosnecatone was found to display micromolar levels 
of toxicity. The IC50 against Human ovarian carcinoma cells in DMSO was 4.48 |J.M 
and that for Human chronic myelogenous leukaemia was 5.78|iM. For a compound to 
progress to further testing against lung and colon cancer, compounds generally have an 
IC50 below 1|JM. The values for rosnecatone are low and suggest that analogues may 
possess desirable chemotherapeutic properties. 
Another fungus, Xylaria grammica, provided an additional candidate for screening. A 
culture of X. grammica was obtained from Edwards (Bradford) and extraction of the 
broth of X. grammica resulted in the isolation of a metabolite, which was shown to be 
epoxydon (209). A survey of the literature revealed that the metabolite had been 
previously isolated from Penicillium uritcae™. 
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Figure 3-18 Epoxydon (209) 
3.8 Structure determination of epoxydon (209) 
'^C N M R Spectroscopy showed the new compound had seven carbon atoms of which 
one was clearly a carbonyl and two others were olefinic. These assignments were made 
on the basis of chemical shifts. The remaining four carbon signals were clustered in the 
53-63 ppm region, suggesting carbon atoms bonded to oxygen. 
The ' H N M R indicated that there were six chemically distinct protons, of which two 
were clearly coupling to each other. Other proton signals were seen as broad doublets 
with small coupling constants. The presence of an AB system suggested a methylene 
group in a chiral environment. 
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Figure 3-19 ' H N M R spectrum of epoxydon (209) isolated from X. grammicin 
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Figure 3-20 " C N M R spectrum of epoxydon (209) isolated from X. grammicin 
' H - ' H C O S Y N M R Indicated coupling of the signal at 3.40 to 3.78, 3.78 to 4.65 and 
4.65 to 6.74. This suggested three protons that were adjacent to one another. However, 
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coupling was also observed between 
methylene protons. 
the olefmic proton and the diastereotopic 
Figure 3 
.21 'H- 'H COSY speemtm of epoxydon (209) isolated from X. irammcin 
Figure 3 
-22 'H-'^C HETCOR Of epoxydon (209) isolated from X. grammicin 
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diastereomers, epoxydon (209) and ep.epxoydon (210). 
Penicillium uritcae 
In order to determine whether the metabolite was epoxydon (209) or epiepoxydon 
(210), it was necessary to determine the relative configuration at C-4. Both epoxydon 
and epiepoxydon (210) have been prepared by synthesis and thus data was available 
from a number of sources. Epiepoxydon (210) has an optical rotation that is nearly 
double that of epoxydon'"" {[ah (epiepoxydon) -1-256.4° whereas [ah (epoxydon) 
-1-106.7" ). The coupling constants between H-3and H-4 are also diagnostic. The trans 
relationship in epiepoxydon results in a coupling constant between H-3 and H-4 of 5Hz 
whereas the same coupling in epoxydon is smaller (4Hz). The optical rotation was 
found to be identical to that of epoxydon ([ah +102.2°, c 0.1, MeOH) and the coupling 
constant between H-2 and H-3 was 4Hz. 
It is concluded that the strain of X. grammicin that was used produced epoxydon (209). 
3.8.1 Growth of and extraction ofX. grammicin as a static culture 
X. grammicin was grown on standard medium to produce a mycelium bed very similar 
in appearance to that of R. necatrix. Six weeks of growth manifested a thin mat with a 
dark underside. Extraction of the mat with EtOAc yielded 20mg of epoxydon. 
3.5.2 Growth ofX. grammicin as a submerged culture 
In light of the unexpected result of transferring R. necatrix to a submerged cutlure, the 
same experiment with X. grammicin was repeated. Both mycelium and spores from 
mature cultures were used to inoculate standard medium and the cultures were shaken 
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(IVOrpm) with constant illumination. As in the analogous experiment with R. necatrix 
the first generation culture grew slowly whereas the second generation culture reached 
maturity within five days. Analysis by TLC showed that the metabolite production was 
identical to the static culture. 
3.8.3 Biological testing of epoxydon 
Epoxydon was screened at the Paterson Cancer Institute. The IC50 against Human 
ovarian carcinoma cells in DMSO was 2.54 \iM and 16.97 jxM against Human chronic 
myelogenous leukaemia. 
These figures are low and are similar to the results found for rosnecatone and suggest 
that analogues Of epoxydon may also possess desirable chemotheraputic properties. 
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3.9 Conclusions 
Static cultures of R. necatrix produce rosnecatone but production is difficult to control 
and ceases i f the incubation temperature is greater than 31°C. This could represent the 
presence of mutations in the mycelium that are incapable of rosnecatone production. 
Rosnecatone is produced by the polyketide and mevalonate pathways, and the 
orientation of the polyketide chain is such that C-10 is derived from an acetate methyl 
group. Mature cultures of R. necatrix produce the amino acid-polyketide derived 
metabolite cytochalasin E. 
Submerged cultures of R. necatrix produce cytochalasin E rather than rosnecatone and 
grow at an enhanced rate relative to static cultures. This suggests that cytochalasin E is 
produced as a stress metabolite and is a response to the exhaustion of nutrients in the 
medium. 
Biological testing of rosnecatone and epoxydon against cancer cell lines showed 
rosnecatone and epoxydon to possess significant cytostatic activity. 
Rosnecatone 
Epoxydon 
Human ovarian 
carcinoma/ICso (M-M) 
Human chronic myelogenous 
leukaemia/ICsod^M) 
4.48 
2.54 
5.78 
16.97 
• • a Pffecv of rosnecatone and epoxydon against 
Table 3-4 Bioactivity table summansmg effecy ot 
two cancer cell lines 
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Chapter 4 
Experimental 
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4 Experimental 
4.1 General 
All NMR were recorded on Varian Mercury 200MHz ('H at 199.99 MHz, '^ C at 50.30 
MHz), Varian Unity 300MHz ( ' H at 299.908 MHz, '^C at 75.45MHz), Varian VXR 
400(S) ( ' H at 399.95 MHz, '^ C at 100.58 MHz), or Varian 500MHz ( ' H at 500.137 
MHz, '^C at 125.76 MHz, ^H at 76.77 MHz). Chemical shifts are reported in parts per 
million quoted relative to the residual proton peak of CDCI3 at 7.27ppm or central '^C 
triplet peak at 77.0 ppm. Coupling constants are reported in hertz. 
Infra red spectra were recorded with absorbance values in cm"' using a Perkin Elmer 
257 between NaCl plates. 
Mass spectra of synthetic samples were performed using a VG Analytical 7070E mass 
spectrometer. Mass spectra of samples of linalyl acetate were recorded using a VG 
TRIO 1000 mass spectrometer equipped with a HP 1 Ultra column. 
The solvents used in reactions were dried, distilled and stored under nitrogen prior to 
use: diethyl ether (sodium, benzophenone), dichloromethane (calcium hydride), THF 
(sodium, benzophenone), acetone (phosphorus pentoxide), and pyridine (calcium 
hydride). Petrol refers to the 40-60°C boiling fraction of petroleum ether. HPLC grade 
heptane was used throughout. 
Reaction glassware was oven dried (120°C) prior to use and cooled under nitrogen. 
Where anhydrous conditions were required, reactions were carried out under dry 
nitrogen atmosphere. 
Thin layer chromotography was performed using Kieselgel 60 glass backed plates and 
preparative thin layer chromotography using Merck F254 glass backed plates with a 1cm 
thickness. Plates were visualised by the use of a UV lamp or by the use of 
permanganate, phosphomolybdic acid or anisaldeyde stains. 
Flash chromotography was performed using Merck, Kieselgel 60 (230-400 mesh). 
Melting points were measured on a Gallenkamp variable heater and are uncorrected. 
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4.2 
Growth and mainunance of U.citrataCU 
A solution of Murashige and Skooge medium (2.2g) and glucose (15g) or fructose 
(15g) in distilled water (500ml) was adjusted to pH 5.5 by the addition of I M NaOH. 
Transformed cultures of Af. citrata were subcultured at ^ 2g per flask (50ml of medium) 
after 20-25 days growth and grown under a 24h day at 29.1°C on an orbital shaker 
(99rpm). 
,.2J ExiracHon ofUnalyi aceUUe M. cUraU CIS (78) 
4.2.1.1 Procedure 1 
After 28 days of growth, the shooty teratoma were harvested, dried between filter 
papers and air dried for one hour to yield 1 Ig of material per flask. The dry plants were 
then blended using a Waring blender into heptane (3 x 200ml) in short bursts (Sxlmin) 
and the heptane decanted into a centrifuge bottle. The heptane was centrifuged (4''C, 
6000rpm, lOmin) and removed to produce a green oil containing linalyl acetate (Umg 
of linalyl acetate per flask). 
5H (CDCI3) 1.55 (3H, s, H-10), 1.58 (3H, s, H-8), 1.69 (3H, s, H-9), 1.75 (4H, m, H-4, 
H-5), 2.01 (3H, s, H-12), 5.10 (lH,m, H-6), 5.25 (2H, m, H-1), 5.89 ( IH , d, J 7.4, 7.6, 
H-2) 
5c (CDCI3) 17.8 (C-8), 23.9 (C-10), 22.4 (C-12), 22.6 (C-5), 25.9 (C-9), 39.9 (C-4), 
83.1 (C-3), 113.3 (C-1), I24.0(C-2), 132.0 (C-7), 142.0 (C-6), 170.1 (C-11) 
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4.2.1.2 Procedure 2 
After 28 days of growth, the shooty teratoma were harvested, dried between filter 
papers and air dried for one hour to yield 1 Ig of material per flask. After chopping into 
1 cm^ pieces, the tissues were soxhlet extracted into heptane (500ml) for 24 h. Removal 
of the solvent under reduced pressure followed by removal of residual heptane under 
high vacuum (1 min.) yielded a green oil containing linalyl acetate (6mg of linalyl 
acetate per flasks). 
Analytical data is described in 4.2.1.1. 
4.2.2 Feeding of substrates to M. citrata 
4.2.2.1 Feeding of[l-"C]-glucose (68) 
On days 7, 13 and 19, [l-'^C]-glucose (49 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two flasks of M. citrata to a final 
concentration of 8.4 mM. The cultures were worked up using procedure 1. 
^.2.2.2 Feeding of sodium [l,2-'^C2]-acetate (63) 
On days 7, 13 and 19, sodium [l,2-'^C2]-acetate (16 mg) was dissolved in water (2ml) 
and administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 5.6 mM. The cultures were worked up using procedure 1. 
4.2.2.3 Feeding of [6,6-^Hihglucose (94) 
On days 7, 13 and 19, [6,6-^H2]-glucose (49 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 8.4 mM. The cultures were worked up using procedure 1. 
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4.2.2.4 Feeding of[3-'^C]-alanine(90) 
On days 5, 11 and 17, [3-'^C]-alanine (10 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 3.2 mM. The cultures were worked up using procedure 1. 
4.2.2.5 Feeding offS-^HjJ-alanine (93) 
On days 5, 11 and 17, [3-^H3]-alanine (11 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 3.3 mM. The cultures were worked up using procedure 1. 
4.2.2.6 Feeding of [3-^^C^HsJ-alanine (86) 
On days 5, 11 and 17, [3-'''C^H3]-alanine (11 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 3.3 mM. The cultures were worked up using procedure 1. 
4.2.2.7 Feeding of [^HsJ-glycerol (101) 
On days 6, 13 and 18, [^Hg]-glycerol (17 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 5 mM. The cultures were worked up using procedure 1. 
A repeat experiment was also performed using the above procedure to feed to a final 
concentration of 8.8 mM 
^.2.2.5 Feeding ofR-[^H2]-glycerol (102; 
On days 7, 13 and 19, /?-[^H2]-glycerol (31 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentrafion of 9.7 mM. The cultures were worked up using procedure 1. 
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4.2.2.9 Feeding of S-[^H2]-glycerol (103) 
On days 7, 13 and 19, 5-[^Ha]-glycerol (28 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 9.1 mM. The cultures were worked up using procedure 1. 
4.2.2.10 Feeding of sodium [2,2,3,3-^ H4]-succinate (84) 
On days 7, 13 and 19, sodium [2,2,3,3-^H4]-succinate (38 mg) was dissolved in water 
(2ml) and administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 7.1 mM. The cultures were worked up using procedure 1. 
4.2.2.11 Feeding of[l,l-^H2]-isopentenyl alcohol(18H) 
On days 7, 13 and 19, [l,l-^H2]-isopentenyl alcohol (15.3 mg) was dissolved in water 
(2ml) and administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 5.2 mM. The cultures were worked up using procedure 1. 
4.2.2.12 Feeding of [1,1-^HzJ-dimethylallyl alcohol (167) 
On days 7, 13 and 19, [1,1-^H2]-dimethyl allyl alcohol (14 mg) was dissolved in water 
(2ml) and administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 4.8 mM. The cultures were worked up using procedure 1. 
4.2.2.13 Feeding of[4-'H]-DX (116) 
On days 7, 13 and 19, [4-^H]-DX (20 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 4.4 mM. The cultures were worked up using procedure 1. 
155 
4.2.2.14 Feeding of [4,5,5-'HsJ-DX (141) 
On days 7, 13 and 19, [4,5,5-^H3]-DX (21 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to two cultures of M. citrata to a final 
concentration of 4.7 mM. The cultures were worked up using procedure 1. 
4.3 Growth and maintenance ofE. coli 
E. coli cultures were grown in standard Luria-Bertani medium containing tryptic soy 
broth (lOg/1), yeast extract (5g/l) and NaCl (lOg/1) and the pH adjusted to pH 7.5 by the 
addiUon of 0.2M NaOH. Starter cultures were grown in lOOml conical flasks containing 
35ml of medium and production cultures were grown in 11 flasks containing 500ml of 
medium. 
Cultures were incubated at 29°C and 130rpm under constant illumination. 
4.3.1 Extraction of ubiquinone (SO) from E. coli 
O 
80 
Mature cultures of E. coli were decanted into centrifuge botties and centrifuged at 
14000rpm at 4°C for 35 min. The cells were collected (lg/1), combined and freeze-dried 
overnight and crushed to give a free flowing yellow powder. The cells were extracted 
by refluxing in a 3:1 mixture of DCM/MeOH (250ml) three times and the extracts 
combined. Removal of the solvent under reduced pressure yielded a dark yellow solid 
(up to 150mg). The solid was extracted using heptane (3 x 50ml) and the solvent 
removed to yield a tacky oil (typically 75mg). Column chromotography with EtOAc as 
the eluent gave ubiquinone-8 (80) (Rf = 0.29) as a yellow solid (4mg). 
6H (CDCI3) 1.56-1.59 (21H, br s, H-11, H-17), 1.69 (3H, s, H-21), 1.78 (3H, s, H-22), 
1.98-2.07 (28H, m, H-12, H-13, H-16, H-18), 3.20 (2H, d, J 7, H-8), 3.98 (3H, s, H-23), 
3.99 (3H, s, H-24), 4.95 ( IH, t, J 7, H-9), 5.05 (7H, s, H-14, H-19). 
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4.3.2 Feeding of labelled substrates to E . coli 
4.3.2.1 Feeding of [6,6-^H2]-glucose (94) to E . coli 
[6,6-'^H2]-Glucose (500 mg) was dissolved in water (2ml) and administered through a 
sterile filter unit to eight production cultures (500ml) f E. coli to a concentration of 
0.7mM. The cultures were worked up using the standard procedure. 
4.3.2.2 Feeding of [methyl-^ HsJ-methionine (192) to E . coli 
[me/Zify-^Hs]-Methionine (200mg) was dissolved in water (2ml) and administered 
through a sterile filter unit to eight production cultures (500ml) of E. coli to a 
concentration of 0.3 mM. The cultures were worked up using the standard procedure. 
4.3.2.3 Feeding offHsJ-glycerol (101) to E . coli 
['HsJ-Glycerol (766 mg) was dissolved in water (2ml) and administered through a 
sterile filter unit to eight production cultures (500ml) of E. coli to a concentration of 1.9 
mM. The cultures were worked up using the standard procedure. 
4.3.2.4 Feeding of [hl-^Hil-ME (211) to E . coli 
[1,1-^H2]-ME (640 mg) was dissolved in water (2ml) and administered through a sterile 
filter unit to eight production cultures (500ml) of E. coli to a concentration of 1.2 mM. 
The cultures were worked up using the standard procedure. 
4.3.2.5 Feeding of [l,l-^H2]-isopentenyl alcohol (34; to E . coli 
[l,l-^H2]-Isopentenyl alcohol (880 mg) was dissolved in water (2ml) and administered 
through a sterile filter unit to eight production cultures (500ml) of E. coli to a 
concentration of 2.5mM. The cultures were worked up using the standard procedure. 
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4.3.2.6 Feeding of [IJ-^Hil-dimethyallyl alcohol (167) to E . coli 
[l,l-^H2]-Dimethylallyl alcohol (800 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to eight production cultures (500ml) of E. coli 
to a concentrafion of 2.3mM. The cultures were worked up using the standard 
procedure. 
4.3.2.7 Feeding of [l,l,2-^H3]-3-methyl-but-3-ene-l,2-diol (176 to E . coli 
[l,l,2-^H3]-3-Methyl-but-3-ene-l,2-diol (430 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to eight production cultures (500ml) of E. coli 
to a concentration of l . l m M . The cultures were worked up using the standard 
procedure. 
4.3.2.8 Feeding of [4,4-^H2]-erythritol (111) to E . coli 
[4,4-^H2]-Erythritol (820 mg) was dissolved in water (2ml) and administered through a 
sterile filter unit to eight production cultures (500ml) of E. coli to a concentration of 1.7 
mM. The cultures were worked up using the standard procedure. 
4.3.2.9 Feeding of[I,l-^H2]-(E)-2-methyl-but-2-ene-l,4-diol (182) to E . coli 
[l,l-^H2]-(E)-2-methyl-but-2-ene-l,4-diol (980 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to eight production cultures (500ml) of E. coli 
to a concentration of 2.4 mM. The cultures were worked up using the standard 
procedure. 
4.3.2.10 Feeding of [4,4-^H2]-(Z)-2-methyl-but-2-ene-l,4-diol (187) to E . coli 
[4,4-^H2]-(Z)-2-methyl-but-2-ene-l,4-diol (600 mg) was dissolved in water (2ml) and 
administered through a sterile filter unit to eight production cultures of E. coli to a 
concentration of 1.5 mM. The cultures were worked up using the standard procedure. 
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4.4 Growth o/Rosellinia sp. and Xylaria grammicin 
4.4.1 Preparation of standard fungal broth 
A solution of glucose (18g) and Oxoid malt broth (9g) in distilled water (300ml) and 
the solution autoclaved at 110°C for one hour in the appropriate flask. After 
autoclaving, the bottles were allowed to cool to ambient temperature in a laminar flow 
hood. 
4.4.2 Growth of static cultures 
Mycelia (3 pieces, 6cm^ total area) from established cultures or from slants was used to 
inoculate P bottles or 20/20 bottles (Bottoms Up, Durham) containing standard fungal 
broth (300ml). Cultures were grown at an angle of 10° under constant illumination 
between 24-27°C and harvested after eight weeks. 
4.4.3 Growth of submerged cultures 
For the first generation of submerged cultures, 250ml conical flasks were charged with 
standard fungal broth (75ml), inoculated with mycelium (4 x 3cm^) from static cultures 
and grown at 29°C, 170 rpm under constant illuminafion. After 10 days growth a 
produce a thin mycellial suspension was used which was used to innoculate (5ml) 
250ml conical flasks containing standard fungal broth (75ml). Subsequent generations 
were inoculated flask to flask with 10% innoculum. 
4.4.4 Isolation of rosnecatone ( 202) from static cultures ofR. necatrix 
Culture supernatant of mature cultures of Rosellinia sp was decanted from the bottle and 
filtered under gravity. The supernatant was then saturated with sodium chloride and 
extracted with EtOAc (3 x 300ml). Removal of the solvent under reduced pressure 
afforded a dark brown tacky oil (typically 200mg) which was purified by column 
chromotography (silica, EtOAc) to yield rosnecatone ( 202) (up to 20mg) as a white 
crystalline solid (Rf = 0.66). 
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OH O 
M/z (EI) 280 (12.6%, [M]""), 263 (5.7%, [M-H2O]*) 
5H (CDCI3) 1.70 (3H, s. H-15), 1.74 (3H, s, H-14), 1.83 (3H. d, 6.4, H-9), 3.80 ( IH, 
d, 5.2, H-3), 4.40 ( I H , d, ' j 14.8, H-10), 4.58 ( IH, d, ' j 14.8, H-10), 4.87 ( IH, d, 
5.2, H-4), 5.08 ( IH, d, 8.8, H-11), 5.10 ( IH, d, ^J, 8.4, H-12), 5.92 ( IH, dq, J 6.4, 
15.6, H-8), 6.00 ( IH , d, 15.6, H-7) 
6c(CDCl3) 18.7 (C-15), 19.2 (C-9), 25.9 (C-14), 57.7 (C-3), 60.5 (C-2), 62.1 (C-10), 
64.1 (C-4), 65.4 (C-11), 120.2 (C-12), 121.6 (C-7), 131.3 (C-6), 135. (C-8), 139.3 (C-
13), 147.7 (C-5), 195.5 (C-1). 
4.4.5 Isolation of cytochalasan E (203j from submerged cultures o/R. necatrix 
A mycelium suspension of submerged cultures of R. necatrix was removed after 5 days 
growth by centrifugation (6000rpm, 4°C, 10 min) to produce a mycelium pellet and a 
yellow supernatant. Extraction of the supernatant with EtOAc (3x 100ml) followed by 
removal of the solvent yielded a pale brown oil (50mg). Column chromotography 
(silica, EtOAc) yielded cytochalasan E (203) as a colourless oil (6mg, Rf =0.77). 
O 7^ 16 
m/z (EI) 495 (5.5%, [M]^) 
5H(CDC13)1.12 ( 3 H , d, J 7.2, H - 2 0 ) , 1.15 ( 3 H , d, J 7.3, H - 2 2 ) , 1.24 ( 3 H , H - 2 1 ) , 1.42 
( 3 H , s, H - 2 3 ) , 2 . 1 4 ( I H , m, H - 1 2 ) , 2.26 ( I H , m , H - 5 ) , 2.63 ( 3 H , m , H - 7 , H-8, H-12 ) , 
2 .70 ( I H , d, J 12.3, H - 2 5 ) , 2 .90 ( I H , d, J 12.3, H - 2 5 ) , 2.95 ( I H , m , H - 1 3 ) , 3.03 ( I H , 
dd, J 3, 5, H - 4 ) , 3.76 ( I H , m, H - 3 ) , 5.22 ( I H , ddd, J 5,5 8, H - 1 1 ) , 5.59 ( I H , d, J 11 , H -
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16), 5.89 ( IH , dd, J 8, 15, H-10), 6.43 ( IH , d, J 11, H-17), 7.15 (2H, d, Ar), 7.29 ( IH, t, 
Ar), 7.36 (2H, t, Ar) 
5c 13.2 (C-20), 19.7 (C-21), 20.1 (C-22), 24.3 (C-23), 35.8 (C-5), 39.1 (C-12), 40.8 (C-
13), 45.2 (C-8), 45.9 (C-25), 48.3 (C-8), 53.6 (C-3), 60.6 (C-7), 87.1 (C-9), 120.3 (C-
16), 127.2 (Ar), 128.4 (C-10), 128.9 (Ar), 129.7 (Ar), 131.4 (C-11), 135.9 (Ar), 142.1 
(C-17), 149.3 (C-19), 170.2 (C-1), 211.9 (C-14) 
4.4.6 Isolation of epoxydon (209) from static cultures ofX. grammicin. 
Culture supernatant of mature cultures of X. grammici. was decanted from the bottle and 
filtered under gravity. The supernatant was then saturated with sodium chloride and 
extracted into EtOAc (3 x 300ml). Removal of the solvent under reduced pressure 
afforded a dark brown tacky oil (typically 120mg) which was purified by silica column 
chromotography to yield epoxydon (209) (up to 20mg) as a white semisolid (Rf = 0.38). 
M/z (£1)156(1.7%, [M]*) 
[tto] +102.2° (c 0.1, MeOH) lit: +106.7° (c 0.1, MeOH)'^^ 
5H (CDCI3) 3.40 ( I H , d, J 3.6, H-6), 3.76 ( IH, br s, H-5), 4.25 (2H, dd, C-7, J 4.2, 1.4, 
H-7), 4.67 ( IH, d, J 4.2, H-4), 6.61 ( IH, br s, H-3) 
5c (CDCI3) 53.4 (C-6), 57.7 (C-5), 60.5 (C-7), 63.0 (C-4), 136.4 (C-2), 138.9 (C-3), 
194.1 (C-1) 
161 
4.4.7 Feeding of labelled compounds to R. necatrix 
4.4.7.1 Feeding of sodium [l,2-^^C2]-acetate (82) 
On days 7, 13 and 19, sodium [l,2-'^C2]-acetate (100 mg) was dissolved in water (2ml) 
and administered through a sterile filter unit to cultures of R. necatrix to a final 
concentrafion of 4.1 mM. The cultures were worked up using according to the standard 
protocol. 
4.4.7.2 Feeding of[6,6-^H2]-glucose (94) 
On days 7, 13 and 19, sodium [6,6-^H2]-glucose (Ig) was dissolved in water (2ml) and 
administered through a sterile filter unit to a culture of R. necatrix to a final 
concentration of 19 mM. The cultures were worked up using according to the standard 
protocol. 
4.4.7.3 Feeding of sodium [2-^H3]-acetate (28) 
On days 7, 13 and 19, sodium [2-^H3]-acetate (100 mg) was dissolved in water (2ml) 
and administered through a sterile filter unit to a culture of R. necatrix to a final 
concentrafion of 4.1 mM. The cultures were worked up using according to the standard 
protocol. 
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4.5 Synthesis 
4.5.1 Synthesis of dimethylallyl alcohol (165)^^' 
O 
OH ^OH 
(168 165 
Acrylic acid (168) (5.0g, 50niM) in ether (25ml) was added to a stirred solution of 
LiAlH4 (5.4g, 160mM) in ether (30ml) at 0°C over 1.5h via a dropping funnel. The 
reaction was quenched by the careful addition of iced water (5ml), followed by NaOH 
(15%, 4nil) and water (3ml). The slurry was filtered through silicon impregnated filter 
papers (Whatman) and the solvent removed to give a colourless oil. Distillation afforded 
dimethyl allyl alcohol (165) (3.35g, 78%). 
Bpt 140-143° (lit 141-142°)"' 
M/z(El) 86 (M+, 28.0%), 71 (M-CH3, 100%), 69 (M-OH, 16.7%) 
5H (CDCI3) 1.64 (3H, s, CH3), 1.70 (3H, s, CH3), 4.76 (2H, d, 'j=6.9, CH=CH20H), 
5.36 ( IH, m, CH=CH20H) 
5c (CDCI3) 17.7 (CH3), 25.6 (CH3), 59.1 (CH2OH), 123.6 (CH=CH(CH3)2). 136.0 
(CH=CH(CH3)2) 
4.5.2 Synthesis of [l,l-^H2]-dimethyl allyl alcohol (161 f'^ 
O 
OH 
165 167 
Acrylic acid (165) (5g, 50mM) in ether (25ml) was added to a stirred solution of LiAlD4 
(6.4g, 160mM) in ether (30ml) at 0°C over 1.5h via a dropping funnel. The reacfion was 
quenched by the careful addition of iced water (5ml), followed by NaOH (15%, 4ml) 
and water (3ml). The slurry was filtered through silicon impregnated filter papers 
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(Whatman) and the solvent removed to give a colourless o i l . Distillation afforded 
dimethyl allyl alcohol 167 as a colourless oil (2.75g, 64%) 
Bpt 142-MS*^ (lit 142-143"^) 
M/z(ET) 88 (M+, 30.4%), 73 (M-CH3, 100%), 71 (M-OH, 20.1%) 
5H (CDCI3) 1.65 (3H, s, CH3), 1.71 (3H, s, CH3), 5.36 ( I H , br, CH=CD20H) 
5c (CDCI3) 17.8 (CH3), 25.7 (CH3), 58.5 (pentet, ^JC-D 21.4 Hz, CD2OH), 123.4 
(CH=CH(CH3)2), 136.3 (CH=CH(CH3)2) 
4.5.3 Benzoyl-2-(t-butyl)-3,5-dimethylimidazolidin-4-one (SS) 
^ / 9H3 CH3 
87 88 
Benzoyl-2-(t-butyl)-3-methyIimidazolidin-4-one (0.5g, 1.91mM) was added to a 
solution of L D A (2.1 I m M ) generated f rom diisopropylamine (0.2lg, 0.29ml, 2.11mM) 
and n-butyllithium (1.32ml, 1.6M in hexanes) at -78°C, and the reaction stirred at 
-78°C for I h to produce a deep red solution. M e l (0.13ml, 1.91mM) was added 
dropwise and stirred at - 78°C for 45min, allowed to warm to room temperature and 
stirred for a further 16h. The reaction was quenched by the addition o f half saturated 
ammonium chloride (20ml) and the layers separated. The aqueous layer was extracted 
with ether (3x25ml) and the organic layers combined, dried (MgS04) and the solvent 
removed to afford a pale yellow powder. Column chromotography (silica, 
ether:petrol:methanol 60:35:5) afforded 88 (374mg, 71%) as a white amorphous solid. 
mp: found 145-146°C (lit : 145.6-146.2°*'*) 
Vn,ax2960, 2888, 1707, 1634 
5H(CDC13) 0.98 (3H, d, J=6.5, C H 3 ) , 1.09 (9H, s, -t-Bu), 3.11 (3H, s, N C H 3 ) , 4.30 ( I H , 
q, J=6.5, CH), 5.65 ( I H , s, CH), 7.55 (5H, m, Ar ) 
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5 c ( C D C l 3 ) 20.57 ( C H 3 ) , 27.43 ( € ( ^ 3 ) 3 ) , 33.02 ( £ ( ^ 3 ) 3 ) , 41.88 ( N C H 3 ) , 58.59 (Ar, 
C-5), 80.50 (Ar, C-2), 129.1 (Ar, C-3), 129.9 (Ar, C-4), 132.8 (Ar, C-5), 137.6 (Ar, C-
2), 173.4 (Ar ,C- l ) 
4.5.4 L-Alanine (9Qi)^'* 
CH3 
Bz -fcH 3 
e 
y 
© 
87 90 
Benzoyi-2-(NbutyI)-3,5-dimethylimidazolidin-4-one (87) (300mg, l.OSmM) was heated 
in a sealed tube with 6 M HCl (4inl) and heated at ISO^C for 15 hours. The solution was 
removed f rom the tube by washing with dichloromethane (20ml) and water (20nil) and 
the solvents removed to produce a brown solid. Purification over Dowex gave 90 as a 
white solid (235mg, 78% yield). 
M p 289-290 °C (decomp) [lit.,^^ 289-290 °C (decomp)] 
5H(D20) 1.37 (3H, d, J 8.0, CH3), 3.60 ( I H , q, J 8.0, C H ) 
5c (D2O) 18.6 (C-3), 53.8 (C-2), 178.7 (C-1) 
.84 4.5.5 Benzoyl-2-(t-butyl}-3-methyl-5-[^^(fH3]-methyUmidazolidin-4-onem 
CH3 Q|_j 
87 89 
Benzoyl-2-(t-butyl)-3-methylimidazoIidin-4-one (0.5g, 1.91mM) was added to a 
solution o f L D A ( 2 . l l m M ) generated f rom diisopropylamine (0.21g, 0.29ml, 2 . l l m M ) 
and n-butyllithium (1.32ml, 1.6M in hexanes) at -78°C, and the reaction stirred at for Ih 
to produce a deep red solution. ['^C^HsJ-Mel (0.13ml, 1.91mM) was added dropwise 
and stirred at -78°C for 45min, allowed to warm to room temperature and stirred for a 
further 16h. The reaction was quenched by the addition of half saturated ammonium 
chloride (20ml) and the layers separated. The aqueous layer was extracted with ether 
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(3x25ml) and the organic layers combined, dried (MgS04) and the solvent removed to 
afford a pale yellow powder. Column chromotography (silica, ether:petrol:methanol 
60:35:5) afforded pure 89 (374mg, 71%) 
mp 145.5-146.7°C (lit.,^'' 145.6-146.2°) 
Vmax2960, 2888, 1707, 1634 
5H(CDC13) 0.98 (3H, d, J 6.5, C H 3 ) , 1.09 (9H, s, -t^Bu), 3.11 (3H, s, N C H 3 ) , 4.30 ( I H , 
br s, J 6.5, CH), 5.65 ( I H , s, CH), 7.55 (5H, m, Ar ) 
5 c ( C D C l 3 ) 20.6 (septet, JI3C.2H 19.9, C^Hj), 27.4 ( € ( ^ 3 ) 3 ) , 33.0 (CiCHsh), 41.9 
( N C H 3 ) , 58.6 (d, J i3ci3c 34.8, C-5), 80.50 ( C - 2 ) , 129.1 (Ar, C - 3 ) , 129.9 (Ar, C-4), 
132.8 (Ar, C-5), 137.6 (Ar, C-2), 171.3 (C-4'), 173.4 (C-1), 
4.5.6 [S-^^CfHjJ-L-Alanine (86) 84 
^ / 9^3 0 
M.^ H 3 N H 
87 86 
Benzoyl-2-(r-butyl)-3,5-dimethylimidazoIidin-4-one 87 (300mg, 1.08mM) was heated 
in a sealed tube with 6 M HCl (4nil) and heated at 180°C for 15 hours. The solution was 
removed f rom the tube by washing with dichloromethane (20ml) and water (20ml) and 
the solvents removed to produce a brown solid. Purification over Dowex gave 86 as a 
white solid (229mg, 7 1 % yield). 
M p 290-292 °C (decomp) [lit.,^^ 289-290 "C (decomp)] 
M / z ( C I ) 9 4 ( 1 0 0 % , [ M - f l D 
5H(D2O )3 .60 (1H , br, CH) 
6c (D2O) 18.4 (septet, J13C-2H 19.4, C-3), 53.4 (d, J,3c-i3C 34.9. C-2), 178.6 (C-1) 
166 
4.5.6.1 D-Mannitol acetonide(170 113 
HO-
HO-
HO-
H-
H-
H-
-H 
-H 
-H 
-OH 
-OH 
-OH 
(169 
HO-
H-
H-
H-
-H 
-H 
-H 
-OH 
-O X 
170 
D-Mannitol (169 (20g, 110 mM) was added to a stirred solution of anhydrous zinc 
chloride (30g, 220 mM) in dry acetone (100ml) and the mixture stirred for 4h. Filtration 
to remove unreacted D-mannitol was performed and the filtrate dropped into a bi phasic 
solution containing potassium carbonate (34g) in water (50ml) and ether (150ml) and 
the mixture stirred for one hour. A slurry was precipitated upon concentration and then 
extracted into dichloromethane (3 x75nil). The extracts were combined, filtered and 
dried (MgS04) and the solvent removed to produce 170 as a white powder (11.4g, 
39%). 
Vn,ax/cm"' 3324, 3376, 2978, 2933, 2890, 1456, 1371, 1258, 1206, 1158, 1125, 1063, 
1005,941.4,855.7,650.1 
5H (D2O) 1.38 (6H, d, J 0.92, CH3), 1.41 (6H, d, J 0.92, C H j ) , 2.81 (2H, dd, J 1.28, 6.74, 
CHOH), 3.74 (2H, td, J 1.52, 6.50, CH(0)CH20), 3.980 (4H, m, CH(0)CH20). 
5c(D20) 25.2 (CH3), 26.7 (CH3), 66.7 (CH(0)CH20), 71.1 (CHOH), 76.1 
(CH(0)CH20), 109.3 (C(CH3)2) 
4.5.6.2 D-Glyceraldehyde acetonide (171) 114 
xt 
HO-
H-
H-
H -
-H 
-H 
-H 
-OH 
170 
H 
171 
NaI04 (8.10g, 37 mM) was added to a solution of 170 (5g, 19mM) in dichioromethane 
(50ml) and water (2ml) with vigorous sfirring. The reaction was monitored via TLC 
(silica, 85:15 DCM:acetone) and found to be complete after Ih . Dry MgS04 (2g) was 
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added and the reaction stirred for a further 15min and then filtered to produce a clear, 
colourless solution. The solvent was removed by distillation through a 6" Vigreux 
column and the residue distilled to produce 170 as a clear, colourless oil (3.13g, 63%) 
m/z (EU) 130 ( M ^ 28.09 %) 
bp 40-42 ° C ( 1 0 t o r r ) 
Vmax/cm'' 2985, 1732, 1456, 1370, 1257, 1211, 1152, 1063, 844.4 
5h (CDCI3) 1.37 (6H, s, CH3), 1.45 (3H, s, CH3), 4.01 (2H, m, CH2), 4.17 ( I H , dd, J 
1.53, 6.45,CH), 9.68 ( lH,s , CHO) 
5c (CDCI3) 25.3 (CH3), 26.4 (CH3), 65.8 (CH2), 80.0 (CH), 111.5 (C(CH3)2), 198.4 
(CHO) 
[a]^'D=+63.2° (c=0.03, EtOH) 
4.5.6.3 l-(2,2 Dimethyl-[l,3]-dioxolan-4-yl)-ethanol (172) 
O OH 
111 172 
Aldehyde 171 (3.13g, 24mM) was added to a 3 M solution of methylmagnesium 
bromide in ether (10.7 ml , 32mM) at 0°C under nitrogen and the reaction mixture stirred 
at 0°C for Ih . After warming to room temperature stirring was continued for 3h during 
which time the reaction was monitored by TLC (silica, 2:1 DCM:acetone) and IR. The 
reaction was quenched by pouring into iced water (25ml) and the layers separated. The 
aqueous phase was extracted with diethyl ether (3x75ml) and the organic fractions 
combined, dried (MgS04) and the solvent removed to produce a clear colourless oi l . 
Distillation afforded 172 (1.58g, 48%) 
m/z(Et) 146 (M*4.52%) 
bp 60 -63°C(10 to r r ) 
Vmax/cm"' 3439, 2977, 2886, 1456, 1369, 1252, 1211, 1152, 1053, 903, 849, 794, 726, 
645 
5h (CDCI3) 1.13 (3H, d, J 6.4, CH3), 1.17(3H, d, J 6.3, CH3). 1.38 (3H, s, 
C(CH3)(CH3)), 1.43 (3H, s, C(CH3)(CH3)), 3.50-4.30 (2H, m, CHOH) 
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5c (CDCI3) 18.5 (CH3CHOH), 25.3 (CH3CHOH)', 25.5 (C(CH3)(CH3)), 26.6 
(C(CH3)(CH3))', 26.7 (C(CH3)(CH3)), 26.8 (C(CH3)(CH3))', 67.0 (CH2), 68.9 (CH3)', 
79.6 (CH), 80.5 (CH), 109.2 (C(CH3)(CH3)), 109.6 (C(CH3)(CH3))' 
4.5.6.4 l-(2,2 Dimethyl-[1,3] dioxolan-4-yl)-ethanone( 174) 
OH 
172 174 
To a solution of 172 (1.58g, 10.7mM) in dry dichloromethane (100ml) was added 
pyridinium dichromate (6.60g, 17.6 mM), 3A activated molecular sieves (8g) and dry 
acefic acid (300|j1) and the reaction stirred under nitrogen for 48h. Hyf lo (2g) was 
added, the mixture sfirred for a further 20 mins and filtered through a MgS04 (2g) plug. 
After removal o f the solvent the dark residue was extracted into diethyl ether (3x75ml) 
which after solvent removal afforded a pale yellow oi l . Purification was performed 
using column chromotography (silica, 9:1 petrol:acetone) to produce 174 as a clear, 
colourless oil (791mg, 50%). 
Vn,ax2360, 1714, 1379, 1211, 1066, 907.8,727.1,645.6. 
m/z ( E f ) 144 ( M ^ 5.6%) 
5H 1.32 (3H, s, CH3), 1.42 (3H, s, CH3), 2.19 (3H, s, CH3CO), 3.94 ( lH,dd , J 5.6, 8.6, 
CH), ( I H , t, J 7.8, CH), 4.34 ( I H , dd, J 5.4, 7.6, CH) 
5c (CDCI3) 25.1 (CH3), 26.7 (CH3), 28.4 (CH3), 65.8 (CH2), 80.0 (CH), 111.5 
(C(CH3)2), 198.4 (CHO) 
[a]\=+l0l.2° (c=0.029, CDCI3) 
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4.5.7 Synthesis of benzyoxyacetaldehyde (118) from benzyloxyacetaldehyde diethyl 
acetal (136)^"^ 
OEt H 
136 118 
Benzyloxyacetaldehyde diethyl acetal (2.95g, 13.2mM) was stirred with TFA (5ml), 
water (5nil) and CHCI3 (5ml) at ambient temperature for Ih . The mixture was extracted 
with CHCI3 (3 X 100ml), dried over MgS04 and the solvent removed under reduced 
pressure to afford a colourless o i l . Column chromatography (silica, 5:1 EtOAc:Petrol) 
yielded benzyoxyacetaldehyde f l l 8 j as a viscous oi l (0.92g, 46%). 
M/z (EI) 150 (5.8%, [M]^) , 107 (86.2 %, [M-CH2CH0]^) 
5H (CDCI3) 3.94 (2H, s, CH2CHO), 4.45 (2H, s, OCHzPh), 7.21 (5H, m, Ar) , 9.52 ( I H , 
s, CHO) 
6c(CDCl3) 73.3 (CH2CHO), 75.5 (0CH2Ph), 128.1 (Ar), 128.5 (Ar), 128.7 (Ar), 137.2 
(Ar), 200.4 (CHO) 
4.5.8 Synthesis of benzyloxyacetaldehyde (118) from 0-benzyloxyethanol (147) 
H O ^ O B n ^ ° V ^ O B n 
H 
118 147 
Oxalyl chloride (320|il, 466mg, 3.7mM) was dissolved in CHCI3 (10ml) and cooled to 
-78°C. To the solution was added a solution of DMSO (440|iL, 484mg, 6.2mM) in dry 
CHCI3 and the mixture stirred at -78°C for 15 min after which 0-benzyloxyethanol 
(480mg, 3.0mM) was dissolved in CHCI3 (10ml) and added dropwise. Stirring was 
maintained at -78°C for 20 min. Et3N (2.00nil, 1.45g, 14.4mM) was added and the 
reaction stirred at -78°C for 30 min. and allowed to warm to RT overnight. The mixture 
was quenched with water (50ml) and the organic layer separated. The aqueous layer was 
extracted with CHCI3 and the organic extracts were combined and dried over MgS04. 
Removal of the solvent yielded a yellow oil which was purified by column 
chromatography (silica, 1:1 EtOAc:Petrol) to give benzyloxyacetaldehyde (118) as a 
colourless oi l . Analytical data was identical to that described in 4.5.7. 
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4.5.9 Synthesis of benzyloxyethanol (Ul) 
144 147 
To a suspension of K O H (796mg, 16mM) in DMSO (4ml) and benzyl bromide 
(0.90niL, 1.36g, 8mM) was added ethylene glycol 144 ( I g , 16mM). The mixture was 
stirred for 0.5h, poured into water (25ml) and extracted into D C M (3x 100ml). The 
aqueous phase was acidified with HCl and extracted into D C M (3x50ml). The organic 
phases were combined, washed with water (3x 100ml) and dried over MgS04. Removal 
of the solvent afforded a pale yellow oi l . Column chromatography (silica, 1:1 
EtOAc:Petrol) gave benzyloxyethanol 147 as a colourless oi l (644mg, 53%). 
IR (neat) 3345, 3028, 2946, 1640, 1486, 1447, 742 
5H 3.54 (2H, t, J=5.1 Hz, CH2OH), 3.70 (2H, t, J=5.1 Hz, CHzOBn), 4.53 (2H,s, 
OCHzPh) 7.34 (5H, m, Ar) 
6c 61.8 (CH2OH), 71.8 (CHaOBn), 73.4 (0CH2Ph), 128.0 (Ar) , 128.1 (Ar), 128.7 (Ar) , 
138.3 (Ar) 
4.5.10 (E)-5-Benzyloxy-3-penten-2-one (126)^"^ 
° Y ^ O B n .OBn 
H - - - - -
147 126 
To a suspension of l-triphenylphosphoranylidene-2-propanone (3.20g, lO.OmM) in 
T H F (20ml) was added benzyloxyacetaldehyde (147) (750mg, 5.0mM) and the mixture 
refluxed for 20h. The solvent was removed under reduced pressure to give a white tarry 
solid which was extracted into ether (4x 150ml). The solution was filtered through a 
silica plug to remove triphenylphosphine oxide and the solvent was removed to afford a 
brown oi l . Column chromotography (silica, PE.EtOAc 5:1) gave (E)-5-benzyloxy-3-
penten-2-one (126) as a colourless oil (817 mg ,86%) 
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M/z (EI) 190 (13%, [M]^) , 147 (7.28%, [M-COCHs]^ ) 
IR (f i lm) 3049, 2865, 1683, 1116, 742 
5H (CDCI3) 2.24 (3H, s, CH3), 4.20 (2H, d, J=4.6 Hz, CHjOBn) , 4.55 (2H, s, OCH2Ph), 
6.30 ( I H , d, CH=CHCH2), 6. 80 ( I H , dt, J=2.1, 4.6Hz, CH=CHCH2) 
6c (CDCI3) 27.4 (CH3), 70.0 (CHiOBn), 73.3 (OCHzPh), 127.7 (Ar), 127.9 (Ar), 128.8 
(Ar), 130.4 (CH=CHCH2), 137.7 (Ar), 143.3 (CH=CHCH2). 193.2 (COCH3) 
4.5.11 5-Benzyl-l-deoxy-D-xylulose (121^^ 
OBn 
OH 
126 127 
(E)-5-Benzyloxy-3-penten-2-one (126) (500mg, 2.42mM) was added to a solufion 
containing Ad M i x P (5.92g), Na2C03 (1.06g, 12.5mM), methanesulphonamide 
(402mg, 4.32mM) in 'BuOH/water (30ml/30ml) and the mixture stirred overnight at 
O^C. EtOAc (50 ml) was added and the reaction was quenched by the addiUon of NaS03 
(8g) and allowed to warm to room temperature. The aqueous layer was separated and 
extracted with EtOAc (3x300ml). The organic fractions were combined, washed with 
water (30ml) and dried over MgS04. Removal of the solvent afforded a colourless oil 
which was purified over silica (3:1 EtOAc:Petrol) to give 5-benzyl-l-deoxy-D-xylulose 
(127) as a colourless semisolid (417mg ,77%) 
M/z (CI) 242 ([M-^NH4]^ 88%), 224 ( [ M ] \ 12.6%) 
5H (CDCI3) 2.19 (3H, s, CH3), 3.57 (2H, m, CHzOBn), 4.14 (2H, m, CH(OH)-CH(OH)), 
4.53 (2H, s, OCHzPh), 7.31 (Ar) 
6c (CDCI3) 25.8 (CH3), 70.6 (CH(0H)CH20Bn), 71.5 (CH(OH)CH20Bn), 73.9 
(0CH2Ph), 77.3 (CH(0H)CH20Bn), 127.3 (Ar) , 127.9 (Ar), 128.3 (Ar) , 137.8 (Ar), 
208.6 (COCH3) 
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4.5.12 1-Deoxy-D-xylulose (122^^^ 
OH 
127 
10% Pd/C (Degaussa type, 50% water by weight) was added to a solution of 5-benzyl-
1-deoxy-D-xylulose (127) (35mg, 0.16mM) in 95% EtOH (10ml) The flask was filled 
with hydrogen three times and then evacuated, and the mixture was stirred for 3 hours. 
The catalyst was removed by filtration through Hyf lo and the solvent removed under 
reduced pressure to afford D X (122) (18mg, 86%) as a colourless oil . 
5H(CDC13) 2.31 (3H, s, CH3), 3.80 (2H, br, CH2OH), 4.25-4.56 (2H, m, 
COCH(OH),CH(OH)COMe) 
4.5.13 Analytical determination ofDX (122) as DX-triacetate 
'oh ""^^ 
Acetic anhydride (2ml) was added to a solution of D X (5mg) in pyridine (2ml) and the 
reaction was stirred until the formation o f product was evident by T L C (EtOAc, Rf 
(triacetate) = 0.73). The reaction was quenched by the addition of water (400|j,I) and the 
solvents removed under high vacuum for 3h. The crude mixture was applied neat to the 
GC colunm. 
M/z (CI) 276 (100%, [M+NH4]^) 
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4.5.14 Synthesis of [l-^H]-benzyloxyacetaldehyde (134)^ 
HO. 
X ^ O B n " ^ Y ^ O B n 
D D i 
139 134 
DMSO (472|J,L, 519mg, 6.65mM) In dry CHCI3 (5ml) was added to a solution of oxalyl 
chloride (343)LI1, 500mg, 3.97mM) in CHCI3 (5ml) at -78°C and the mixture stirred at 
-78°C for 15 min. A solution of [l,l-^H2]-benzyloxyethanol (139) (515mg, 3.21mM) in 
CHCI3 (10ml) was added dropwise to the reaction and stirring was maintained at -78°C 
for 20 min. EtsN (2.14ml, 1.56g, 15.4mM) was added and the reaction stirred at - 78°C 
for 30 min. and allowed to warm to RT for 12h. The reaction was quenched by the 
addition o f water (50ml) and the organic layer was separated. The aqueous layer was 
extracted into CHCI3 and the combined organic extracts were dried over MgS04. 
Removal of the solvent gave a yellow oi l which was purified over silica (1:1 
EtOAc:Petrol) to give [l-^H]-benzyloxyacetaldehyde (134) as a colourless oil (309mg, 
63%). 
M/z (EI) 151 (3.7%, [M]*) , 106 (75.2%, [M-CH2CDO]*) 
6H(CDC13) 4.07 (2H, t, JH-D 0.48, CH20Bn), 4.53 (2H, s, OCHzPh), 7.32 (5H, m, Ar) 
5c(CDCl3) 73.7 (0CH2Ph), 73.4 (CH20Bn), 127.3 (Ar) , 127.9 (Ar) , 128.3 (Ar), 137.8 
(Ar) , 200.1 (CHO, t, 'JC-D 27HZ). 
4.5.15 [3-^H]-(E)-5-Benzyloxy-3-penten-2-one (135/"^ 
O D 
OBn OBn 
D 
134 135 
To a suspension of l-triphenylphosphoranylidene-2-propanone (1.44g, 4.49mM) in 
THE (20ml) was added [l-^H]-benzyloxyacetaldehyde 134 (337mg, 2.25mM) and the 
reaction heated under reflux for 23h. The solvent was removed under reduced pressure 
to give a white tarry solid which was extracted into ether (4x200ml). The solution was 
filtered through a silica plug to remove triphenylphosphine oxide and the solvent 
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removed to afford a brown oi l . Purification over silica (PE:EtOAc 5:1) gave [3-^H]-(E)-
5-benzyloxy-3-penten-2-one ( 1 3 5 ) as a colourless oil (292mg, 68%). 
M/z (EI) 191(18%, [M]*) , 148 (9.3%, [M-COCH3]* ) 
IR ( f i lm) 3027, 2868, 1685, 1102, 738 
5H(CDC13) 2.09 (3H, s, CH3), 4.01 (2H, br, CH20Bn), 4,40 (2H, s, CH2Ph), 6.10 ( I H , 
br, CH=COMe), 7.20 (5H, Ar) 
5c(CDCl3) 27.2 (CH3), 68.8 (OCHsPh), 72.9 (CHiOBn), 127.7 (Ar), 127.9 (Ar), 128.4 
(Ar) , 130.2 (Ar) , 137.9 (CH=COMe), 143.1 (t, JC-D 23.4, CH=CD), 199.0 (COCH3) 
4.5.16 [3-^H]-5-benzyl-l-deoxy-D-xylulose (140)^"^ 
O D O D p H 
,OBn ^Ji^^J^^OBn 
HO 
1 3 5 ( 1 4 0 ) 
[3-^H]-(E)-5-Benzyloxy-3-penten-2-one ( 1 3 5 ) (280mg, 1.39mM) was added to a 
solution containing A d M i x |3 (3.3Ig), Na2C03 (0.59g, 7mM), methanesulphonamide 
(225mg, 2.37mM) in 'BuOH/water (20ml/20ml) and the mixture stirred overnight at 
0°C. EtOAc (50 ml) was added and the reaction was quenched by the addition of NaS03 
(5g) and allowed to warm to room temperature. The aqueous layer was separated and 
extracted into EtOAc (3x300ml). The organic fractions were combined, washed with 
water (30ml) and dried over MgS04. Removal of the solvent afforded a colourless oil 
which was purified via column chromatography (silica, 3:1 EtOAc:Petrol) to give [3-
^H]-5-benzyl-l-deoxy-D-xylulose (140) as a colourless semisolid (238mg,76%) 
M/z ( C I ) 243 ([M-t-NH4]^ 94%), 225 (M+, 18.2%) 
5H(CDC13) 2.27 (3H, s, CH3), 3.62 (2H, s, CH2Ph), 4.25 ( I H , br, CH(OH)C(OH )D) , 
4.47 (2H, br, CH20Bn), 7.20 (5H, Ar) 
5c(CDCl3) 25.6 (CH3), 70.5 (t, JC-D 31-5, CH(OH)C(OH )D) , 71.0 (OCH2Ph), 73.6 
(CH20Bn), 77.5 (CH(OH)C(OH )D) , 127.8 (Ar) , 128.0 (Ar), 128.3 (Ar) , 138.4 (Ar), 
208.1 (COCH3) 
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4.5.17 [4-^H]-l-Deoxy-D-xylulose (lUy 
0 D P H 9 D P H 
5H 
(140) 116 
[3-^H]-5-Benzyl-l-deoxy-D-xylulose (140) (46mg, 0.20mM) was dissolved in 95% 
EtOH (10ml) was 10% Pd/C (Degaussa type, 50% water by weight,lOmg ) added. The 
flask was flushed with hydrogen and then evaporated three times and the mixture was 
stirred under H2 for 3 hours. The catalyst was removed by filtration through Hyf lo and 
the solvent removed under reduced pressure to afford [4-^H]-DX (116) as a colourless 
oil (24mg, 89%) 
5H (CDC13) 2.25 (3H, s, CH3), 3.85 (2H, br, CH2OH), 4.25 ( I H , br, CH{OH)COMe) 
4.5.18 [4-^H]-DX-triacetate 
OAc 
OH 
[4-^H]-DX (116) (3mg) was stirred in pyridine (2ml) and acetic anhydride (2ml) until 
formation of product was evident by TLC (EtOAc, Rf (triacetate) = 0.77). The reaction 
was quenched by the addition of water (300fll) and the solvents removed under high 
vacuum for 3h. The crude mixture was applied neat to the GC column. 
M/z (CI) 279 (100%, [M+NH4]^), 160 (18.6%, [M-hNH4]*-2 x CO2CH3) 
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4.5.19 Synthesis of [1,1,2,2-^H4]-benzyloxyethanol (ISiy 
D D D D 
143 151 
[^He]-Ethylene glycol (143) (2g, 29mM) was added to a suspension of K O H (1.64g, 
29mM and benzyl bromide (1.69ml, 2.56g, 15mM) in DMSO (6m]) and the mixture 
was stirred for 0.5h. The mixture was poured into water (40ml) and extracted with D C M 
(3x 100ml). The aqueous phase was acidified with HCl and extracted with D C M 
(3x50ml). The organic phases were combined, washed with water (3xl00ml) and dried 
over MgS04. Removal of the solvent afforded an oil which was purified by column 
chromatography (silica, 1:1 EtOAc:Petrol) to give [l,l,2,2-'^H4]-benzyloxyethanol (151) 
as a colourless oil ( l .O lg , 43%). 
m (neat) 3343, 3020, 2941, 1645, 1472, 1438, 740 
Mz 156(72%, [M-^]) 
5H(CDC13) 4.43 (2H, S, OCHiPh) 7.26 (5H, m, Ar) 
6c(CDCl3) 64.6 (pentet, JC-D 22.5HZ, CD2OH), 74.6 (pentet, JC-D 23.2HZ, CD20Bn) 76.9 
(OCHzPh), 127.9 (Ar) , 128.3 (Ar), 128.5 (Ar), 138.6 (Ar), 
4.5.20 Synthesis of [1,2,2-^HjJ-benzyloxyacetaldehyde (152) 
D D D D 
^ ° X ^ O B n — ° Y ^ O B n 
D D D 
151 152 
[^H^l-DMSO (434)iL, 564mg, 6.12mM) In dry CDCI3 (5ml) was added to a solution of 
oxalyl chloride (315|il , 460mg, 3.64mM) in CDCI3 (5ml) at -78''C and the mixture 
stirred at -78°C for 15 min. 151 (474mg, 2.95mM) in CDCI3 (10ml) and added 
dropwise. Stirring was maintained at - 78°C for 20 min. Et3N (1.97ml, 1.44g, 14.2mM) 
was then added and the reaction stirred at -78°C for 30 min. and allowed to warm to RT 
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overnight. The mixture was quenched with water (50ml) and the organic layer 
separated. The aqueous layer was extracted with CHCI3 and the organic extracts 
combined and dried over MgS04. Removal of the solvent yielded a yellow oil which 
was purified by column chromatography (silica, 1:1 EtOAc:Petrol) to give [1,2,2-^H3]-
benzyloxyacetaldehyde (152) as a colourless oil which was stable to decomposition for 
2 d a y s a t O ° c . (321mg ,71%) 
M/z (EI) 153 (2.3%, [M]*) , 106 (86.1%, [M-CDzCDO]^) 
5H(CDC13) 4.56 (2H, s, 0CH2Ph) 7.30 (5H, m, Ar) 
8c(CDCl3) 73.8 (OCHjPh), 72.0 (t, 'JC-D 23, CD20Bn), 127.8 (Ar), 128.0 (Ar), 128.3 
(Ar) , 138.4 (Ar) , 200.1 (CHO, t, 'JC-D 27). 
4.5.21 [4,5,5-^H3]-(E)-5-Benzyloxy-3-penten-2-one (U2) 
Oc .>C„„ Q p 
OBn 
D 
OBn 
D' D 
152 142 
To a suspension o f l-triphenylphosphoranylidene-2-propanone (1.24g, 3.89mM) in 
THE (20ml) was added [l,3,3-^H3]-benzyloxyacetaldehyde (152) (292mg, 1.94mM) and 
the mixture refluxed for 23h. The solvent was removed under reduced pressure to give a 
white tarry solid which was extracted with ether (4x200ml). The solution was filtered 
through a silica plug to remove triphenylphosphine oxide and the solvent removed to 
afford a brown oi l . Column chromotography (silica, PE:EtOAc 5:1) gave [4,5,5-'^H3]-
(E)-5-benzyloxy-3-penten-2-one (142) as a colourless oil (303mg, 81%) 
M/z (EI) 193 (11%, [M]^ ) , 150 (4.4%, [M-COCH3]* ) 
IR ( f i lm) 3027, 2868, 1685, 1100, 738 
5H(CDC13) 2.26 (3H, s, CH3), 4.45 (2H, s, CHaPh), 7.34 (5H, Ar) 
8c(CDCl3) 25.6 (CH3), 70.5 (pentet, JC-D 22.6, CD20Bn), 71.0 (0CH2Ph), 137.9 
(CH=C0Me) , 143.1 (t, JC-D 23.4, C H = C D ) , 127.8 (Ar), 128.0 (Ar), 128.3 (Ar), 138.4 
(Ar) , 199.6 (COCH3) 
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4.5.22 [4,5,5-^H3]-5-Benzyl-l-deoxy-D-xylulose (154) 
HO D D 
Q D O D pH 
. O B n ^ ^jK^JK^OBn 
142 
[4,5,5-^H3]-(E)-5-Benzyloxy-3-penten-2-one 142 (200mg, 0.99 m M ) was added to a 
solution containing A d M i x P (2.36g), Na2C03 (420mg, 5.0 mM), 
methanesulphonamide (161mg, 1.69mM) in 'BuOH/water (17ml/17ml) and the mixture 
stirred overnight at 0°C. EtOAc (50 ml) was added and the reaction was quenched by 
the addition of NaS03 (5g) and allowed to warm to room temperature. The aqueous 
layer was separated and extracted with EtOAc (3x300ml). The organic fractions were 
combined, washed with water (30ml) and dried over MgS04 . Removal of the solvent 
afforded a colourless oi l which was purified via column chromatography (3:1 
EtOAc:Petrol) to give [4,5,5-^H3]-5-benzyl-l-deoxy-D-xylulose (154) as a colourless 
semisolid (127mg, 55%). 
M/z (CI) 245 ( [M+NH4]^ 96%), 227 (M+, 12.5%) 
5H(CDC13) 2.17 (3H, s, CH3), 4.15 ( I H , br, CH(OH)C(OH)D), 4.74 (2H, s, CH2Ph), 
7.26 (5H, Ar) 
5c(CDCl3) 25.6 (CH3), 70.5 (t, JC-D 31.5, CH(OH)C(OH)D), 71.0 (OCHaPh), 73.6 
(pentet, JC-D 22.5, CDjOBn), 77.5 (CH(OH)C(OH)D), 127.8 (Ar) , 128.0 (Ar), 128.3 
(Ar) , 138.4 (Ar) , 208.1 (COCH3) 
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4.5.23 [4,5,5-^HjJ-l-deoxy-D-xylulose (Ul) 107 
.OBn 
O H D D 
O D P H 
OH n D 
[4,5,5-^H3]-5-Benzyl-l-deoxy-D-xylulose ( 1 5 4 ) (40mg, 0.30mM) was dissolved in 95% 
EtOH (lOml) was 10% Pd/C (Degaussa type, 50% water by weight, ) added. The flask 
was flushed with hydrogen and evacuated three times and the mixture was stirred under 
H2 for 3 hours. The catalyst was removed by filtration through Hyf lo and the solvent 
removed under reduced pressure to afford [4,5,5-^H3]-DX ( 1 4 1 ) as a colourless o i l (36 
mg,91%) 
5H(CDC13) 2.25 (3H, s, CH3), 4.25 ( I H , br, CH(OH)COMe) 
4.5.24 [4,5,5-^HjJ-DX-triacetate 
O D P H ?\ 
D D ^ 
OH 
[ 4 , 5 , 5 - ' H 3 ] - D X ( 1 4 1 ) (2mg) was stirred in pyridine (2ml) and acetic anhydride (2ml) 
overnight until a the reaction showed the formation of product by TLC (EtOAc, Rf 
(triacetate) = 0.72). The reaction was quenched by the addition of water (200|J.l) and the 
solvents removed under high vacuum for 2h. The crude mixture was applied neat to the 
GC column. 
M/z (CI) 281 (100%, [M+NH4]^), 162 (19.2%, [M+NH4]^-2 x CO2CH3) 
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